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Abstract 
Introduction: Free tissue transfer using an abdominal tissue flap is a commonly used 
method of breast reconstruction. However, there are well recognised complications 
including venous congestion, fat necrosis and flap loss associated with the perfusion of 
these flaps. Post-operative aesthetic outcome assessment of such breast reconstructions 
have also proven to be difficult with current methods displaying poor inter-rater reliability 
and patient correlation. The aim of this research was to investigate potential improvements 
to the post-operative outcome of free abdominal tissue transfer breast reconstruction by 
assessing the effects of vascular augmentation interventions on flap perfusion and to assess 
the use of real-time digital video as a post-operative assessment tool.  
Methods: An in-vivo pilot study carried out on 12 patients undergoing DIEP flap breast 
reconstruction assessed the effect on Zone IV perfusion, using LDI and ICG angiography, 
of vascular augmentation of the flap using the contralateral SIEA and SIEV. A further 
animal experimental study was carried out on 12 Sprague Dawley rats to assess the effects 
on main pedicle arterial blood flow and on Zone I and Zone IV perfusion of vascular 
augmentation of the abdominal flap using the contralateral vascular system. A separate 
post-operative assessment study was undertaken on 35 breast reconstruction patients who 
evaluated their own reconstructions via patient questionnaire and underwent photograph 
and real-time digital video capture of their reconstructions with subsequent panel 
assessment. 
Results: Our results showed that combined vascular augmentation of DIEP flaps, using 
both the SIEA and SIEV together, led to an increase in Zone IV perfusion. Vascular 
augmentation of the rat abdominal flaps also led to a significant increase in Zone I/IV 
perfusion, but the augmentation procedure resulted in a decreased main pedicle arterial 
blood flow. Our post-operative assessment study revealed that real-time digital video 
footage led to greater inter-rater agreement with regards to cosmesis and shape than 
photography and also correlated more with patient self-assessment.  
Conclusion: Vascular augmentation of abdominal free tissue flaps using the contralateral 
vascular system results in an increase to Zone IV perfusion, however this may lead to 
decreased main pedicle arterial blood flow. Real-time digital video is a valid post-operative 
aesthetic assessment method of breast reconstruction outcome and is superior to static 
photography when coupled with panel assessment.  
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Chapter 1: Introduction 
1.1 Microvascular surgery and Free Tissue Transfer 
The term “microvascular surgery”  (microsurgery) was first devised in 1960 by Jules 
Jacobson when he published his laboratory based results of using the aid of an operative 
microscope and the techniques familiar to him as a vascular surgeon to anastomose small 
blood vessels with diameters less than 4mm
1
. Prior to his experimental work, the operating 
microscope was only routinely used by surgeons in the field of otolaryngology and 
neurosurgery to aid in middle ear and temporal bone surgery. 
The potential use of such techniques became apparent to surgeons worldwide and the field 
of microvascular research grew. A few years later in 1963, Kleinert and Kasdan published 
their success in re-vascularising a partially amputated finger using microvascular surgical 
techniques
2
 and later in 1965 Komatsu and Tamai successfully replanted a completely 
amputated thumb, publishing their results in 1968
3
. During the same time period, Dr Harry 
Buncke began undertaking his own animal based research into microvascular surgery and 
the potential applications. He went on to perform the first successful ear re-implantation in 
a rabbit, using vessels as small as 1mm in 1964
4
 and later the first toe to hand 
transplantation in a monkey in 1966
5
. His research and pioneering advances continued and 
in 1969, in collaboration with Captain Donald McLean, he went on to perform the first 
successful microvascular transplant in a human, transferring omentum to reconstruct a 
scalp defect; albeit not publishing the results until 1972
6
. Later in 1973 Taylor and Daniel, 
using a modification of the groin flap, described by McGregor the previous year
7
; raised it 
as a completely free variant, transplanting it through microsurgery to the leg of a trauma 
victim. They published their findings naming this type of composite tissue transfer a “free 
flap”; a term which has become synonymous with all types of microvascular free tissue 
transfer since
8
. 
The introduction of microvascular free tissue transfer (free flap) completely revolutionised 
the concept of reconstruction in plastic surgery. Prior to the advent of this type of 
procedure, plastic surgeons had to rely on donor sites in close proximity to the defect or 
upon multiple cumbersome delay or transfer type procedures. Through the concept of free 
tissue transfer virtually any part of the body with a suitable vascular supply could become 
a donor site leading to a huge potential selection in terms of the reconstructive surgeons’ 
arsenal.  
15 
 
 
1.2 Skin and Fat Blood Supply 
An in-depth understanding of the blood supply to the tissue being considered as a donor 
site is essential for any successful flap raising and transfer.  
The skin and subcutaneous fat receives a rich blood supply from perforating cutaneous 
blood vessels. They can be either arterial or venous and vary in size, configuration and 
geometry but all can be traced back to supplying “source” vessels9.  
The route which these perforating vessels travel, prior to penetrating the deep fascia after 
originating from their source vessel to reach the subcutaneous fat and skin varies. As the 
popularity of basing flaps upon isolated perforating blood vessels has increased, there has 
been a number of conflicting descriptions of different types of perforators based upon their 
geometry published in the medical literature. In an effort to address this issue, and provide 
a simple acceptable classification system for the plastic surgery community to utilise, the 
“Gent” consensus was published in 200310. This consensus suggested that perforators 
could be divided into the 5 following types based upon their surgical importance in terms 
of dissection: 
1. Direct perforators which perforate the deep fascia only. 
2. Indirect muscle perforators which predominantly supply the subcutaneous tissues. 
3. Indirect muscle perforators which predominantly supply the muscle but have 
secondary branches to the subcutaneous tissues. 
4. Indirect perimysial perforators which travel within the perimysium between muscle 
fibres before piercing the deep fascia. 
5. Indirect septal perforators which travel through the intermuscular septum before 
piercing the deep fascia.   
This is shown in Figure 1.1 
16 
 
 
 
Figure 1.1: “Gent” Consensus on perforator terminology 
1, Direct perforators perforate the deep fascia only; 2, indirect muscle perforators 
predominantly supply the subcutaneous tissues; 3, indirect muscle perforators 
predominantly supply the muscle but have secondary branches to the subcutaneous 
tissues; 4, indirect perimysial perforators travel within the perimysium between muscle 
fibers before piercing the deep fascia; 5, indirect septal perforators travel through the 
intermuscular septum before piercing the deep fascia. Image reproduced with permission 
from Wolters Kluwer Health, Inc. (Blondeel P, Van Landuyt K, Monstrey S, et al 2003)
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Perforator geometry has implications with regards to perforator flap raising as direct 
perforators and indirect septal perforators tend to be much easier to dissect in comparison 
to perforators which have an intramuscular course, which often require a tedious and 
technically demanding dissection through muscle to reach their vessel of origin. 
Regardless of which type of perforator, upon piercing the deep fascia the perforating 
vessels will course through the superficial tissues often branching widely, forming 
interconnections with other perforating vessels especially as the skin is approached. 
1.2.1 Cutaneous Territories, Angiosomes and Venosomes 
Anatomical knowledge of cutaneous perforating blood vessels in terms of their origin, their 
course through the body and their vascular territory (surface area of tissue which they 
perfuse) is paramount to successful flap raising in plastic surgery. There have been a 
number of pioneers involved in furthering this knowledge over the past 125 years. 
Carl Manchot, a German anatomist, published his cadaveric study on the cutaneous arterial 
supply to the body in 1889. In this study he made extremely detailed drawings of the 
arterial blood supply to the skin (albeit through mysterious methodology) linking 
perforating blood vessels back their source which remain accurate to this day
11
.  
Further advancements came in the 1930s when Michel Salmon (a French anatomist and 
surgeon) revisited the previous work of Manchot and with the aid of radio-opaque dye and 
17 
 
 
x-rays (not available to Manchot at the time) made even more detailed anatomical 
drawings of the various cutaneous territories of the body, whilst also including the 
territories of the hands, feet, head and neck. He also went on to describe the various 
interconnections between perforators to the skin and those occurring within muscles. The 
significance of these highly detailed and influential vascular maps, provided by Manchot 
and Salmon, were not however recognised at the time, perhaps because they were both 
only published in the author’s native language of German and French respectively12. 
Coinciding with the emergence and growing popularity of free tissue transfer in the early 
to mid-seventies; an effort to map potential donor sites in the body was undertaken by 
Taylor and Palmer. They re-visited the works of Manchot and Salmon and undertook 
cadaveric injection, dissection and radiographic studies. Whilst the work of Manchot and 
Salmon was confined to the cutaneous vascular territory, Taylor and Palmer significantly 
advanced this knowledge by offering a three-dimensional model of tissue perfusion 
matching each source artery (and its accompanying vein) not only to the area of skin they 
perfused but also their perfusion of the underlying deeper tissues. These three-dimensional 
composite anatomical blocks of tissue were defined as angiosomes and the angiosomes of 
the body are shown in Figure 1.2
13
.   
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Figure 1.2: The angiosomes of the body 
Image reproduced with permission from Elsevier Ltd. (Taylor and Palmer 1987)
13
 
This work was initially only studying the arterial supply (arteriosomes) of the body, 
however, further research by the same team demonstrated that the venous supply 
(venosomes) closely matched the arterial supply, further corroborating the angiosome 
concept
14,15
. As such each angiosome can be considered as consisting of a paired 
arteriosome and venosome. 
At the border of each angiosome they also identified a collateral arterial supply provided 
by smaller calibre anastomotic connections between perforating blood vessels which link 
adjacent angiosomes at all levels throughout the body. These connections were referred to 
as “true” or “choke” anastomotic vessels. These interconnections linked through the 
capillary bed mean that essentially every vessel in the body is connected in an unbroken 
network. A similar picture was found in the venous architecture to compliment these 
“choke” arterial anastomoses in the form of oscillating avalvular veins which connect the 
valved venous systems to each other and allow bi-directional flow. Upon raising a flap, the 
choke vessels linking the adjacent angiosome to the source vessel will dilate and it is 
usually feasible that the choke vessel increase will allow immediately adjacent angiosomes 
to be perfused safely, however, those out-with this area are subject to tissue necrosis
13,16
. A 
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similar process occurs in the venous architecture allowing additional venous draining of 
adjacent angiosomes through the linking avalvular oscillating veins. A schematic diagram 
showing closed and open choke vessels is shown in Figure 1.3.  
 
Figure 1.3: Diagrammatic representation of closed and open choke vessels 
The maximum increase in choke vessel diameter is within the first 48-72 hours and is 
complete by day 7
17
. This increase in vessel diameter is permanent and irreversible
18
. The 
proposed trigger mechanism for change in choke vessel calibre is thought to be due to 
tissue hypoxia
12
. These findings essentially explain why the traditional delay type 
procedure (incising the borders of the proposed skin flap in a staged fashion rather than 
raising the flap in a single stage) worked; as by staging the flap raising it allowed the 
opening of adjacent choke vessels and improved perfusion to other areas of the flap.  
The knowledge of three-dimensional vascular territories provided by Taylor and Palmer 
essentially offer the reconstructive surgeon a map through which they can plan the type of 
flap they require based upon reconstruction aims in terms of size, volume, constituents and 
pedicle length. 
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1.2.2 Perforasomes 
Further advances in the understanding of tissue perfusion in perforator flaps have been that 
of the Perforasome concept.  Saint-Cyr et al initially described the use of contrast enhanced 
CT angiography coupled with cadaveric dissection to aid in the identification of the 
vascular supply to perforator flaps
19
. Building upon this initial work, they went on to 
describe the concept of a perforasome as the three-dimensional area of tissue (vascular 
territory) perfused by a single arterial perforator, rather than the global area of tissue 
supplied by all the perforating vessels of a source vessel, as described by the angiosome 
theory
20
.  (See Figure 1.4) 
 
Figure 1.4: Common perforasomes of the body 
Image reproduced with permission from Wolters Kluwer Health, Inc. (Saint-Cyr et al. 2009)
20
  
They also identified that a perforasome was linked to each adjacent perforasome via direct 
linking vessels or indirect linking vessels; in a similar fashion to that of true and choke 
vessels as described by Taylor et al
13,16
. The direct linking vessels are large vessels which 
anastomose directly between perforators and can allow for capturing of multiple adjacent 
perforasomes providing the flow/filling pressure through the original perforator is high. 
The indirect linking vessels link adjacent perforasomes via their supply to the subdermal 
plexus and recurrent flow
20
. (See Figure 1.5)  
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Figure 1.5: Linking of adjacent perforasomes via direct and indirect vessels 
Image reproduced with permission from Wolters Kluwer Health, Inc. (Saint-Cyr et al. 2009)
20
  
Taylor accepted the concept of the perforasome and believed that each perforasome 
territorial unit would link together to form the same overall angiosome territory from the 
source artery of the perforators
21
. (See Figure 1.6) 
 
Figure 1.6: Schematic diagram showing territory of a solitary perforator (left) and 
perforators from a single source artery combined to show overall cutaneous territory (right) 
Image reproduced with permission from Wolters Kluwer Health, Inc. (Taylor et al. 2011) 
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Taylors’ original work on angiosomes proved revolutionary to reconstructive surgeons in 
identifying potential donor sites to be used for free tissue transfer. With the current trend 
towards performing perforator based flaps; the perforasome concept may prove similar in 
allowing the identification of suitable donor site areas for perforator based flaps. 
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1.2.3 Perforator flap perfusion physiology 
Perfusion refers to the blood flow within specific organs or tissues, such as the skin and fat 
of perforator based flaps. In normal physiological circumstances this should be a dynamic 
process with the events following a continuous circuit. 
Within a healthy perforator flap blood flow is characterised by high pressure input/supply 
via arterial perforating vessels, subsequent microcirculation within the capillary bed and 
low pressure output/drainage via the perforating veins.  
In order to understand the perfusion within perforator flaps the basic physiological 
principles of flow most be comprehended. 
In its most simplistic form flow can be calculated using the following equation:  
𝐹𝑙𝑜𝑤 𝑅𝑎𝑡𝑒 (𝑚𝐿/𝑚𝑖𝑛)  =  
𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒 𝑃𝑒𝑟𝑓𝑢𝑠𝑖𝑜𝑛 𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒 (𝑚𝑚𝐻𝑔)  
𝑅𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑐𝑒 (𝑚𝑚𝐻𝑔 x (min/mL))
 
Or 
𝑄 =
∆𝑃
𝑅
 
Where the effective perfusion pressure (ΔP) is the mean intraluminal pressure at the 
arterial end minus the mean pressure at the venous end (i.e. pressure difference) of the 
vascular circuit
22
.  
Resistance to blood flow through vessels; however is a complex process dependent upon 
multiple factors. Blood vessels are essentially cylindrical in nature and Poiseuille described 
various factors known to influence the resistance to flow through a cylindrical tube. These 
factors include the radius within the cylinder, the length of the cylinder; viscosity of the 
fluid within the cylinder and the inherent resistance to the flow.  
Incorporating these factors resistance (R) within blood vessels can be calculated using the 
following equation: 
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𝑅 =
8𝐿η
𝜋𝑟4
 
where L = vessel length, η = viscosity of blood, and r = radius of the vessel lumen. 
By combining both equations into a single expression (commonly known as the Hagen-
Poiseuille Equation) it allows the calculation of blood flow: 
𝑄 =
∆𝑃𝜋𝑟4
8𝐿η
 
Where Q = Flow; ΔP = effective perfusion pressure; L = vessel length, η = viscosity of 
blood, and r = radius of the vessel lumen. 
In order to ensure adequate perfusion and thus perforator flap survivability each 
component of the above equation has to be addressed. Effective perfusion pressure is 
crucial and the successful completion of the microcirculatory process (delivering of 
oxygen/nutrients to the tissues and removal of waste products) within the capillary bed is 
dependent upon the existence of the high pressure (at arterial end) to low pressure (at 
venous end) gradient and is essential for tissue survival. Failure of this process will lead to 
tissue ischaemia and ultimately necrosis.  Inadequate arterial supply will lead to tissue 
hypoxia and ischaemia whereas inadequate venous drainage in the presence of an 
appropriate arterial supply will result in an increase in venous resistance, loss of the 
pressure gradient and failure of the microcirculatory process. 
 In general patients undergoing perforator flap surgery should be optimised peri and post 
operatively ensuring that their blood pressure is adequate (to maintain a good effective 
perfusion pressure) and they are kept well hydrated (to prevent an unwanted increase in 
blood viscosity). With regards to the vasculature supplying perforator flaps it is apparent 
that the radius of the supplying blood vessels is incredibly important and changes in this 
factor will have huge influences on overall perfusion (i.e an approximate increase in vessel 
radius of 19% will double blood flow). As such efforts must be taken during perforator flap 
surgery to ensure that flaps are based on vessels of adequate calibre and that these vessels 
are free from spasm or external compression.  
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1.3 Breast Reconstruction 
The ideal goal of breast reconstruction surgery is to replace the excised breast tissue with 
something similar in terms of size, shape and texture which can best achieve symmetry 
with the contralateral breast or act as a substitute to that lost in the case of bilateral 
mastectomies
23
. 
It has been shown that breast reconstruction after mastectomy leads to an improvement in 
patients’ self-esteem, quality of life and sexuality24-28. 
The types of surgical reconstruction available consist of implant based reconstruction or 
autologous based reconstruction. Autologous based reconstructions involve using the 
patients’ own tissue to reconstruct the breast. The current options for autologous 
reconstruction involve regional tissue transfer or free tissue transfer.  A relatively new 
method of autologous reconstruction in the form of free fat transfer (lipomodelling) has 
also been described as an option to carry out total reconstructions, but is much less utilised 
in comparison to the other available methods
29
. Instead this technique is often used when 
the defect is only small; such as after wide local excision or to further augment/revise the 
other reconstructive techniques by adding more volume or addressing contour 
irregularities, usually at a later stage
30
. 
When it is not possible to recreate a symmetrical replacement to the contralateral breast 
(usually due to volume of implant or tissue required) secondary subsequent procedures, 
such as symmetrising breast reduction, may be considered on the normal breast.  
Where bilateral mastectomies are required, the aim of the reconstruction is to provide 
bilateral substitutes of similar size and shape to achieve an aesthetically acceptable result 
for the patient. 
1.3.1 Choice of Reconstruction 
As with any type of reconstructive procedure the reconstruction should be tailored to each 
individual patient, encompassing their reconstructive requirements and also their 
expectations and wishes. As such, each of the various types of reconstruction may have 
significant indications in one patient, but significant contraindications in another patient.  
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Dispute, however, remains amongst the plastic surgical forum as to which reconstructive 
technique provides the best results for patients and some surgeons advocate certain types 
of reconstruction over others.   
Recent evidence amongst larger studies would suggest that patients undergoing autologous 
tissue breast reconstruction have higher satisfaction rates than those undergoing implant 
based techniques
24-26,31,32
. Furthermore it may be that those patients undergoing free 
abdominal tissue breast reconstruction have the highest satisfaction
33
 and that these 
patients are more satisfied with their breast from an aesthetic point of view in the long-
term in comparison to those undergoing implant based techniques
24,26
.  
This thesis will concentrate on autologous free tissue transfer and in particular the Deep 
Inferior Epigastric Perforator (DIEP) Flap.  
1.4 Free Autologous Tissue Breast Reconstruction 
1.4.1.1 Donor Site Selection 
In terms of donor site selection for reconstructing a defect; the ideal donor site would offer 
completely the same mix of tissue to that which has been removed, whilst leaving a 
suitable secondary defect which can be closed primarily or reconstructed, without 
significant further deformity or insult to the patient.  With regards to breast reconstruction, 
the human female breast consists of primarily adipose (fat) tissue, glandular tissue and 
skin. The proportion of breast glandular tissue varies throughout a woman’s lifetime and 
undergoes significant atrophy upon aging. It would not be appropriate, in reconstructive 
terms, to replace the removed glandular tissue with further breast glandular tissue. As such, 
dependent upon the amount of skin removed at time of mastectomy, the donor site for 
breast reconstruction would have to supply a suitable amount of soft tissue to replace the 
removed glandular and adipose tissue with the option of a skin paddle if required.  
Adipose tissue is the ideal replacement of composite breast tissue given its consistency, 
rich vascular supply, texture and abundance within the human body. As with any type of 
surgery, patient selection for each type of procedure is key and different patients will have 
different volumes of adipose tissue in different areas of the body. There are a variety of 
flap donor sites which can be utilised for breast reconstruction, ranging from regional flap 
transfer options in the abdomen and back; to free tissue transfer options from the abdomen, 
back, buttocks and thighs which in general offer good volumes of adipose tissue, option of 
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a skin paddle and a suitable blood supply for breast reconstruction. In some of the sites 
muscle tissue also has to be taken to ensure blood supply or increase volume of tissue 
available. Out of all the sites, in the majority of patients, the lower abdomen will offer a 
good option for free tissue transfer, due to the abundance of skin, subcutaneous fat, reliable 
blood supply and a defect that can generally be closed easily with acceptable scarring to 
the patient.  
1.5 Abdominal Blood Supply 
The abdominal skin and fat receives a rich vascular supply from various sources. These 
include perforating vessels from the intercostal muscles, the epigastric arcades (superficial 
/ deep superior and inferior epigastric vessels), the superficial (and possibly deep 
circumflex vessels) and to a smaller degree the superficial pudendal vessels as shown in 
Figure 1.7.  
 
Figure 1.7: Arterial supply to the anterior abdominal skin and fat 
 
Huge anatomical variation exists between individuals as to the presence or absence of 
these perforating vessels, their location, branching patterns, and their anastomoses.
34
 
Constantly, however, the main vascular supply to the anterior abdomen comes from the 
bilateral epigastric arcades consisting of the superficial and deep superior and inferior 
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epigastric vessels. Of note the superficial superior epigastric artery and vein are often 
absent in humans and as such are usually disregarded anatomically.  
The deep superior epigastric artery (commonly referred to as the superior epigastric artery) 
arises from the internal thoracic artery at the level of sixth intercostal space and runs 
anterior to the transversus thoracis muscle, passing inferiorly through the diaphragmatic 
origins on the xiphoid process and costal margin remaining anterior to the transversus 
abdominus muscle. It is initially deep to the rectus abdominus muscle but then perforates 
the fascia branching diffusely and sending perforating vessels through the muscle to supply 
it and the overlying soft tissue/skin. It is accompanied by the superficial epigastric vein / 
venae comitantes which is a continuation of the internal thoracic vein / venae comitantes. 
The deep inferior epigastric artery arises from the external iliac artery just superior to the 
inguinal ligament. It travels through the extra-peritoneal tissue obliquely and in a medial 
direction along the medial edge of the deep inguinal ring continually passing superiorly to 
eventually pierce the transversalis fascia and enter the rectus sheath. As with the superior 
epigastric artery at this level it branches widely and sends perforating branches through the 
muscle to supply both it and the overlying soft tissue/skin. The artery is accompanied by 
the deep inferior epigastric vein / venae comitantes which drains into the external iliac 
vein.   
The superficial inferior epigastric artery usually arises from the common femoral artery 2-
5cm inferior to the inguinal ligament as part of a shared trunk with the superficial 
circumflex iliac artery; however other originating patterns can occur. It initially is deep to 
the cribriform fascia, but as it approaches the inguinal ligament it penetrates through and 
runs superiorly in the subcutaneous tissues. It is accompanied by venae comitantes, which 
drain into the femoral vein, and also the superficial inferior epigastric vein, which runs 
medial to the artery and drains into the saphenous bulb.  
The main vascular supply to the anterior abdomen comes from the superior and deep 
inferior epigastric system. Both these systems have diffuse anastomotic connections with 
each other cranial to the level of the umbilicus at their terminal branches. It has been 
shown that the deep inferior epigastric arterial system is the more dominant; providing a 
more significant arterial blood supply to the anterior abdominal skin
35
. The angiosome 
supplied by the Deep Inferior Epigastric Artery (DIEA) can be seen in Figure 1.8.   
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Figure 1.8: Human angiosome map showing area supplied by DIEA 
Image reproduced with permission from Wolters Kluwer Health, Inc. (Taylor et al. 2011)
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The number of main DIEA trunks can vary (between one and four) but they consistently 
gives rise to a medial row and a lateral row of perforators through the deep fascia to supply 
the anterior abdominal tissue
36
. (See Figure 1.9) 
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Figure 1.9: CT angiogram showing medial and lateral rows of the DIEA 
Image reproduced with permission from John Wiley and Sons. (Rozen et al. 2011)
36
 
The largest perforating vessels from the DIEA medial and lateral rows are located at its 
terminal branches 3-5cm around the umbilicus
37
 . The perforating vessels will take a direct 
course through the deep layer of adipose tissue prior to reaching Scarpa’s fascia where they 
then branch on the superficial surface of Scarpa’s fascia or in the subdermal plexus38.  
As well as anastomosing with the superior epigastric vessels these para-umbilical 
perforating branches also show widespread anastomoses with other perforating branches of 
the deep inferior epigastric, superficial inferior epigastric, superficial circumflex iliac and 
intercostal arteries
37
. 
The connections between these cutaneous perforating vessels are through either “true” or 
“choke” (cf. 1.2.1). True anastomoses are those where the calibre of joining vessel remains 
the same, in comparison to choke anastomoses whereby the calibre of the joining vessel is 
smaller, but has the potential to dilate and improve vascular flow
12,13,16
. 
In contrast to the dominant arterial supply to the lower abdominal tissue arising from the 
DIEA, the dominant venous drainage usually occurs via the superficial venous system, in 
particular the SIEV
39,40
. Deep branches from the SIEV arise throughout its course 
(particularly in the peri-umbilical area) and these branches drain into the venae comitantes 
of the DIEA perforators
41
.  
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1.6 Abdominal Tissue Transfer in Breast Reconstruction 
Autologous tissue transfer using abdominal tissue as a donor site has been used for 
decades. The benefits of this site are the volume of tissue available for harvest, appropriate 
colour match (when skin paddle required); good tissue pliability; robust vascular supply 
and relatively low donor site morbidity.  
These abdominal tissue flaps are based upon blood supply from the superior or inferior 
epigastric vessels. Traditionally these flaps were pedicled based upon the superior 
epigastric vessels and incorporated the rectus abdominus muscle along with the underlying 
pedicle. However, as time progressed these flaps have evolved to be routinely based upon 
the inferior epigastric vessels (the dominant anterior abdominal skin/fat blood supply as 
discussed above) and rather than being pedicled, are raised as free flap alternatives, which 
are transferred to the recipient site via microsurgical techniques. Furthermore the need to 
incorporate the rectus abdominus muscle along with the pedicle during flap raising has 
declined over time, with many choosing to raise the flap as a perforator based alternative. 
1.6.1 TRAM Flap 
The first use of a one stage abdominal based chest wall reconstruction was in 1974, when 
Tai & Hasegawa described the use of a “transverse abdominal flap” consisting of skin and 
fat from the upper abdomen, based upon the perforating vessels of the superior epigastric 
artery and vein, to reconstruct the chest wall in 5 patients following radical operations for 
recurrent breast cancer
42
. However, these flaps were utilised solely for chest wall coverage 
rather than the recreation of an aesthetic breast mound. 
The first published description of breast reconstruction in terms of cosmesis (i.e. creating a 
breast mound) by using an abdominal tissue based flap actually broke the trend mentioned 
above in terms of historical evolution. Holmstrom, in May 1979, described an 
experimental free tissue transfer reconstruction from the lower abdomen based upon the 
deep inferior epigastric vessels, which he carried out on two patients
43
. He termed this the 
“free abdominoplasty flap” due to the fact that the overlying skin and fat was essentially 
what was discarded at the time of an abdominoplasty. At this time, Holmstrom noted the 
good vascular supply to the flap but commented on the precarious venous drainage, as 
unfortunately the flap failed in one of these patients secondary to venous thrombosis.   
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A few months later, in October 1979, Robbins published his technique of using a pedicled 
rectus abdominus myocutaneous flap to reconstruct a post-mastectomy wound
44
. He used a 
vertically orientated islanded flap, incorporating tissue from the upper and lower abdomen, 
on the same side as the mastectomy defect based upon the superior epigastric vessels. 
Drever
45
 and Dinner
46
 subsequently went on to publish their experience; techniques and 
refinements on using a vertically based rectus abdominus myocutaneous type flap for 
breast reconstruction. 
In 1982, Hartrampf et al published their findings on using an ellipse of skin and fat 
obtained from the lower abdomen for breast reconstruction
47
. This transversely based flap; 
which they named the horizontal lower rectus abdominus flap (more commonly referred to 
as the Transverse Rectus Abdominus Myocutaneous (TRAM) flap in current literature) 
could be harvested based upon the superior epigastric pedicle of either the ipsilateral or 
contralateral rectus abdominus muscle to the mastectomy defect.  They published their 
success of such a flap in 8 patients and also discussed the successful use of this type of flap 
in a bilateral breast reconstruction.  They commented that this flap had advantages in terms 
of easily hidden donor site scarring in the supra-pubic area and also that the superior 
pedicle to the flap was well protected as it did not need to be identified. In this key paper, 
they also discuss the vertical rectus abdominus musculocutaneous (VRAM) flap as 
previously described by the authors above
44-46
 and provide another transverse alternative 
(horizontal upper rectus abdominus flap) based upon the upper abdominal tissue, which 
they reserved for patients with infra-umbilical scars. A diagram showing the various flaps 
described is shown in Figure 1.10. 
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Figure 1.10: Abdominal flaps based on the Rectus Abdominus muscle. 
As described by Hartrampf et al. 1982
47
 
 
1.6.2 DIEP Flap 
The next major breakthrough in terms of the lower abdominal tissue donor site came in 
1989, when Koshima and Soeda, recognising the disadvantages associated with the harvest 
of the rectus abdominus muscle, described a muscle preserving alternative coining the term 
“perforator flaps”48.  They described the use of such a flap in two cases; one as a pedicled 
flap to reconstruct a groin defect following a malignant lymphoma resection and the other 
as a free flap used to reconstruct an intra-oral defect following a squamous cell carcinoma 
excision. It was a natural evolution of the established VRAM/TRAM flap with the benefit 
that it did not rely upon harvesting a portion of the rectus abdominus muscle. Instead the 
perforating blood vessels supplying the abdominal tissue could be carefully dissected 
through the muscle tissue to their vessels of origin (the Deep Inferior Epigastric Artery and 
Vein) leaving the muscle tissue behind. The flap became known as the DIEP flap 
secondary to the vessels which supplied it. They presumed at the time of publication that 
this flap overcame the problems of post-operative herniation and additional bulkiness 
associated with the rectus abdominus myocutaneous flap, whilst still having the benefit of 
a similar area of vascular perfusion as the TRAM flap. However, they did point out that 
this flap could be technically demanding in terms of the perforator dissection and also the 
variability in terms of perforator size and location. 
33 
 
 
The first published description of the use of the DIEP flap in breast reconstruction was in 
1994 by Allen and Treece
49
. Recognising the benefits that such a flap could provide in 
terms of the large volume of tissue available, they published their experience of using a 
free DIEP flap for breast reconstruction in 15 patients.  Over the subsequent years the flap 
gained popularity worldwide with others, including Blondeel and Hamdi et al publishing 
their experiences of utilising the flap to provide a successful breast reconstruction
50,51
. 
Since then the DIEP flap has become a workhorse flap for breast reconstruction with many 
authors publishing their results in large series.  
1.6.2.1 TRAM Flap vs DIEP Flap 
The choice of a TRAM or DIEP flap is controversial amongst many surgeons. 
Modifications to the TRAM flap since its conception have been to adopt a muscle/rectus 
fascia sparing approach during flap raising, this involves harvesting only a small portion of 
the rectus muscle and fascia around the perforating blood vessels rather than harvesting the 
complete section of muscle. Advocates of this technique feel that it is at least comparable, 
if not better, to the DIEP flap, since only a small portion of the muscle is removed with or 
without a small portion of fascia then the recovery of the patient is likely to be better with 
less chance of herniation whilst foregoing the time-consuming technical difficulty of 
intramuscular pedicle dissection.  
The literature varies greatly on the comparison between free TRAM and free DIEP flap 
patients’ donor site morbidity. Despite the preservation of muscle tissue, as occurs in DIEP 
flap raising, there is still the potential complication of donor site abdominal bulging to 
occur, without any evidence of herniation. The rate of abdominal bulging post DIEP flap 
transfer quoted varies in the literature between 0.7-5%
52-54
. Nahabedian et al in 2005 
attempted to ascertain whether risk factors such as previous abdominal surgery, diabetes 
mellitus, age, bilateral reconstructions, smoking, previous childbirth, plication or mesh use 
were associated with increased rates of abdominal bulging but the results were not 
statistically significant
55
. They did, however, find that previous pregnancy may have a 
slightly protective mechanism to reduce the rate of abdominal bulging
55
. Blondeel et al, 
found that those patients having breast reconstructions with free TRAM flaps had a weaker 
abdominal wall and higher rate of abdominal bulging, in comparison to those having free 
DIEP flap breast reconstructions
52
. This is in direct contrast to other authors who have 
found no statistically significant difference between TRAM or DIEP flaps with regards to 
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hernia or abdominal bulging
55-58
. Kroll also identified that it appears that DIEP flap 
patients have a lower requirement for post-operative opiate analgesia and thus DIEP flap 
donor sites may be less painful than those of TRAM donor sites
59
. A meta-analysis in 2009 
concluded, that patients with TRAM flap donor sites have a higher rate of abdominal wall 
morbidity, in comparison to those with DIEP flap donor sites
60
.  
Another significant difference between the free TRAM and free DIEP flap is in terms of 
their venous drainage. The classical DIEP flap venous drainage relies solely upon the 
perforating (usually one or two) veins it has been raised upon. In contrast the free TRAM 
flap, which is raised as a composite block including muscle rather than dissecting the 
perforators free to their point of origin, will have a more abundant venous drainage system 
as there are likely to be more venous perforators within the block of harvested tissue. As 
such, venous congestion complications of free TRAM flaps are much rarer than those 
experienced in free DIEP flaps
61
. 
With regards to flap related complications, it appears that the free TRAM is more robust 
than that of the free DIEP flap and this may be due to the differences in their blood supply, 
as discussed above. It has been well documented in some studies that there is a 
significantly higher incidence of major flap complications in those patients undergoing 
DIEP flap breast reconstruction
57,58
. The same meta-analysis from 2009 also concluded 
that there is a higher rate of flap related complications (such as fat necrosis or partial flap 
loss) in those patients undergoing free DIEP flap surgery in comparison to free TRAM 
flaps
60
. 
1.6.3 SIEA Flap 
Another lower abdominal flap which can be used for breast reconstruction is that based 
upon the superficial inferior epigastric artery (SIEA). This flap was first described in breast 
reconstruction by Grotting in 1991
62
 and, much like the DIEP, many others have since 
advocated its use believing that it is the best option in terms of free lower abdominal tissue  
flap for breast reconstruction
63-65
.  The benefit of the SIEA flap is that it requires no 
intrusion into the rectus sheath and injury to the rectus abdominus muscle.  However, the 
anatomy with regards to the pedicle of this flap is extremely variable between patients and 
studies have shown that in many patients the artery is unsuitable for microvascular transfer 
or even completely absent (quoted absence between 13-51% and unsuitability between 13-
70% dependent upon the literature)
65-67
. Many surgeons will routinely assess the 
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favourability of the SIEA flap during lower abdominal tissue harvest and if suitable 
proceed with this flap rather than a TRAM/DIEP flap due to the ease of harvesting, 
excellent donor site and rapid recovery of patients post-operatively
65,67
. A proposed 
algorithm based on their experience of 99 SIEA flap reconstruction by Speigel and Khan 
suggests only proceeding with SIEA flap reconstruction if the artery diameter is >1.5mm
68
. 
However it has been reported that SIEA flaps have a much greater risk of flap related 
problems in terms of necrosis, arterial complications, need for re-exploration and failure 
rate in comparison to DIEP flaps
69
. 
1.6.4 Lower abdominal “zones” 
Scheflan and Dinner were instrumental in providing a classification and division system as 
to the blood supply to each part of the lower abdomen when raised as a flap based upon the 
epigastric vessels. They published their results of using a uni-pedicled TRAM flap and 
described a method of classifying different areas of the flap based upon their impression of 
perfusion to each area. They divided the lower abdominal ellipse upon which the flap was 
to be based into four equal areas which they named “zones”. Each zone of the flap was 
numbered I-IV in terms of degrees of diminishing perfusion (i.e. Zone I best perfusion and 
Zone IV worst perfusion). Zone I overlies the perforating vessels, Zone II is across the 
midline adjacent to perforating vessels. Zone III is on the ipsilateral periphery to the 
perforating vessels and Zone IV is on the furthest periphery on the contralateral side from 
the perforators
70,71
. 
Despite this original description with regards to classification of perfusion zones being 
carried out by Scheflan and Dinner, the zone’s became known colloquially as “Hartrampf’s 
Zones” due to his previously published work on TRAM flaps47. (See Figure 1.11) 
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Figure 1.11: Hartrampfs' Zones of Perfusion 
 
In a subsequent publication by Dinner and Scheflan highlighting refinements in their 
technique, they had changed their classification system by switching “Hartrampf’s zone 
II/III
72
. (See Figure 1.12)  
 
Figure 1.12: Dinners' Zones of Perfusion 
 
These zonal classification systems were originally designed specifically with regards to a 
uni-pedicled TRAM flap based upon the superior epigastric vessels but they have become 
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universally adopted for the description purposes of flaps based upon the Deep Inferior 
Epigastric Vessels in modern practice and literature. 
Both classifications were based upon observations and clinical impressions rather than 
scientific evidence. More recent studies assessing perfusion to the specific zones using 
ultrasonography
73
; Indocyanine green angiography
74
 and tissue oxygenation
75
 would agree 
that Dinner’s revised zonal classification is more accurate, as perfusion does not appear to 
occur as easily across the midline. Controversially, despite the revised publication by 
Dinner advocating the change in Zone II/III, the original Hartrampf’s zones are still 
commonly used.  
Despite the disputes over the flap classification system in terms of using Hartrampf’s or 
Dinner’s zones; there is no dispute with regards to the location and perfusion 
characteristics of Zone I and Zone IV. For the purposes of this thesis Hartrampf’s classical 
zones will be utilised in discussion. 
The perforasome concept offers an alternative classification system. Rozen et al proposed a 
perforasome type classification for lower abdominal perfusion when based upon a single 
perforator from their findings in cadaveric dye injection studies and CT angiography
76,77
. 
This system divides the lower abdominal zones based upon whether a medial or lateral row 
perforator has been used in flap raising.  As with Hartrampf’s and Dinner’s Zones, Zone 
IV remains the furthermost from the perforating vessel and the least well perfused. (See 
Figure 1.13)  
 
Figure 1.13: Perforasome Zones of perfusion based on medial (left) or lateral (right) row 
perforators 
Image reproduced with permission from John Wiley and Sons. (Rozen et al. 2010)
76
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1.6.5 Vascular related complications associated with DIEP flaps 
Despite the widespread use of the DIEP flap in breast reconstruction significant issues 
associated with poor vascularity of the flap can occur. 
1.6.5.1 Venous Congestion 
When the venous return of a flap through the venous anastomosis is not adequate, then 
parts of the flap or the entire flap can become congested; clinically presenting as a rapid 
skin paddle capillary refill with subsequent swelling and discolouration of the flap skin 
paddle. This is often the earliest sign of a failing flap and can signify that there may be a 
problem with the venous anastomosis (i.e. thrombosis or kinking). This usually 
necessitates an immediate return to theatre to assess the patency of the venous anastomosis 
to the flap.  
In the standard DIEP flap, the total venous outflow of the flap is directed through the 
perforating venae comitantes accompanying the arterial perforator(s) chosen to base the 
flap upon into the DIEV. Experimentally, it has been shown that venae comitantes are not 
the best choices of venous drainage in free flaps and that draining veins should be situated 
far enough away from the feeding artery to improve drainage
78
. 
Problems associated with venous congestion resulting in compromised perfusion to DIEP 
flaps are well documented and it is the most likely vascular related complication.
41,54,61,79-82
 
Excluding technical or unfavourable geographical problems (kinking) with perforator 
dissection or the primary DIEV anastomosis, venous congestion in the DIEP flap can still 
occur leading to potential partial or complete flap failure. Patent DIEV anastomosis with 
concomitant venous congestion has been reported to arise between 2.1 to 27 percent of the 
time in the literature
53,61,83,84
. 
The causes of venous congestion in the DIEP flap are poorly understood however several 
theories as to why venous congestion occurs have been described, including inadequate 
calibre of the perforating veins
85
; inadequate venous midline crossover
41,61,81
 and an 
inadequate communication between the superficial and deep venous system
61,83
. 
With regard to the calibre of the perforating veins Kroll suggested that in order to allow 
adequate venous outflow in a DIEP flap then a perforating vein with a diameter of at least 
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1mm should be selected
85
. However, this was only based on his own experience rather than 
any anatomical or scientific research.   
Others have theorised that inadequate midline crossover of the venous architecture in DIEP 
flaps may be a significant risk factor in the development of venous congestion particularly 
to Zone IV of the flap. In an anatomical injection study by Blondeel et al in 2000 they 
found that communicating venous branches crossing the midline were absent in 36% of 
specimens they examined and the only venous communications were via the subdermal 
plexus
61
. Arguably however, their study group was small consisting of only 15 cadaveric 
and 3 abdominoplasty specimens and limited by the fact that they would be unable to 
assess the contribution of the opening of oscillating veins in non-living specimens. A 
similar anatomical study by Schaverien et al in 2008 also found absence of midline venous 
crossover vessels in 1 out of 12 (8%) specimens they examined
81
.  A larger in-vivo study 
consisting of 100 patients by Rozen et al in 2009 found an absence of midline crossover in 
14% of the cohort
41
. 
The relationship of the deep and superficial vascular system is particularly interesting and 
its importance has gained significant evidence in the literature over the past 15years.  
Blondeel initially proposed that the venous communication between the DIEV and the 
SIEV may be inadequate in patients with an SIEV >1.5mm and that in these patients the 
superficial venous system is required to drain the flap
61
.  
Tran et al agreed with this proposition in their study to assess microvascular complications 
of DIEP flaps and advocated that the SIEV should always be initially identified and 
preserved as a “lifeboat vessel”. 11% of their DIEP flaps suffered intra-operative venous 
congestion despite patent DIEV anastomosis and 45% of these required additional bypass 
anastomosis to the SIEV to successfully salvage
83
.  They also suggested that a very small 
diameter SIEV may be positive predictive indicator as it may correlate to a better 
communication and a deep system dominant enough to drain the flap
83
.  
The most convincing evidence of the correlation between the deep and superficial system 
was in a study published by Schaverien et al in 2010 assessing the relationship between 
venous congestion and intra-flap venous anatomy in 54 DIEP flaps using contrast 
enhanced MRA they found that DIEP flaps raised on venous perforators which lack a 
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direct communication with the SIEV system are significantly more likely (p<0.0001) to be 
complicated by venous congestion
86
. 
1.6.5.2 Fat Necrosis 
Fat necrosis can be classified as partial flap necrosis without any skin paddle changes.  
This complication arises when areas of fat throughout the flap are not adequately perfused 
however the overlying skin paddle still has an adequate blood supply and remains healthy.  
This can occur weeks to months after the flap reconstruction and often presents as firm 
lumps within the body of the reconstruction, non-healing wound edges plus or minus 
discharge. Furthermore, this fat necrosis can be of particular distress to breast 
reconstruction patients due to their history of breast cancer as they are often extremely 
concerned with finding firm lumps within their reconstruction. 
Some degree of fat necrosis can be considered a relatively common complication of DIEP 
flap surgery, especially when larger flaps are required. The rate of fat necrosis associated 
with DIEP flaps vary within the literature quoted anywhere from 2.8-17.1%
85,87
. A recent 
meta-analysis by Khansa et al in 2013, including 70 articles deemed suitable, found the 
rate of fat necrosis in free DIEP flaps to be 14.4%
88
. 
However, the rate of absolute fat necrosis may be vastly higher than that actually 
presenting clinically or being reported. A study by Peeters et al, showed that evidence of 
fat necrosis was found ultrasonographically in 35% of all their DIEP flap patient cohort, 
whilst only being clinically detectable by physical examination in 14%
89
. 
Despite the problems of fat necrosis, many of the patients can be managed conservatively 
with reassurance and dressings if required. In the same study by Peeters et al, only 7% of 
the 35% of their patients affected by fat necrosis required a return trip to theatre
89
. 
However, in patients with a large degree of fat necrosis a return to theatre for open 
debridement or lipo-suction to the area may be required. Large volumes of fat necrosis can 
lead to significant volume deficit of the flap, contour irregularities and the need for 
subsequent revision procedures. 
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1.6.5.3 Flap Failure 
Free flap failure is a catastrophic event for both patient and surgeon. It most commonly 
occurs in the immediate/early post-operative period as a result of vascular compromise to 
the pedicle of the flap. The causes of vascular compromise are usually attributed to 
thrombosis at the site of micro-anastomosis of the artery or vein. Venous problems are 
more commonly encountered and often are secondary to unfavourable pedicle geometry 
(kinking of the pedicle), technical aspects of the anastomosis or due to external pressure on 
the pedicle i.e. haematoma. Every effort is taken to ensure free flap survival with careful 
tissue handling/dissection of the pedicle; meticulous microsurgical anastomosis techniques 
and stringent post-operative care/monitoring of the patient and flap. Any evidence of flap 
compromise should necessitate an immediate return to the theatre for evaluation of the flap 
and pedicle anastomoses.  Despite these interventions and precautions there is still a quoted 
acceptable rate of free flap loss of up to 5%
90
. With regards to the DIEP flap which has 
become a popular well-established choice in modern microsurgical breast reconstruction 
some experienced authors are quoting free DIEP flap failure rates of less than 1%. Gill et 
al had a 0.5% flap failure rate their series of 758 free DIEP flaps for breast 
reconstruction
53
. This appears to be similar to that quoted for free TRAM flaps as shown 
by Vega et al who quoted a free flap failure rate of 0.3% in their series of 500 free TRAM 
flaps
91
. 
Late free flap failure (that occurring after 7 days) is incredibly rare and is often associated 
with infection or recurrence of tumour at the recipient site
92
. 
1.6.6 Vascular augmentation of DIEP flaps 
Regardless of the cause of venous congestion, a number of studies have attempted to 
salvage congested DIEP flaps through the use of vascular augmentation, by anastomosis of  
an additional vein
50,61,80,82-84,93-100
.  
Flap vascular augmentation procedures are often referred to as “supercharging” or 
“turbocharging” of the flap depending upon the vascular configuration of the additional 
anastomosis(es). This nomenclature however can be confusing and the terms are often 
incorrectly used interchangeably in clinical practice or even in the literature. A useful 
analogy to remember the terms and configurations they describe was provided by Semple, 
who suggests thinking of flaps like an engine in a motor vehicle. Supercharging refers to 
boosting the engines performance from an external source and turbocharging refers to 
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using the engines own exhaust to provide additional power
101
. These are the generally 
accepted definitions in current practice
102,103
. An example to illustrate “supercharged” and 
“turbocharged” flaps is shown in Figure 1.14. 
 
Figure 1.14: Illustration representing a supercharged and turbocharged flap 
Note the lower right image refers to the use of an inter-positional vein graft. Image 
reproduced with permission from Wolters Kluwer Health, Inc. (Hallock 2000)
102
 
However, further disparity exists as to whether the terms “supercharging” or 
“turbocharging” should be used for only additional arterial anastomosis(es) or venous 
anastomosis(es) and which terms should be used when. 
Given the difference in expert consensus opinion regarding the terms, and indeed what 
they imply, in an effort to reduce confusion within this thesis the terms “supercharging” 
and “turbocharging” will not be utilised. Instead the terms arterial augmentation; venous 
augmentation and combined arterial/venous augmentation will be used to clearly explain 
when an additional arterial input, additional venous output or combined arterial/venous 
input/output is used respectively.  
Whilst the use of vascular augmentation has been documented widely in DIEP flap surgery 
over the past 15 years, the evidence is limited to isolated case reports or case series based 
upon salvage procedures performed once venous congestion has already occurred. 
43 
 
 
In one of the early large case series of DIEP flap breast reconstructions Blondeel described 
his experience of the first consecutive 100 flaps performed
50
. He was the first to describe 
venous augmentation of the DIEP flap via an external source. He mentions in the 
discussion of this paper that two obese patients had inadequate venous drainage and that 
the problem was overcome through vascular augmentation, using a free arterial 
transposition graft between the SIEV and the venae comitantes of the IMA.  Shortly after 
Villafane et al went on to describe a similar successful salvage using a saphenous vein 
interposition graft from the SIEV to circumflex scapular vein labelling the SIEV as a 
“lifeboat ”100.  
Wechselberger et al in 2001 published the benefits of venous augmentation from their 
experience of 37 free DIEP flap breast reconstructions. In 3 of these flaps they noted 
significant venous congestion despite patent anastomosis of the main DIEV to the IMV. 
These flaps were salvaged by venous augmentation by anastomosing the SIEV to an 
additional recipient vein out-with the flap in a procedure they termed “venous 
superdrainage”84. A number of other surgeons have since described their salvage of 
congested free abdominal flaps utilising venous augmentation of the flap by anastomosing  
DIE venae comitantes or the flap SIEV to various other recipient veins including the 
perforating  intercostal
82
, chest wall
83
, thoracodorsal
97
, cephalic
80,97
,basilic
93
, lateral 
thoracic
84
 and even external jugular veins
97
. 
Utilising components within the flap to augment venous drainage has also been described 
as a method to salvage the congested DIEP flap. Rohde and Keller initially described their 
technique of DIEP flap salvage by anastomosing the ipsilateral SIEV to the proximal end 
of one of the flap venae comitantes
99
. Liu et al in 2007, then described a similar technique 
of salvage but in a reverse-flow pattern by anastomosing the ipsilateral SIEV of the flap to 
the distal end of one of the flap venae comitantes providing additional reverse flow venous 
drainage
95
. However, concerns were raised about the reverse flow technique as potential 
valves present within the vein may prevent retrograde flow
98
. 
Recognising the need for venous salvage procedures in those flaps showing intra-operative 
venous congestion, despite patent venous anastomosis and no clear consensus in the 
literature Galanis et al proposed an elegant intra-operative algorithm in 2014
104
. (See 
Figure 1.15) 
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Figure 1.15: Suggested algorithm for management of intra-operative venous congestion 
Image reproduced with permission from Wolters Kluwer Health, Inc. (Galanis et al. 2014)
104
 
Some surgeons have started to routinely carry out venous augmentation procedures on their 
flaps, in an effort to reduce the risks of venous congestion. 
Enajat et al in 2010, published the results of a large retrospective study of 564 consecutive 
DIEP flap cases performed by four surgeons comparing those DIEP flaps which had one 
venous anastomosis (273) versus those flaps (291) which at the time of the original 
operation had an additional primary venous anastomosis to either a second venae 
comitantes or the SIEV
105
. In this study they found that use of two venous anastomoses 
significantly reduced the number of cases of post-operative venous congestion (0 flaps) in 
comparison to the group which only had one venous anastomosis (7 flaps) without 
increasing overall complication rate. They recommend that where possible all flaps should 
have an additional venous anastomosis performed. Whilst this is a large study comprising 
of 564 flaps, it is inherently flawed by the fact that it was retrospective in nature and the 
cohorts were not randomised. The choice to perform a primary second venous anastomosis 
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was on an individual surgeons’ preference and one of criteria for performing a second 
primary anastomosis was intra-operative suspicion of venous congestion. 
Boutrous in 2013 published his similar opinion that where possible all DIEP flaps should 
have double system (deep and superficial) venous drainage
79
. In his case series of 352 free 
DIEP flaps used for breast reconstruction he performed an additional venous augmentation 
procedure in 311 of the flaps by additionally anastomosing the SIEV from the DIEP flap to 
an internal mammary perforating vein or internal mammary venae comitantes. Out of the 
double venous drainage cohort there was one flap requiring return to theatre for venous 
congestion (0.3%); in the remaining 41 single venous drainage flaps two required return to 
theatre (4.9%). He believed this was a statistically significant reduction however 
comparison between both groups is difficult due to the completely different cohort sizes 
and also the fact that those patients in the non-double venous drainage group could be 
considered as having non favourable venous anatomy to begin with if the original venous 
augmentation procedure was not possible. 
Whilst all instances above represent venous augmentation to treat venous congestion, 
arterial augmentation can also be performed to improve arterial flow, however, this is often 
not an issue in a standard DIEP flap. 
1.7 Assessment of DIEP flap flow/perfusion 
Laser Doppler Flowmetry and ICG angiography are two well established non-invasive 
methods of assessing superficial flap blood flow/ tissue perfusion. Ultrasonic transit time 
flowmetry provides an invasive measurement of intravascular blood flow. These 
techniques were used in the methodology of this thesis and will be discussed in detail 
below.  
1.7.1 Laser Doppler Flowmetry 
In 1964 Yeh and Cummins carried out an experiment using a continuous wave helium 
neon laser beam directed at small polystyrene spheres immersed in water. They 
demonstrated that the scattering of the laser light which occurred could be measured and 
utilised to assess flow within fluids using the principle of the Doppler shift effect
106
. After 
the initial discovery another group of researchers working at Brown Engineering Company 
(Huntsville, Alabama) realised the technique could be used not only to assess flow rates 
within fluids but also within gases and designed a machine capable of measuring this 
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which they called a Laser Doppler Flowmeter
107
.  The advantages of this technique became 
widely apparent as it offered a reliable, accurate non-invasive method of measuring flow 
even at low velocity.  
1.7.1.1 History of Laser Doppler Flowmetry in Plastic and Reconstructive 
Surgery 
In 1975 Stern was the first to use Laser Doppler Flowmetry to assess skin perfusion in 
humans. He realised that the technique offered a rapid method by which to assess changes 
in skin perfusion and foresaw potential clinical applications in assessing patients with 
vascular disease and also the “assessment of the viability of burns and grafts108. Sterns’ 
initial predictions were correct and the technique became established in the medical world 
for a variety of specialities ranging from rheumatology to plastic surgery. In plastic surgery 
the use of Laser Doppler Flowmetry has become well established in the burn subspecialty 
to aid in the estimation of burn depth
109-111
 and in the microsurgery subspecialty to aid in 
the monitoring of free flaps
112-116
. 
1.7.1.2 Principles 
Laser Doppler is a non-invasive technique which allows the measurement of superficial 
microvascular blood flow within tissues.  
In the assessment of skin perfusion it operates generally upon the following principles. 
Laser light (usually in the near-infrared/infrared spectrum) is generated and directed at the 
target tissue from a stationary point. Upon contact the laser light will have several 
interactions with the target tissue including absorption, transmission, scatter and reflection. 
The scattered and reflected laser light energy from the tissue can be measured using 
specialised photoreceptor sensors within a receiver. The scattered and reflected laser light 
energy will have different characteristics dependent upon the type of tissue it interacts 
with. Interactions with static tissue will produce much less scattering of the laser light and 
thus will have a lesser effect upon the frequency of the reflected beam. However 
interactions with moving tissue (such as red blood cells moving within intravascular 
spaces) will produce a greater degree of scattering and thus broaden the frequency of the 
reflected laser beam known as the doppler shift effect. The difference between the 
frequency of the reflected laser light from static tissue and that occurring from moving 
tissue is detected by the receiver and the velocity of the moving tissue (i.e. red blood cells) 
47 
 
 
calculated thus allowing a measure of blood flow and  in turn; perfusion of the tissue to be 
calculated.  
The perfusion of the tissue as obtained by laser doppler measurement is commonly 
expressed as “flux” (which is the number of red blood cells multiplied by their velocity) 
and this in turn is converted to arbitrary perfusion units by software within the laser 
doppler machine often in graphical displays which allow statistical comparison between 
different areas of interest. 
1.7.1.3 Methods of Laser Doppler Measurement 
The laser light energy can be delivered to the target in two ways.  
The laser light energy can be delivered (from a distance) to the target tissue via a low 
intensity focused laser light beam which is scanned across the target area using moveable 
mirrors and the resultant “doppler shift” assessed (from a distance) via photoreceptor in the 
receiver. This technique is known as Laser Doppler Imaging (LDI) or “scanning laser 
doppler” and allows relatively large areas of tissue to be measured in a short period of 
time.  
Another method of delivering the laser light energy is via optic fibres. Generated laser light 
is transmitted from the source via an afferent optical fibre to an optical probe which must 
be in direct contact with the target tissue. As well as the afferent optical fibre terminating 
in the probe there is usually one or more efferent optical fibre(s) originating from the probe 
which capture the scattered and reflected laser light from the tissue and transmit it to 
photoreceptors in a receiver allowing the doppler shift and thus blood flow to be 
calculated. This technique is known as Laser Doppler blood flow monitoring. As a result of 
the probe being in direct contact with the tissue and the relatively short distance between 
the afferent and efferent fibre(s) only the blood flow within relatively small areas of tissue 
can be measured; albeit very accurately. This technique is useful for measuring blood flow 
in areas which are difficult to access using a laser beam (i.e. within body cavities). 
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1.7.2 Indocyanine Green Angiography 
1.7.2.1 History of Indocyanine Green Angiography 
Indocyanine Green (ICG) is a tricarbocyanine dye initially developed as a cyan forming 
layer in the production of Technicolor film by Dr Brooker and Heseltine of the Eastman 
Kodak Research Laboratories.  
In 1955 an executive of Eastman Kodak Research Laboratories was a patient undergoing 
treatment by cardiologist Dr Irwin Fox at the Mayo Clinic. Coincidentally at the same time 
Dr Fox was searching for a biocompatible dye that could be detectable in blood and 
recruited the aid of his patient in this search. The executive sent a variety of dyes to Dr Fox 
for evaluation; amongst which ICG was one. The ICG dye met the characteristics which Dr 
Fox required; however it was very unstable in its aqueous form. Subsequent refinements to 
the dye were undertaken by a pharmaceutical company (Hynson, Westcott & Dunning Inc. 
Baltimore, Maryland) producing a stable lyophilised form and Dr Foxs’ team began further 
trials
117
.  
Initially ICG dye was used in assessing cardiac output
118
 and then hepatic blood 
flow/function.
119
 It was not until 1969 that the first use of ICG in absorption angiography 
was undertaken by Kogure et al when they obtained detailed images of the cerebral 
vasculature of a canine brain 
120
 and subsequently fundus circulation in a monkey
121
. These 
early angiography studies relied upon invasive intra-arterial injections of ICG as it was 
believed that intravenous injections of the dye failed to obtain acceptable results and as 
such was not deemed appropriate for human use.  
Hochheimer described a technique using ICG dye intravenously in cats for near-infrared 
absorption angiography purposes in 1971
122
 solving the requirement for intra-arterial 
administration and in conjunction with Flowers’ went on to describe the first successful 
human near infra-red absorption angiography imaging of large choroidal vessels using ICG 
the following year
123
.  
Further research and improvements upon their technique; altering the concentrations of dye 
and camera systems, led to the development of near-infrared fluorescence angiography 
using ICG dye allowing visualisation of the smaller blood vessels within the eye and blood 
flow within them
124
.  The potential application of the ICG angiography process in 
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obtaining detailed images of the vasculature of the human eye were quickly realised and 
the technique has been used extensively in the speciality of ophthalmology since
125
. 
Further to the successful medical uses of ICG angiography listed above, interest began to 
grow for the potential application of the technique in surgery when Raabe et al described 
the first use of ICG angiography intra-operatively to assess real time blood flow through 
the vasculature in neurosurgical procedures
126
. Since then further applications of the 
technique have been found in not only Neurosurgery but Cardiac; Vascular; Oncological; 
Hepatic; Breast and Plastic and Reconstructive surgery
127
. 
1.7.2.2 Indocyanine Green Angiography in Plastic and Reconstructive 
Surgery 
In a specialty such as Plastic and Reconstructive Surgery where fundamental knowledge of 
the vascular perfusion of tissues is essential it is of no surprise that ICG angiography 
should have an established role. 
Rubben et al first alluded to the potential use of ICG angiography in Plastic and 
Reconstructive surgery when they published their successful experimental results of using 
ICG angiography to assess skin flap perfusion in animal models and a select patient cohort 
in 1994
128
. However, it was not until 8 years later when Holm et al. utilised the technique 
to intra-operatively assess the perfusion/viability of skin flaps
129
 and the post-operative 
monitoring of free flaps
130
 that ICG angiography became popular in the speciality. Since 
then a wide variety of applications in the realms of plastic surgery have been found not 
only in the design and assessment/monitoring of flaps but also in terms of 
lymphography
131
; sentinel lymph node biopsy
132
 and burn depth estimation
133
. 
1.7.2.3 Principles 
ICG dye absorbs energy in wavelengths of the electromagnetic spectrum between 600-
900nm and fluoresces strongly when exposed to wavelengths between 750-950nm.  Upon 
injection into the living human circulation ICG dye rapidly binds to plasma proteins 
(predominantly albumin) and remains confined to the intravascular space circulating 
around the body. 
By utilising a laser light source emitting energy in the wavelength between 750-900nm the 
dye will fluoresce. This fluorescence is not visible to the human eye however can be 
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detected by an appropriate optical video detector and the real-time images recorded. The 
laser light source and detector are usually coupled within the same machine allowing 
simultaneous fluorescence and detection. The half-life of the dye in human circulation is 
very short at between 150-180seconds
134
 and thus the capture sequence must be 
commenced soon after injection.  As a result of the rapid excretion of the dye; repeated 
measurements can be taken after alteration of variables without risk of artefact or having to 
wait for long periods of time in contrast to fluorescein which can take up to 18 hours to 
clear
135
. 
 A laser of the appropriate wavelength and a fluorescence detector can be used to allow 
real-time visualisation of blood flow. Metabolisation of the dye occurs solely via the liver 
parenchymal cells and the by-products are excreted via bile salts; no cellular absorption 
occurs and thus toxicity is low
136
.  
1.7.3 Intravascular flow measurement using ultrasonic transit-
time flow meter 
1.7.3.1 History of ultrasonic transit-time flow meters 
The first ultrasonic transit-time flowmeter was invented by Franklin et al and described in 
a paper published in 1962 in which they discussed the potential of their invention and that 
it could allow flow within a blood vessel to be continuously measured
137
. However it was 
not until 1978 that Drost described the theoretical basis of the transit-time volume flow 
principle through which these devices could accurately measure the velocity of fluids 
138
. 
The advantages of ultrasonic transit-time flow measurement is that the probes utilised do 
not require to be in direct contact with the vessels being assessed and are not influenced by 
vessel internal/external diameter, vessel shape or the blood flow profile. The recordings 
obtained via the technique are stable and calibration is also unnecessary as there is little 
zero-drift from baseline
139
. 
1.7.3.2 Principles 
Intravascular flow can be detected through the process of transit-time ultrasound flow 
theory. This theory dictates that when ultrasonic energy moves from a point of origin to a 
destination through a flowing liquid (in this case blood) the time taken to reach the 
destination is altered. If the ultrasonic energy is moving with the direction of flow transit 
time is decreased and conversely if the ultrasonic energy is moving against the direction of 
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flow transit time is increased. Providing that the distance between the point of origin and 
destination is fixed and the normal transit-time between these two points known, then by 
measuring changes in transit time occurring secondary to the liquid through which the 
ultrasonic energy is passing, it allows the calculation of liquid velocity.   
1.8 Volume/skin requirements in DIEP flap transfer and 
associated problems with Zone IV 
Acceptable outcome in DIEP flap breast reconstruction is not solely based upon successful 
flap transfer but also upon being able to transfer an adequate volume of tissue to shape 
such tissue to meet the reconstructive needs of the patient.   
On the occasions when large volume reconstructions are required (i.e. large contralateral 
breast), large skin paddles required (delayed breast reconstructions) or reconstructions 
requiring additional projection (less ptotic breast) then the majority of the lower abdominal 
pannus may be required as a donor site.  As an example Zone IV can be useful to provide 
more volume and skin particularly when performing delayed reconstructions of large 
breasts.  
Despite the widespread utilisation of the free DIEP flap in breast reconstruction there are 
well recognised flap related vascular complications
41,54,61,79,80,82-84,86
. This is particularly 
true of Zone IV as it is the area of the flap which receives the least perfusion/drainage from 
the perforating vessels and is therefore the most likely to suffer from perfusion related 
issues such as ischaemia, venous congestion and fat necrosis.  Despite some authors 
reporting variable success with the inclusion of Zone IV in their DIEP flaps
61
 others have 
commented that Zone IV almost always suffers from problems
83
. In addition there is the 
belief that inclusion of Zone IV may compromise the overall arterial perfusion to the other 
Zones of the DIEP flap
83
. Secondary to this many surgeons routinely excise and discard 
Zone IV from the DIEP flap prior to flap transfer to the defect site. As a result the volume 
of the DIEP flap available for transfer is reduced by approximately 15-20% and can be 
difficult to shape to fit the geometry of a natural breast. 
There are various strategies described to increase the volume/projection of free DIEP flap 
breast reconstructions including dividing the DIEP flap in the midline and “stacking” each 
hemi-flap on top of each other
140-142
; stacking an SIEA flap on top of a hemi-DIEP 
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flap
142,143
 or in the extreme stacking a Superior Gluteal Artery Perforator (SGAP) or 
Profunda Artery Perforator (PAP) flap on top of a DIEP flap
144
. 
However, these procedures all have a significant learning curve in terms of arranging flap 
and pedicle geometry, require additional dissection; require additional operating time or in 
the case of the stacked DIEP/SGAP/PAP flap combinations an additional donor site out-
with the abdomen. 
Others advocate delayed augmentation of DIEP flaps using lipomodelling as the simplest 
method to address any volume deficiencies or contour irregularities
145,146
.  However, this 
often leads to the requirement of multiple additional procedures for the patient. 
If Zone IV of the DIEP flap could reliably be included without increasing the risk of flap 
related complications then this may allow surgeons the necessary volume or skin paddle 
required for reconstruction rather than having to resort to additional or second stage 
procedures. 
1.8.1 Pro-active vascular augmentation of DIEP flaps 
Vascular augmentation of the DIEP flap through the additional anastomosis of an extra 
artery / vein or both at the time of the original operation is another option to potentially 
improve blood supply to the flap and increase prospective flap volume.  
Whilst most vascular augmentation procedures are performed as salvage to treat the 
congested DIEP flap (cf. 1.6.6), some authors are now proposing pro-active vascular 
augmentation of DIEP flaps to improve blood flow to the flap or to increase the size of the 
flap which can be taken. Such procedures have previously been described to augment the 
blood supply of TRAM flaps
101,147-152
 but are only recently being described exclusively in 
DIEP flap breast reconstructions. 
The first cases of vascular augmented DIEP flaps for breast reconstruction were actually 
described in 2002 by Mu et al who performed 5 cases of vascular augmented DIEP flaps 
using both ipsilateral and contralateral DIE vessels attached respectively to the proximal 
and distal ends of the IM vessels
153
. 
However it was not until 2007 when Hamdi et al later described their use of vascular 
augmented DIEP flaps that the technique received widespread acknowledgment
154
.  In their 
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series of 16 free DIEP flap breast reconstructions inclusion of all Zones of the flap was 
required secondary to the need for a large volume reconstruction or issues with abdominal 
vascular supply (i.e. previous scarring on one side of the flap). Various augmentation 
configurations were utilised in this case series. 13 of the flaps underwent vascular 
augmentation procedures using the IM vessels to supply the main pedicle and various 
intra-flap anastomoses. The remaining 3 flaps had vascular augmentation procedures using 
the thoracodorsal vessels attached to a secondary pedicle to provide blood supply to the 
flap in addition to the main pedicle IM vessel anastomoses.  Hamdi et al also attempted to 
provide a classification system for the various types of flap configurations. (See Figure 
1.16) 
 
Figure 1.16: Proposed classification system for abdominal perforator flap and vascular 
augmentation configurations 
Image reproduced with permission from Elsevier Ltd. (Hamdi et al. 2007)
154 
Since the description by Hamdi et al a variety of other authors have reported their 
experiences in providing large volume reconstructions with vascular augmented DIEP 
flaps and suggested various modifications to the above classification system
155-161
. 
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1.9 Potential concerns of vascular augmentation of 
abdominal flaps 
There are numerous documented cases concerning the use of vascular augmented flaps; 
mostly as a salvage procedure to improve venous drainage in congested flaps 
50,61,80,82-84,93-
100
, or as an attempt to utilise larger more robust flaps
101,147-158,160,161
. However, the results 
of these cases are simply reported in terms of free flap survival or failure with little in the 
way of scientific evidence supporting their use. 
Whilst the experimental animal studies have provided some evidence that vascular 
augmentation of abdominal flaps in rats leads to increased areas of flap survival; these are 
all post-operative outcome assessments with no account for the in-vivo effects on blood 
flow or perfusion occurring at the time of augmentation procedure
162-167
.  Also it would 
appear from some of these experimental studies that arterial augmentation is more 
important than venous augmentation
166,167
. 
Though it may seem logical that increasing the number of blood vessels used to supply a 
flap will lead to an increase in flap perfusion and improvement in flap outcome; recent 
evidence has shown that counter-intuitively this may not be the case. An elegant 
experimental animal and in-vivo human study was published by Douglas et al in 2014 
assessing the effect of perforator number and location on total pedicle blood flow and on 
Zone IV skin and fat perfusion of DIEP flaps
168
. In the first part of this study carried out on 
twenty abdominal flaps in rats they found that there was a significant decrease in main 
pedicle blood flow when the flaps were based on more than a solitary perforator. In the 
second part of this study they assessed in-vivo using LDI and ICG angiography the effect 
of perforator number on Zone IV perfusion and interestingly found that basing flaps on 
more than one perforator resulted in significantly lower perfusion to Zone IV of the flap. In 
their discussion they suggest that their findings could be accountable to changes in 
pressure gradients within the flap and that by adding additional perforators the overall 
venous filling pressures to this area of the flap are reduced resulting in poorer perfusion. 
The results of this study would corroborate the findings published by Gill et al in 2004 in 
which they found a significant positive correlation between increasing the number of 
perforators used to supply flaps and flap related complications, including partial flap loss, 
in a retrospective review of 758 DIEP flaps
53
. 
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1.10 Outcomes of DIEP flap breast reconstruction 
The outcome of DIEP flap surgery is due to far more than flap survival or the presence or 
absence of any of the potential complications discussed previously. Although complete or 
partial flap failure in itself is an important outcome better measures are now required for 
audit and in many areas justification of funding. Given the primarily aesthetic aim of breast 
reconstruction; i.e. replacing the excised breast tissue for something similar in terms of 
size, shape and volume; then the major outcomes are patient satisfaction and post-operative 
cosmesis. 
1.10.1 Patient Reported Outcome Measures 
Traditional outcome assessment in the field of Plastic Surgery has focussed on 
surgeon/peer opinion and analysis of photographic evidence or complication rates. 
However, whilst this data is important to consider, it fails to take into account individual 
patient perceptions of the surgical results and the profound effect that surgical 
interventions can have on a patients’ quality of life. In an effort to address this issue 
specially designed questionnaires, known as Patient Reported Outcome Measures 
(PROMs), have been developed that quantify health-related quality of life and/or other 
significant outcome variables (e.g., satisfaction) from the patient’s perspective169. The 
results obtained via these questionnaires have become increasingly important in clinical 
practice and also plastic surgery research.  
Whilst capturing of any patient response to treatment is crucial, in order to ensure their 
satisfaction with the results, it is important to do so in a reliable and reproducible manner. 
Concerns have been raised that in plastic surgery research many of the studies using 
PROMs to assess surgical outcome have utilised questionnaires which have not been 
adequately validated or designed according to established guidelines
170
. The development 
of validated PROM questionnaires with particular reference to the population that they are 
assessing rather than generic questionnaires is paramount to ensure that the data observed 
is reliable.  
Studies assessing the outcomes of breast reconstruction and breast aesthetic surgery lend 
themselves well to the use of PROMs as it is well established that overall patient 
satisfaction is the most important factor in determining the success of any form of surgery 
dealing with aesthetics
171
. However, a systematic review by Pusic et al in 2007 highlighted 
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that there were major issues with the PROM questionnaires used in the field of breast 
surgery as only seven of two hundred and twenty three studies utilised appropriate 
psychometrically validated PROMs for a breast population
172
. The use of such generic 
questionnaires in a breast population can lead to a lack of sensitivity, failing to identify 
specific problems encountered by breast surgery patients, over-estimating treatment effects 
and leading to reporting bias
173
.  
The BREAST-Q, developed in 2009 by Pusic et al, is a PROM questionnaire designed to 
study the impact and effectiveness of breast surgery from the patient perspective
174
. It 
covers six domains involved in breast surgery; satisfaction with breasts, overall outcome, 
process of care, and psychosocial, physical and sexual well-being. It can be utilised in a 
modular fashion for breast augmentation, reduction or reconstruction. Since its 
introduction in the plastic surgery literature the BREAST-Q has become well validated in 
breast research and outcome-reporting
175
. 
With regards to the superiority of abdominal based reconstruction versus the other 
treatment options, utilising PROMs as an assessment tool, there is much conflicting 
evidence in the literature. 
A retrospective study of by Alderman et al in 2000 assessing determinants of patient 
satisfaction after breast reconstruction found that in the 212 patients those opting for 
autologous based abdominal flap reconstructions were more than twice as likely to be 
satisfied with their reconstruction than those patients with implant based reconstructions
25
. 
Similar retrospectives studies by Christensen et al
26
 and Saulis et al
31
 assessing the 
outcomes of 263 and 268 women respectively found that women who had opted for 
autologous reconstruction over implant based reconstruction were significantly more 
satisfied with their reconstruction. 
In a large study by Yueh et al in 2010 comparing outcomes of 538 patients undergoing 
various types of autologous flap (TRAM, DIEP or LD) or implant based breast 
reconstructions. They found that patients undergoing DIEP flaps had the highest 
satisfaction rates and that 80% of all DIEP patients were happy with their reconstruction
33
. 
This corresponds to the results of a study by Damen et al who reviewed satisfaction rates 
after DIEP flap breast reconstruction and found that in the 72 woman they reviewed 94% 
were satisfied with the appearance of their breast reconstruction when dressed and 89% felt 
that the reconstructed breast felt like their own
176
.  
57 
 
 
Other studies have shown that there may be no real difference in satisfaction or that 
implant based reconstructions may have higher rates of patient satisfaction. In a study of 
206 patients by Andrade et al they could find no difference in terms of patient satisfaction 
between implant or autologous tissue reconstruction
177
. A later study by Fogarty et al in 
2004, assessing patient satisfaction after TRAM flap reconstruction or implant based 
reconstruction found similar results, in that whilst the mean patient satisfaction in the 
TRAM group was higher than the implant group, it did not reach statistical significance
178
. 
However, this study was small consisting of data comprised from only 57 patient 
questionnaires. In a larger study of 168 patients, Spear et al found that patients with 
implant reconstructions had the highest satisfaction scores in comparison to those with 
autologous based reconstructions
179
. 
1.10.2 Aesthetic Outcome 
Advocates of DIEP flap breast reconstructions state that they offer a natural shape, feel and 
good aesthetic outcomes
49-51,53
. This relates to the evidence available in the literature 
concerning aesthetic outcomes of abdominal flap breast reconstructions.  
Alderman et al in 2000 found patients undergoing autologous based abdominal flap 
reconstructions were 4.72 times more likely to be satisfied from an aesthetic point of view 
than those undergoing implant based reconstructions
25
. A similar finding was made by 
Tonseth et al, in that DIEP flap based reconstruction scored significantly higher from an 
aesthetic point of view, in terms of shape, symmetry, volume, position and consistency, in 
visual analogue scales than those having expandable implant based reconstructions
180
.  
A study in 2003 by Cocquyt et al, showed that patients undergoing a DIEP flap breast 
reconstruction had superior results in terms of cosmesis, as assessed by expert panel, to 
those patients having breast conserving surgery procedures
181
. 
In their comparison of 538 patients, Yuet et al found that patients undergoing autologous 
breast reconstruction with abdominal based flaps were happier from an aesthetic point of 
view than those undergoing implant based, or latissimus dorsi flap reconstructions but 
could find no difference in terms of aesthetic satisfaction whether a TRAM or DIEP flap 
was utilised
33
. 
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Despite finding higher patient satisfaction rates amongst implant based reconstruction 
patients, Spear et al found significantly higher expert panel rated aesthetic outcomes in the 
TRAM cohort of patients in their study
179
. 
Furthermore, since the tissue being used is the patient’s own, rather than foreign materials, 
then these aesthetic results tend to be longer lasting, as they are not subject to 
complications, such as capsular contracture which can change the shape of the appearance 
at a later stage. Autologous tissue will also reflect changes in a patients’ body habitus over 
time; i.e. losing or gaining weight will also effect the volume of their reconstruction. 
A five year retrospective review of breast reconstruction patients by Weichman et al in 
2015, found that those patients who underwent free abdominal based reconstructions were 
more satisfied with the appearance of their breasts than those patients who underwent 
implant based reconstruction
32
.  
1.10.3 Problems associated with outcome assessment 
Whilst some studies suggest that overall patient satisfaction is linked to cosmetic 
result
177,182
, it is obvious from the conflicting patient satisfaction and aesthetic outcome 
evidence listed above that this may not be the case. It is well known that post-operative 
patient satisfaction questionnaires may be flawed, as patient perceptions of satisfaction can 
be influenced by other beliefs, such as general acceptance or gratitude for their care and 
that satisfaction ratings should be interpreted with caution as they may hide other areas of 
concern
183-185
. This may help to explain why some patients are delighted with their 
cosmetic outcome, despite their surgeon critically believing it to be a poor result or vice 
versa. This topic was investigated in a study by Beesley et al in 2012, who retrospectively 
investigated the reasoning behind patient answers to a previous breast reconstruction 
satisfaction audit questionnaire
186
. In this study they found that the main influence on 
patient overall satisfaction was due to far more than cosmesis but also by the patient’s 
relationship with their medical practitioners; the role of their reconstruction in their cancer 
journey and their clinical outcomes. It may also be that a patient’s responses may be 
influenced by the point at which they are questioned upon their reconstructive journey
187
.   
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1.10.4 Conventional subjective methods of aesthetic 
assessment 
Given the confounding factors in determining overall patient satisfaction and links to 
aesthetic outcome through questionnaires, it is clear that we must have other reliable 
assessment tools to record and assess pre and post-operative aesthetic outcomes. Without 
adequate outcome assessment measures, it becomes problematical to compare and contrast 
the various types of breast reconstruction available to each patient. However, due to the 
subjective nature of cosmesis, as discussed previously, the current assessment methods we 
have are lacking. 
Conventional methods of post-operative aesthetic outcome assessment of breast 
reconstruction surgery have often relied upon comparing post-operative still photographs 
(See Figure 1.17) coupled with ratings of various aspects of the reconstruction obtained by 
panel assessment.  
 
Figure 1.17: Conventional still photograph views obtained post breast reconstruction 
 
Whilst many studies have utilised this technique for assessment of cosmesis post breast 
conserving surgery or reconstruction,
188-196
 there is huge variation in terms of methodology 
as shown in a systematic review by Potter et al in 2011
197
.  There have also been concerns 
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that the methodology employed in these studies lack precision and are difficult to 
reproduce
189
.  
Furthermore many of the researchers involved in the aforementioned studies will 
statistically analyse the results obtained from panel ratings to show the degree of inter-rater 
reliability between the members of the assessment panel
189,190,198-200
.  A greater degree of 
inter-rater agreement between panel members is believed to relate to more scientifically 
robust results.  
Whilst still photographs are able to convey a certain degree of information to the panel, 
they are inherently limited by the fact that they are two-dimensional in nature, offer no 
demonstration of breast mobility and are subject to great panel dispute. Breast mobility is 
of particular interest in terms of autologous tissue transfer, as it is believed that autologous 
tissue reconstructions move much more like a natural breast, in comparison to implant 
based reconstruction and this may explain the trend towards patients reporting higher 
levels of aesthetic satisfaction; however this cannot be visualised on static photographs. 
1.10.5 Novel objective methods of aesthetic assessment 
In an effort to improve upon the flaws described above, other more objective assessment 
methods have been described, such as the use of computer software designed to take 
objective measurements from two dimensional digital photographs with subsequent 
computer analysis of various indices linked to symmetry
198,199,201
.  
This technique has been further improved upon through the use of three-dimensional 
imaging systems; allowing the capture of a greater amount of information
202,203
. The 
objective data obtained from three-dimensional imaging system shows promise in being 
more accurate than traditional subjective assessments
200
. However, these complex systems 
are all very expensive, require vast user expertise in terms of set-up and analysis and are 
not available in the majority of plastic surgery units.  
1.11 Summary 
In summary, breast reconstruction using free abdominal tissue, such as the DIEP flap, 
offers many advantages to the patient and appears to be linked to high satisfaction in terms 
of cosmesis, despite inadequate techniques of post-operative aesthetic outcome assessment. 
Unfortunately, it is evident that problems can occur with the DIEP flap particularly with 
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regards to its vascular supply and venous congestion leading to potential compromise of 
the flap. Zone IV of the flap is the most liable to suffer these problems and as such is 
commonly discarded in an effort to prevent flap related complications but these can still 
occur regardless. In an effort to allow the harvest of larger flaps or to salvage compromised 
flaps, strategies in the form of vascular augmentation procedures have been described, but 
there is little research into the effect that these procedures have on flap perfusion.  Further 
research into the effects on perfusion of these procedures may allow the harvest of larger 
DIEP flaps with a better vascular supply. 
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Chapter 2: Outline of Completed Studies 
Use of abdominal flaps, including the free DIEP flap is well established in reconstruction 
of the breast following cancer. However, there are issues identified in terms of post-
operative outcome assessment of such reconstructions and the problems associated with 
Zone IV DIEP flap perfusion. 
As such the following studies have been undertaken: 
2.1 The effect of vascular augmentation on DIEP flap  
Zone IV perfusion utilising the contralateral 
SIEA/SIEV    
The aim of this study was to assess in-vivo the effects of vascular augmentation on DIEP 
flap Zone IV perfusion by augmenting the flap using the contralateral SIEA, SIEV or both 
in combination.  
2.2 The effects of vascular augmentation on abdominal 
flap Zone I / IV perfusion and main pedicle arterial 
blood flow in an experimental animal model 
The aim of this experimental study was to investigate the effects of vascular augmentation 
upon flap Zone I / Zone IV perfusion and also the effect this intervention has upon the 
main pedicle arterial blood flow in a rat abdominal flap.  
2.3 The use of real-time digital video in the assessment 
of post-operative outcomes of breast reconstruction  
The aim of this study was to assess whether standardised real-time digital video footage 
was a valid assessment tool in assessing post-operative outcomes and to compare its use 
against standardised static photography. 
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Chapter 3: Materials and Methods 
3.1 Materials and Methods for Chapter 4 
3.1.1 Ethical Approval 
Ethical approval for this study was sought and granted by the West of Scotland Research 
Ethics Committee (REC 4 - 11/WS/0117).  
3.1.2 Statistical Design 
This was a pilot study. Determining sample size for a pilot study is known to be difficult 
and the literature concerning this issue is limited. Van Belle
204
 and Julious
205
 suggested the 
“rule of 12” for pilots studies as they found that increasing a sample size to 12 participants 
had a large effect upon the confidence intervals of observed data; but increasing the sample 
size further did not. A sample size of 12 is also considered practical for small scale studies 
whilst still being able to provide valuable preliminary information
206
. This was discussed 
with a medical statistician and it was felt that a sample size of 12 would feasibly provide 
enough data to drive a statistically valid study or indeed provide data to generate power 
calculations for further larger scale studies in this area.  
3.1.3 Patient Selection 
Patients due to undergo breast reconstruction with free unilateral DIEP flaps by Mr IR 
Mackay were identified from the surgical waiting list at Canniesburn Plastic Surgery Unit, 
Glasgow Royal Infirmary. 
3.1.3.1 Inclusion Criteria 
1. Female breast reconstruction patients 
2. Age between 18-70 years 
3. Due to undergo either immediate or delayed unilateral free DIEP flap breast 
reconstruction 
3.1.3.2 Exclusion Criteria 
1. Bilateral reconstructions 
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2. History of hyperthyroidism or thyroid adenoma (ICG dye contraindicated in 
such patients) 
3. History of allergic reaction to iodine or ICG dye 
4. ASA grade ≥ 3  
5. Patients with abdominal scarring 
3.1.3.3 Consent 
Potential participants were approached with an information sheet about the study. Written 
informed consent was obtained from all patients.  
3.1.4 Clinical assessment 
Patient information including demographics, past medical history, drug history and social 
history were collected, as per standard pre-operative breast reconstruction surgery, during 
each patients’ pre-operative assessment and this information stored in the patients notes. 
3.1.5 Randomisation Process 
In order to assess the contribution of each individual component of the superficial vascular 
system on the perfusion of Zone IV four different intervention sequences were required. 
These sequences were as follows  
 Both SIEA and SIEV clamped (traditional flap) 
 Both SIEA and SIEV unclamped (arterial and venous augmentation) 
 SIEA unclamped and SIEV clamped (arterial augmentation) 
 SIEA clamped and SIEV unclamped (venous augmentation) 
The order in which each intervention sequence was carried out was randomised via an 
independent internet based randomisation service; utilising true randomness generation via 
atmospheric noise
207
, for every patient prior to the commencement of their operative 
procedure.  
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3.1.6 Environmental Conditions 
All procedures/measurements were carried out in the same theatre under the same 
controlled environmental conditions.   
Previous studies with regards to measurement of cutaneous blood flow using Laser 
Doppler suggest that capillary blood flow within skin is stable when environmental 
temperatures are between 17-28 degrees Celsius
208,209
 thus ambient theatre temperature 
was set at a level between 25 and 27 degrees Celsius and was recorded prior to and during 
the measurement process to ensure that it was kept constantly within this range.  
It has been shown that reflected light can interfere with LDI scan results in terms of falsely 
high flux readings
209
. In order to standardise environmental lighting and reduce possible 
interference from reflected light sources during the scanning process the main operating 
theatre lights were turned off and the internal lighting dimmed to lowest possible level. 
Windows were temporarily occluded to block any other external sources of light from 
entering the theatre.  
During the scanning capture period of the study all entrances to the theatre were closed and 
signs placed to prevent intrusion and interruption to the study. 
3.1.7 Laser Doppler Imaging 
3.1.7.1 Laser Doppler Imaging Machine Specifications 
A MoorLDI2-IR laser Doppler blood flow imaging system (Moor Instruments, Axminster, 
Devon, UK) owned by the Canniesburn Research Trust was used during the human study. 
The device is portable, based upon a mobile stand and consists of an imaging head, 
monitor and computer. The imaging head is linked to an articulated arm allowing easy 
positioning over the study area; containing an infra-red laser diode operating at 785nm 
optical capture device and also a digital video/photo capture device which can display 
images in real time. The central computer contains the software necessary to capture, 
process and then store the LDI images for each patient study. The monitor allows real-time 
viewing of the digital video feed intra-operatively and to review the captured LDI images 
post-operatively. (See Figure 3.1) 
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Figure 3.1: MoorLDI2-IR laser Doppler blood flow imaging system  
Image reproduced with permission from Moor Instruments Ltd. 2015 
This system was serviced and calibrated prior to the commencement of the study by Moor 
Instruments, Axminster, Devon, UK.  
3.1.7.2 Preparation for Laser Doppler Imaging 
The LDI machine was brought into the theatre suite and turned on prior to the 
commencement of each patients operation, as per manufacturers’ guidance that a 30 
minute period should be allowed to elapse from initialisation of the system to first scan 
sequence. Once the 30minute period had passed the LDI machines calibration was ensured 
using the supplied sealed calibration block and the machine recalibrated if required to 
ensure validity of scan results. The machine was then placed to the side within the 
operating theatre until required for the first scanning sequence.  
3.1.7.3 Technique of Laser Doppler Measurement 
The LDI machine was positioned prior to the start of the first scanning sequence. In order 
to standardise the positioning of the LDI imaging head and ensure that the same area of the 
67 
 
 
flap was scanned in each subsequent scanning sequence the mobile base of the LDI 
machine was locked in position and its articulating arm set at the furthermost point with 
the area of the flap to be scanned within the imaging window. The imaging head height 
was set at 30cm from the flap and this position locked. The mobile base was not moved 
between individual scanning sequences and only the articulating arm was fully retracted 
and fully extended between scanning sequences. 
Moor BDA version 5.3 software was used to acquire images due to its ease of use, greater 
reliability and consistency. Scanning parameters were set as medium scan type (resolution 
of 64) on a large vertical rectangle at 4milliseconds/pixel. Each LDI scanning sequence 
took exactly two minutes. Scanning sequences for each patient in the study were stored on 
the hard drive for subsequent analysis. 
3.1.8 ICG Angiography 
3.1.8.1 ICG Angiography Machine Specifications 
A SPY® intra-operative fluorescence vascular angiography system developed and 
manufactured by Novadaq® (Novadaq Technology Inc., Mississauga, Ontario, Canada) 
was used in the human study. This device was supplied to our plastic surgery unit on loan 
by CardioLogic® (CardioLogic Ltd, Yorkshire, United Kingdom) the UK distributor of the 
Novadaq SPY imaging technology. (See Figure 3.2)  
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Figure 3.2: SPY® intraoperative imaging system 
 
The device is portable and easily movable around the theatre suite.  It consists of an 
imaging head, monitor, computer and optical storage drive. The imaging head is linked to 
an articulated arm allowing easy positioning over the study area, containing both a laser 
operating at 805nm (to cause fluorescence of the ICG dye) and an optical capture device 
which can record in real time the resultant fluorescence. The central computer contains the 
software necessary to capture; process and then store the image sequences on the optical 
storage drive for each patient study. The monitor allows real-time viewing of the 
fluorescence intra-operatively and to review the captured sequences. 
This system was serviced and calibrated prior to the commencement of the study. 
3.1.8.2 Preparation for ICG Angiography 
The SPY® imaging system was brought into the theatre suite and turned on prior to the 
commencement of each patients operation. The machine was then placed to the side within 
the operating theatre until required for the first ICG angiography scanning sequence.  
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The ICG dye used in this study was ICG-Pulsion® manufactured by Pulsion Medical 
Systems (PULSION Medical UK, Middlesex, United Kingdom). This comes in a sterile 
vial containing a lyophilised form with approximately 25mg of active ICG and sodium 
iodide as a preservative. This was reconstituted with 5ml of sterile water prior to yield a 
constitution of 5mg/ml. 
3.1.8.3 Technique of Indocyanine Green Angiography Measurement 
The SPY® imaging system was positioned prior to the start of the first scanning sequence. 
In order to standardise the positioning of the SPY® imaging head and ensure that the same 
area of the flap was scanned in each subsequent scanning sequence the mobile base of the 
SPY® machine was locked in position and its articulating arm set at the furthermost point 
with the area of the flap to be scanned within the imaging window. The imaging head 
height was set at 40cm from the flap and this position locked. The mobile base was not 
moved between individual scanning sequences and only the articulating arm rotated 
between scanning sequences. 
2ml of reconstituted ICG dye (5mg/ml) (cf. 3.1.8.2) was injected into a peripheral access 
line immediately followed by a fluid bolus of 20mls of sterile water. 20 seconds was 
allowed to elapse to allow the dye to fully enter the circulation (as per the manufacturers’ 
guidelines) and then the scan of flap skin paddle using the SPY® intraoperative imaging 
system was commenced. Immediately following the scan of the flap skin paddle a 
subsequent scan was performed upon the fat component of the flap to assess fat perfusion. 
Each scanning sequence lasted 38 seconds and sequences were stored on hard drive for 
subsequent analysis.  
Between each change in variable to be assessed and subsequent scanning sequence; a time 
interval of 10 minutes was allowed to pass in order for the dye to be fully eliminated from 
the circulation as was the protocol in a previous study carried out within our unit
168
 and 
shown in other published work
210
. 
2ml of ICG dye (5mg/ml) was required for each combined skin/fat scanning sequence and 
a total of 40 mg was used upon each study participant. 
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3.1.9 Operative Procedure and Measurement Process 
To improve standardisation of the results, a single Consultant Plastic Surgeon (Mr I R 
Mackay) was responsible for the raising of all DIEP flaps within the research cohort.  
Each patient was marked pre-operatively, with the borders of the abdominal flap being 
defined as per the surgeons’ routine practice.  The upper incision curves down bilaterally 
from the superior umbilicus to the left and right anterior superior iliac spines. This incision 
can be extended more laterally beyond the anterior superior iliac spines, if required to 
prevent “dog ear” deformity, dependent upon each patient’s body habitus. The lower 
incision is designed like a skewed “W” with the lowest points being approximately 8 cm 
lateral to midline and a slightly upward curve over the mons pubis area. (See Figure 3.3) 
 
Figure 3.3: Patient prepped and draped for surgery to commence with pre-operative 
markings visible 
 
All procedures were carried out under General Anaesthesia by one of three senior 
consultant anaesthetists. The nature of the study had been discussed in detail with each 
anaesthetist prior to commencement of each procedure in an effort to ensure that each 
patient was kept as haemodynamically stable as possible during the measurement process. 
Patient variables (heart rate and systolic/diastolic blood pressure) were recorded every 5 
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minutes throughout the operation. Patient core temperature was also recorded every 15 
minutes through the use of a nasal temperature probe. Maintenance of patient temperature 
was aided by the use of Bair Hugger™ blanket covering areas of the patient out-with the 
operative field. 
Raising of each DIEP flap was carried out as standard from lateral to medially bilaterally; 
however considerable additional care was taken to identify and preserve the superficial 
vascular system (SIEA/SIEV), initially on both sides. (See Figure 3.4) 
 
Figure 3.4: Right SIEA (white vessel sloop) and SIEV (blue vessel sloop) dissected free 
 
Concomitantly the patient underwent mastectomy (unless delayed) by one of two 
Consultant Breast Surgeons. The medial 4
th
 costochondral cartilage was removed and the 
underlying internal mammary artery (IMA) and internal mammary vein (IMV) prepared to 
act as recipient vessels for microvascular transfer. 
After deciding upon which side to base the flap (dependent upon the adequacy of the 
perforating blood vessels in terms of size, dissection required and pulsatility); the 
perforator(s) were dissected to their origin from the main pedicle (DIEA/DIEV). (See 
Figure 3.5) 
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Figure 3.5: Patient 12 in study showing DIEP flap based on a left large medial row and small 
lateral row perforator with an intramuscular course 
The preserved motor nerve can be seen crossing over the top of the pedicle 
The ipsilateral superficial vascular system to the main pedicle was divided, leaving the 
contralateral superficial vascular system intact. 
The DIEP flap was completely islanded on only the perforators supplied from the main 
pedicle (DIEA/DIEV) and contralateral superficial vascular system (SIEV+/-SIEA).  
The flap was divided into the classical Hartrampf’s zones of perfusion (I-IV) and these 
areas marked. The flap was then temporarily secured in its anatomical position with several 
silk sutures on the side not being assessed (i.e. contralateral side to zone IV), as shown in 
Figure 3.6. 
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Figure 3.6: Left DIEP flap divided into Zone I-IV and secured in place prior to scanning. 
 
Single arterial and venous Acland clamps (3A and 3V respectively) were used to occlude 
the SIEA, SIEV or both as per the randomised intervention sequence (cf. 3.1.5). Following 
each clamping/unclamping intervention a period of 5mintues was allowed to elapse prior to 
allow perfusion within the flap to stabilise and reactive hyperaemia to settle
211
.  
Perfusion measurements using LDI (cf. 3.1.7.3) and ICG angiography (cf. 3.1.8.3) were 
obtained.  
Each measurement sequence was carried out as per the flowchart diagram shown in Figure 
3.7. 
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Figure 3.7: Flowchart summarising clamping intervention and scanning process 
 
Upon completion of the measurement process the patients operation proceeded as standard, 
with Zone IV of the flap being discarded (surgeons’ routine practice), the flap detached 
completely and transferred to the recipient site. The DIEA/DIEV was anastomosed to the 
IMA/IMV end to end using 9.0 sutures; flap inset, rectus sheath repaired and the abdomen 
closed via an abdominoplasty. 
3.1.10 LDI Scan Analysis 
Moor BDA version 5.3 software was used to analyse all captured patient LDI images. This 
post-processing software allows objective measurements to be made on each of the 
captured LDI images. A region of interest can be set for only a specific area within the 
entire LDI image to be assessed independently; in this case Zone IV of the flap.  
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In order to ensure that the same region of interest was set for each patients flap, between 
the varying scan sequences, the region of interest was always measured as the area 
encompassing 1cm from the flap peripheral margins to 1cm within the marked Zone IV 
border. By measuring 1cm from the flap periphery this also helped to reduce the artefact 
created by the slight curvature of the cut edges which can influence light reflection and 
lead to inaccurate flux readings
209
. 
Median flux values of Zone IV perfusion values for each patient were obtained. Median 
LDI flux values were used as previous published work by Tollan et al assessing similar 
aspects of DIEP flap perfusion has suggested that median LDI flux values give more 
accurate results
212
.   
3.1.11 ICG Scan Analysis 
Captured SPY imaging sequences were analysed via SPY-Q analysis toolkit software. This 
post-processing software allows objective measurements to be made on each of the 
captured study sequences. A region of interest can be set for the area to be reviewed within 
the image sequence and baseline fluorescence intensity for this area can be calculated for 
the duration of the capture sequence. The baseline fluorescence intensity can then be used 
for quantitative comparisons between imaging sequences. 
In order to ensure that the same region of interest was set for each patients flap, between 
the varying scan sequences, the same process was utilised as for LDI Scan analysis (cf. 
3.1.10) with the region measured at 1cm from the flap periphery.  
Mean Zone IV skin and fat perfusion values for each patients scanned sequences were 
obtained.   
3.1.12 Statistical Analysis 
All results were analysed using Minitab version 16 (Minitab Inc., State College, PA). 
Continuous data was assessed for normality using the Anderson-Darling test of Normality. 
A repeated measures analysis of variance (ANOVA) test was used to assess for statistically 
significant differences between each of the clamping/vascular augmentation interventions. 
Where p<0.05 in the repeated measures ANOVA test the Bonferroni correction method 
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was used to assess for pairwise differences between each vascular augmentation 
intervention and the control group (traditional flap). 
Since it was well established that the SIEA may be absent in up to 13-35% of patients
65-67
 
it was proposed that should the SIEA be absent in any of our study cohort that the SIEV 
clamping and unclamping still be utilised for analysis.  In such cases when the SIEV was 
clamped the result obtained was placed in the “Both Clamped” and when the SIEV was 
unclamped the result was placed in the “SIEA Clamped / SIEV Unclamped” category to 
allow for correlation. Separate sub-analysis excluding those patients where the SIEA was 
not present was undertaken to ensure accuracy of the results. 
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3.2 Materials and Methods for Chapter 5 
3.2.1 Ethical Approval 
This study was approved by the University of Glasgow Ethical Review Panel. A personal 
investigator licence (60/12807) and project licence (60/4415) under the terms and 
conditions of the Animals (Scientific Procedures) Act 1986, was granted by the UK 
Government Home Office.  
3.2.2 Statistical Design 
As this was a pilot study measuring the effects on perfusion and flow of vascular 
augmentation of rat abdominal flaps there was not sufficient data in the literature upon 
which to base a power calculation.  
The Home Office and The National Centre for the Replacement, Refinement and 
Reduction of Animals in Research (NC3Rs), a UK based scientific organisation dedicated 
to reducing the number of animals used in research, suggest the following resource 
equation when deciding upon animal numbers to be used in small non-routine pilot studies 
such as our own. 
E = N (number of animals per treatment x number of treatments) - T (number of 
treatments)
213
. 
They state that E (the sample size) should be a number between 10 and 20, to use the 
minimal number of animals possible whilst providing scientifically valid results. 
10 animals were proposed to be used in this study comprising of two treatment groups 
(traditional vs vascular augmented) and thus the following resource equation was made: 
E = ((10 x 2) – (2)) = 18 
This fell within the recommended sample size of 10-20 as stated above. However the 
resource equation wasn’t entirely applicable to our study as the above equation considers 
the number of treatment arms to require two separate animal cohorts. In our study we were 
proposing to perform each treatment arm upon the same abdominal flap of a single animal 
using the clamping intervention as described above rather than requiring a separate cohort 
of animals. As such rather than requiring 20 animals (10 in each cohort) to perform our 
78 
 
 
research upon we would only require 10 overall. After discussion with the Veterinary 
Surgeon representing the Biological Research Division, Veterinary Research Facility, 
University of Glasgow he suggested the addition of a further 2 animals to our proposed 
cohort of 10 to account for any unexpected complications or mortalities secondary to 
anaesthesia or procedure during the experiment.  
Thus 12 animals were proposed to be utilised in this experiment and the ethical review 
panel and Home Office were satisfied that this adequately reduced the number of animals 
required whilst still providing scientifically valid results. 
3.2.3 Animals 
Male out-bred Sprague Dawley rats were chosen to be used for this research study. This 
decision was made following advisement from the Veterinary surgeon from the Biological 
Research Division, Veterinary Research Facility, University of Glasgow. 
3.2.4 Anaesthesia and Peri-operative care 
All animals in this study had the same anaesthetic protocol devised by the named 
Veterinary surgeon for the project. Anaesthetic induction was carried out by the named 
Veterinary Surgeon and maintenance of their anaesthesia and peri-operative care provided 
by specialist animal technicians under his direct supervision.  
Animals were weighed pre-operatively; results recorded and their anaesthesia requirements 
calculated. Induction was carried out via administration of gaseous Isofluorane in an 
animal containment box combined with further intra-peritoneal injection of Inactin
®
 
(thiobutylbarbitole). Following induction all animals received an additional intraperitoneal 
injection of atropine to reduce secretions.  
Maintenance inhalational anaesthesia (N2O/Isoflourane/O2) was provided to each animal 
via voluntary respiration through the use of a nasal cone secured to each animals’ snout. 
Each animal in the study had their heart rate and oxygen saturations continuously 
monitored via the use of a Nonin 8500AV pulse oximeter probe (Nonin Medical Inc., 
Plymouth, MN, USA) attached to a hind limb.  
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Each animals’ temperature was maintained through the use of an ambient heat source 
situated in proximity to the animal. Core temperature was monitored throughout the 
procedure through the use of a rectal probe and the heat source moved as necessary to 
maintain an adequate temperature between 37-38°C. The rectal probe temperature monitor 
was also connected via analogue output to a Powerlab® 400 System to allow continuous 
capture and recording of temperature data throughout the measurement period. 
3.2.5 Randomisation Process 
The side upon which to base the flap and the order of scanning (traditional or vascular 
augmented) was randomised via an independent internet based randomisation service
207
. 
3.2.6 Environmental Conditions 
All procedures were carried out in the same room within the same research facility with 
ambient temperature controlled between 21-24.5°C.  
3.2.7 Laser Doppler Flowmetry 
3.2.7.1 Laser Doppler Flowmetry Machine Specifications 
A Moor VMS-LDF2 laser Doppler flowmetry system (Moor Instruments, Axminster, 
Devon, UK) obtained via loan from Moor Instruments to the Canniesburn Research Trust 
was used during the animal study. The device is small and portable, consisting of a central 
base unit containing a 785nm diode laser and two input/output channels for the attachment 
of optical probes. The base unit has its own digital display on the face panel but also has an 
additional analogue output connection.  Optical probes supplied with the unit consist of a 
probe head (to be attached to the target area of tissue), optical cable and a probe tail which 
can be inserted into the base unit. (See Figure 3.8) 
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Figure 3.8: MoorVMS-LDF2 laser Doppler monitor 
Image reproduced with permission from Moor Instruments Ltd. 2015 
This system was serviced and calibrated by Moor Instruments, Axminster, Devon, UK 
prior to the commencement of the study. 
3.2.7.2 Technique of Laser Doppler Measurement 
Two optical probe heads were secured in direct perpendicular contact to the central portion 
of Zone I and Zone IV of the flap respectively using plastic probe head holders and 
adhesive stickers. Due to respiration causing the animals’ abdomen to move and poor 
adhesion from the stickers supplied an additional piece of Micropore
™
 tape was placed 
over the top of the probe heads to ensure good contact of the probe head to the target 
tissue. Care was taken to avoid any external pressure on the probe head whilst placing the 
tape to prevent any falsely decreased perfusion readings. Real-time LDF capture sequences 
were recorded for each study intervention using Moor-VMS-PC for Windows software and 
stored for subsequent analysis. 
3.2.8 Microvascular Flow Measurement 
3.2.8.1 Microvascular Flow Measurement Machine Specifications 
Microcirculation transit-time flow probes (Transonic V series type 0.5V; Transonic 
Systems Inc., Ithaca, NY, USA.), were used during this study to assess microvascular flow 
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through the main pedicle DSEA. These probes are designed to be able to assess flow 
within vessels of between 0.25-0.5mm in outer diameter, are specifically calibrated for 
blood temperature of approximately 37°C and can detect flow rates from 0-50ml/min. The 
probes operate at an ultrasound frequency of 7.2Hz, can detect flow rate changes of 
0.05ml/min and have a relative accuracy of ±3%. Probes had been calibrated for use in a 
study performed the previous year. 
Probes consist of a handle (within which runs the cabling to connect to an analogue input) 
connected to a probe body and reflector. The space between the probe body and reflector 
create a natural lumen also known as the ultrasonic window. (See Figure 3.9) 
 
Figure 3.9: Microcirculation flow probe 
 
Two transducers present on either side of the probe body simultaneously convert electrical 
energy to ultrasonic energy and ultrasonic energy back to electrical energy. The ultrasonic 
signals are passed back and forth through the ultrasonic window, this is shown in Figure 
3.10.  
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Figure 3.10: Mechanism through which the flow probe operates 
Image reproduced with permission from Transonic System Inc. (2015) 
The time taken for these signals to reach the opposite transducer can be detected in terms 
of changes in the electrical signals sent and received using a flowmeter.  
Flow probes were attached to a transit-time ultrasonic flowmeter (T204, Transonic 
Systems Inc.) which converts the analogue signal received from the flow probe into an 
estimation of mean flow in mL/min and this is displayed on the digital display on the face 
panel of the machine. Given the small size of the vessels studied and microvascular probes 
used, the flowmeter was set on low-flow setting which allows a more accurate assessment 
of intravascular flow within small vessels by recording separate flow measurements every 
0.0025 seconds. This data was subsequently digitised through an analogue output 
connection to a Powerlab® 400 System (AD Instruments Pty Ltd.). The Powerlab® 400 
System was in turn connected via USB cable to a laptop PC running Chart V5.56 for 
Windows (AD Instruments Pty Ltd.) software allowing continuous capture of flow data. 
3.2.8.2 Preparation for intra-vascular flow measurement 
Flow probes were soaked in sterile saline (maintained at a temperature of 37°C) for at least 
ten minutes prior to the measurement process commencing. This was in line with 
manufacturer recommendations to eliminate a random-drift in zero offset.   
3.2.8.3 Technique of intra-vascular flow measurement 
Flow probes were sited within the incised rectus sheath and held firmly in a stable position 
using an external stand and microvascular clamp. The DSEA was placed within the lumen 
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of the probe and drops of sterile saline (maintained at a temperature of 37°C) were used to 
submerge the area and act as an acoustic couplant. A five minute interval was observed 
after the placing of the microvascular flow probe prior to obtaining any measurements to 
allow for stabilisation of the vessel and flow following positioning within the lumen of the 
probe. 
Continuous capture and recording of flow data was made using the Powerlab® 400 System 
/ PC interface (cf. 3.2.8.1). 
3.2.9 Experimental Procedure 
3.2.9.1 Flap Raising 
To ensure standardisation of the results obtained all animal flaps were raised in the same 
manner by the same surgeon (thesis author). Following anaesthetic induction (cf. 3.2.4) 
each animal’s abdomen was depilated using a mechanical razor.  
Animals were positioned supine upon a dissecting board and their limbs extended. The 
periphery of the abdominal flap was marked and the flap subdivided into four Zones to 
mimic Hartrampf’s Zone of perfusion (cf. 1.6.4) (See Figure 3.11) 
 
Figure 3.11: Anaesthetised Sprague Dawley rat in supine position with abdominal flap 
marked 
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Raising of each abdominal flap was carried out as per similar technique to the method 
described by Oskar et al
214
 under the aid of an operating microscope and is described 
below. 
Initial incision through the skin and fat to the level of the muscle fascia/rectus sheath was 
made using a disposable 15 blade scalpel on one side of the flap.  Haemostasis was 
achieved throughout the procedure via the use of bipolar diathermy. Upon reaching the 
level of the muscle fascia/rectus sheath microsurgical scissors were used to raise the 
abdominal flap in a lateral to medial fashion until the perforating blood vessels supplying 
that side of the flap were identified. The perforating vessels were carefully dissected free 
circumferentially and the dissection continued until the midline was approached. (See 
Figure 3.12) 
 
Figure 3.12: Left half of the abdominal flap raised from lateral to medial with the perforating 
vessels supplying the skin and fat dissected free and clearly visible 
 
At this stage the other side of the flap was raised following the same method to that 
described above until the flap was completely islanded on only the perforating blood 
vessels on both sides of the flap. Once islanded an incision was made in the rectus sheath 
on both sides of the abdomen parallel to the perforating blood vessels. (See Figure 3.13) 
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Figure 3.13: Abdominal flap completely islanded on perforating blood vessels with the 
bilateral incisions through the cranial rectus sheath visibile 
 
Once the main deep superior epigastric vascular pedicle was identified cranially bilaterally 
it was dissected in a cranial to caudal direction taking extreme care to preserve the 
perforating blood vessels. Dependent upon the results of flap randomisation (cf.3.2.5), on 
the side which the flap was to be based the cranial most perforating blood vessels 
supplying that side was identified and all caudal perforating vessels cauterised. (See Figure 
3.14) 
 
Figure 3.14: Flap based on right side with the solitary cranial perforator clearly visible  
All caudal perforators on this side have been cauterised 
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The solitary perforating blood vessels were then carefully dissected through the rectus 
sheath (taking a small cuff of rectus sheath and rectus muscle to preserve the integrity of 
the extremely small perforators) to their point of origin from the main deep superior 
epigastric pedicle. Caudal to the origin of these perforating vessels the deep superior 
epigastric artery (DSEA) and vein (DSEV) were ligated using 10.0 Ethilon sutures.  
On the contralateral side of the flap a similar process was undertaken although the most 
caudal perforator was selected and dissected completely free to its origin and all cranial 
perforating blood vessels cauterised above the rectus sheath and ligated at their respective 
origins from the DSEA and DSEV using 11.0 Ethilon sutures. (See Figure 3.15) 
 
Figure 3.15: Dissection of the caudal most perforator on the contralateral side of the flap 
 
The DSEA and DSEV were then ligated caudal to the dissected caudal-most perforating 
vessels using 10.0 Ethilon sutures. At the cranial-most point where the DSEA and DSEV 
are emerging from below the rib-cage on this side of the flap the DSEA and DSEV were 
dissected free. 
In summary at this stage of completed flap dissection the flap is obtaining its vascular 
supply from a pedicle containing the cranial most perforating artery and vein from the 
DSEA and DSEV (main pedicle) on one side of the flap and the contralateral DSEA and 
DSEV pedicle (augmentation pedicle) containing only the caudal most perforating artery 
and vein. 
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A transit-time ultrasound flow probe (Model 0.5V, Transonic Systems Inc.) was then 
inserted through the incision in the rectus sheath and the main pedicle DSEA supplying the 
flap was placed within the flow probe (cf 3.2.8.3). The flow probe was secured externally 
in position using a clamp attached to a stand. 
The flap was then sutured back into its original position taking care to avoid any tension 
using 5.0 Ethilon sutures. (See Figure 3.16) 
 
Figure 3.16: Flap completely raised and secured in anatomical position 
The transit-time ultrasound flow probe placed around the right DSEA can be observed held 
in position with a clamp  
MoorVMS-LDF2 laser Doppler monitor optical probes were then attached to Zone I and 
Zone IV of the flap respectively (cf. 3.2.7.2). 
The set-up of the multiple machines used in this experiment (MoorVMS-LDF2 laser 
Doppler monitor; T204 flowmeter, Powerlab® 400 system) is shown in Figure 3.17. 
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Figure 3.17: Equipment set-up in animal experiment model 
 
If the first scanning sequence had been randomised to assess the traditional flap initially 
then the contralateral DSEA/DSEV pedicle was occluded using a removable Acland B1-V 
microvascular clamp. 
3.2.9.2 Measurement Process 
Upon completion of flap raising (irrespective of clamped or non-clamped pedicle) there 
was a five minute interval observed prior to the commencement of the measurement 
process to allow the flap to stabilise and the effects of any reactive hyperaemia to 
settle
168,211
. 
Prior to each measurement sequence animal heart rate and oxygen saturation were 
recorded. 
LDF perfusion readings obtained through the optical probes attached to Zone I and Zone 
IV of the flap were recorded for a period of one minute (cf. 3.2.7.2) and the results stored 
for subsequent analysis. 
Concurrent flow rate measurements through the main ipsilateral SEA were obtained for the 
same one minute period (cf. 3.2.8.3) and recorded in Chart V5.56 for Windows for 
subsequent analysis. 
89 
 
 
Once these measurements were complete the clamp was either placed on or removed from 
the contralateral DSEA and DSEV and a further 5 minute interval was observed to again 
allow for reactive hyperaemia to settle. 
At the end of the measurement process all animals were humanely terminated via a method 
approved under schedule 1 to the Animals (Scientific Procedures) Act 1986. 
3.2.10 Laser Doppler Flowmetry Analysis 
Moor-VMS-PC for Windows was used to analyse the data obtained via the MoorVMS-
LDF2 laser Doppler monitor optical probes. Subsequent analysis of captured sequences 
utilising this software allow for the calculation of mean flux results over the entire capture 
period. 
Mean flux values were obtained from Zone I and Zone IV in the traditional and vascular 
augmented flaps. 
3.2.11 Intravascular Flow / Temperature Analysis 
LabChart Reader Version 8 (AD Instruments Pty Ltd.) for Microsoft Windows was used to 
analyse all data captured by the PowerLab® 400 system.  This software allows the user to 
analyse and interrogate the digital data generated by the Powerlab® 400 System and its 
analogue inputs. 
Mean core temperature values for the entire procedure and mean flow rate through the 
main pedicle DSEA (for the one minute observation period of the study) were obtained.  
3.2.12 Statistical Analysis 
All results were analysed using Minitab version 16 (Minitab Inc., State College, PA). 
Continuous data was assessed for normality using normal probability plots and an 
Anderson-Darling test of Normality. Data was found to be non-normally distributed and as 
such non-parametric tests were chosen for statistical analysis. 
Wilcoxin Signed Rank tests were used to assess for any statistically significant differences 
in the results obtained from the traditional flaps and those obtained for the vascular 
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augmented flaps. Comparisons were made between Zone I and Zone IV perfusion; flow 
rate through main DSEA and pulsatility index  pre and post vascular augmentation.  
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3.3 Materials and Methods for Chapter 6 
3.3.1 Ethical Approval 
Ethical approval for this study was sought and granted by the West of Scotland Research 
Ethics Committee (REC 1 – 12/WS/0082). 
3.3.2 Statistical Design 
A medical statistician was recruited to the research team to provide their input for this 
study in terms of sample size and analysis of the results.  
A formal power calculation to judge the required sample size was not possible as this was a 
pilot study and as such there were no available studies on the topic upon which to obtain a 
reasonable estimate of the standard deviations required for a calculation. 
Traditional studies utilising inter-rater agreement between responses have focussed upon 
assessing kappa scores (cf. 1.10.4). Simple kappa scores can only recognise absolute 
agreement or disagreement between raters and do not make any account of the varying 
levels of disagreement. A modification to the simple kappa score is that of weighted kappa 
scores; these scores measure varying degrees of disagreement by assigning different 
“weights” to each of the responses measured. The further apart the responses from each 
other the higher the weight assigned; i.e. higher levels of disagreement are associated with 
higher weight allocations.  
On the statisticians advice utilising the suggestions by Norman and Streiner
46
 who 
indicated that the sample size for weighted kappa would require too many guesses and 
invoke a rule of thumb; the minimum number of objects being rated should be more than 
2c² (where c is the number of categories).  
For our purposes utilising an assessment grading based on four categories we should 
ideally have 2x4
2
=32 subjects. 
As such it we deemed recruitment of 35 patients to be appropriate for the requirements of 
the study. 
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3.3.3 Patient Selection 
Participants were recruited from the Canniesburn Plastic Surgery Unit areolar tattooing 
clinic. This was to ensure that all oncological, adjuvant and surgical reconstructive 
treatments had been completed.  
3.3.3.1 Inclusion Criteria 
1. Females aged 18 or more years 
2. Breast reconstruction patients 
3.  Greater than six months post breast reconstruction 
4. Due to attend for areolar complex tattooing  
3.3.3.2 Exclusion Criteria 
1. Bilateral reconstructions 
2. Unilateral reconstruction less than six months ago 
3. Breast reconstructions not specifically carried out following breast cancer 
excision 
3.3.3.3 Patient Consent 
Patients meeting the above criteria were written to with a patient information leaflet 
detailing the study in question. Patients who wished to participate in the study were met 
prior to their tattooing procedure or tattoo follow-up review and shown the instructional 
demonstrational digital video clip to ensure that they were fully informed as to what would 
be expected. Written informed consent was obtained and each patient was given a unique 
identifiable subject number. Patients were able to withdraw from the study at any time.  
3.3.4 Clinical assessment 
Information including patient demographics and details upon type of breast reconstruction 
surgery were collected. 
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3.3.5 Patient Satisfaction Assessment 
Each patient in the study was asked to complete a 22 item Breast Cancer Treatment 
Outcomes Scale (BCTOS) questionnaire developed by Stanton et al with regards to their 
opinion on their reconstruction
215
 (See Appendix B). This questionnaire requires the 
patient to compare their reconstruction with the non-reconstructed breast and to score on a 
simple 1 (no difference) – 4 (large difference) scale for various aspects ranging from 
cosmesis to function. 
3.3.6 Standard photography 
All participants underwent standard breast photography as per current Canniesburn Plastic 
Surgery Unit Guidelines. These comprise of the following static photographic views of 
both breasts: antero-posterior with hands at sides, antero-posterior with hands raised above 
head, right lateral, left lateral, left oblique and right oblique. (See figure). Photographs 
were taken by one of two clinical photographers in the same dedicated photography studio 
using a Nikon D200
®
 digital single-lens reflex camera. These digital photographs were 
transferred from the camera onto computer as JPEG image files. 
3.3.7 Video capture 
As no standard for digital video capture exists, a novel protocol for digital video capture 
was created by Mr A Malyon (Consultant Plastic & Reconstructive Breast Surgeon). This 
outlined the instructions for a sequence of movements (incorporating all views obtained by 
photography), deemed necessary to allow subjective assessment. (See Figure 3.18) 
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Figure 3.18: Scripted sequence of movements for digital video capture 
Image reproduced with permission from Elsevier Ltd. (Gilmour et al. 2014)
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The movements were designed to protect patient anonymity at all stages and to prevent 
defining facial shots to be captured during the filming stages.  
The services of a professional female model were utilised to perform the above scripted 
routine whilst undergoing digital video capture by a cinematographer within a dedicated 
studio of the Medical Illustration Department; Glasgow Royal Infirmary.  
Narrated position and movement instructions were then added to the video footage to 
create an instructional demonstrational digital video clip providing both clear visual and 
audio instructions to the viewer. 
Following the photography session the patients were moved to a filmography studio and 
underwent digital video capture whilst being requested to copy exactly the visual and audio 
instructions of the demonstration video which was being played to them concurrently via a 
televised feed in their direct view within the studio. All digital video capture was carried 
Stand facing 
camera with 
hands on hips 
Turn fully to one 
side, pause then 
turn back to 
centre 
Repeat to other 
side 
Turn halfway  to 
one side, pause 
then turn back 
to centre 
Repeat to other 
side 
Stand facing 
camera with 
hands hands 
above head 
Turn fully to one 
side, pause then 
turn back to 
centre 
Repeat to other 
side 
Turn halfway  to 
one side, pause 
then turn back 
to centre 
Repeat to other 
side 
Stand facing 
camera with 
hands hands 
above head 
Turn fully to one 
side and pause 
Lower arms to 
hips and pause 
Raise arms 
above head 
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other side and 
repeat 
Stand facing 
camera with 
hands above 
head 
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one side and 
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side 
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side 
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out by a single cinematographer in the same dedicated studio using a Sony PMW-EX1
®
 
digital video camera. The video clips were then cropped using Final Cut Pro
©
 software 
(Apple Inc.) and made into Windows
®
 Media Audio/Video files. 
3.3.8 Creation of image/video sets 
The six digital photography images for each patient in the study were transferred onto a 
single Powerpoint slide (Microsoft Powerpoint 2010) to create an image set for each 
patient and their unique subject number was placed in the non-visible notes section to 
allow later identification. (See Figure 3.19)  
 
Figure 3.19: Example of an image set used in panel assessment presentation 
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Each separate patient slide was then compiled to create a complete Powerpoint 
presentation of all the patient photography image sets. The order of these patient slides was 
randomised using an online random list generator
207
 and the heading of each slide named 
Image set 1,2,3 and so forth; yet being patient identifiable due to their hidden unique 
subject number. The same process was repeated to create a separate Powerpoint 
presentation comprised of the patient video sets.    
3.3.9 Panel Assessment Process 
A panel comprising of seven Plastic Surgeon (six Consultant Plastic Surgeons all with 
subspecialist interest in breast reconstruction and one senior onco-plastic breast fellow), 
five Consultant General Breast Surgeons and nine non-surgical allied health professionals 
was convened. 
Each panel member was issued with a Panel Member Instruction sheet welcoming them to 
the panel and explaining the assessment process. 
The panel members were issued with a simple assessment score sheet in which to record 
their views. The footer of each assessment score sheet was numbered with a unique panel 
member assessment number in order to ensure that each sheet was unique to each panel 
member.  
The assessment score sheet asked panel members to record their opinions initially as to 
their overall opinion of the reconstruction on a simple 1-4 scale as originally devised by 
Harris
194
. (See Table 3.1) 
Score Rating 
1 Excellent - Treated breast nearly identical to untreated breast 
2 Good – Treated breast slightly different than untreated breast 
3 
Fair – Treated breast clearly different from untreated breast, but not seriously 
distorted 
4 Poor – Treated breast seriously distorted 
Table 3.1: Breast cosmesis assessment scoring scale  
(Harris et al. 1979)
194
 
In addition the panel was also asked to rank their opinion on individual aspects of each 
reconstruction in terms of Size, Shape and Elevation (and in the case of the video clips 
Mobility) using a similar 1-4 scale as developed by Stanton et al
215
. (See Table 3.2) 
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Score Rating 
1 No difference between treated and untreated breast and area 
2 Slight difference between treated and untreated breast and area 
3 Moderate difference between treated and untreated breast and area 
4 Large difference between treated and untreated breast and area 
Table 3.2: Breast cancer outcomes treatment scale (BCTOS)  
(Stanton et al. 2001)
215
 
The panel was then shown each photograph image set (cf. 3.3.8) as part of the Powerpoint 
presentation via a projector.  
The panel was given approximately 45 seconds to record their opinions upon the static 
photograph image sets on the dedicated assessment sheets. 
Following this the panel was shown the Powerpoint presentation containing the video clips 
(cf. 3.3.8). Panel members were given the duration of the entire video clip to record their 
findings; approx. 150 seconds.  
Panel members were blinded as to the identity of each patient at all stages. Each panel 
member was also asked to provide their opinion on whether they found the still 
photographs or video clips more useful/informative in assessing the post-operative 
outcome of breast reconstruction.  
At the end of the assessment process all panel assessment forms were collected and the 
results correlated and analysed. 
The assessment process was completed in a single evening lasting approximately 3 hours 
and including a 45 minute refreshment break for the assessors. 
3.3.10 Statistical Analysis 
All results were analysed using Minitab version 16 (Minitab Inc., State College, PA). 
Panel inter-rater agreement was calculated using Kendall’s Coefficient of Concordance for 
both still photographs and video assessments. Kendall’s Coefficient of Concordance was 
chosen due to the ordinal scale based nature of the assessment scores and the fact that this 
test allows for the measurement of agreement between multiple raters assessing the same 
sample. The test also takes into consideration the association between the rankings 
observed. 
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The values obtained range from 0 (no agreement) to 1 (complete agreement) and can be 
further interpreted using the guideline developed by Schmidt
217
. (See Table 3.3) 
Score Level of agreement 
0.1 Very weak agreement 
0.3 Weak Agreement 
0.5 Moderate agreement 
0.7 Strong agreement 
0.9 Unusually strong agreement 
Table 3.3: Guideline allowing interpretation of Kendall's Coefficient of Concordance Scores 
(Schmidt 1997)
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Overall median panel photograph and video scores for each patient were compared to the 
patient questionnaire self-scores relating to cosmesis (size, shape and elevation) using a 
Spearman’s rank correlation test. This test was chosen due to the difference in assessment 
scales used by the patient (cf. 3.3.5) and panel (cf. 3.3.9), as it allows the measure of 
agreement between two sets of linear data. The levels of agreement between panel and 
patient can be interpreted in a similar manner to the scores above.  
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Chapter 4: The effect of vascular augmentation on 
DIEP flap Zone IV perfusion utilising the 
contralateral SIEA/SIEV    
4.1 Introduction 
Despite the growing volume of reported vascular augmentation procedures being 
performed in the literature (cf. 1.8.1) the scientific evidence supporting their use is poor. 
There are various experimental animal models
162-167
 suggesting that these techniques lead 
to increased flap survivability but there is little in the way of in-vivo research.  
The aim of this study was to assess in-vivo the effects of vascular augmentation on DIEP 
flap Zone IV perfusion by augmenting the flap utilising components of the contralateral 
SIE vascular system (SIEA & SIEV) and to assess whether arterial, venous or combined 
augmentation had the greatest effect. 
4.2 Methods 
DIEP flaps were raised in patients undergoing unilateral breast reconstruction and islanded 
on only the perforators supplied from the main pedicle (DIEA/DIEV) and contralateral 
superficial vascular system (SIEV+/-SIEA) (cf. 3.1.9). The flap was divided into 
Hartrampf’s zones of perfusion (cf. 1.6.4). A randomised clamping sequence of the various 
components of the superficial vascular system was undertaken (cf. 3.1.5) and the resultant 
effects on Zone IV perfusion measured by LDI (cf. 3.1.7) and ICG angiography (cf. 3.1.8). 
4.3 Results 
4.3.1 Patients 
Twelve consecutive patients due to undergo free unilateral DIEP flap based breast 
reconstruction meeting the inclusion/exclusion criteria were identified and recruited to this 
study which was performed from 01/02/12 to 14/02/13.  
A summary of patient demographics is shown in Table 4.1.  
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Patient 
Age 
(years) 
ASA 
Grade 
BMI 
(kg/m2) 
Smoking Status 
Pre-operative 
Chemotherapy 
Pre-operative 
Radiotherapy 
1 52 1 30 Non Smoker No No 
2 42 1 23 Ex-Smoker 2 years prior No 
3 39 1 29 Ex-Smoker No No 
4 59 2 27 Ex-Smoker Neo-Adjuvant No 
5 50 1 26 Non Smoker No No 
6 34 2 24 Current Smoker 2 years prior 2 years prior 
7 40 2 26 Non Smoker No No 
8 33 1 28 Non Smoker No No 
9 43 1 23 Non Smoker Neo-Adjuvant No 
10 52 1 27 Non Smoker No No 
11 54 1 27 Ex-Smoker No 3 years prior 
12 53 2 32 Non Smoker No No 
Table 4.1: Summary of patient demographics 
 
One total flap loss occurred in Patient 6 of our cohort. The other eleven flaps (92%) healed 
uneventfully with no recorded partial flap loss or fat necrosis. The mean number of post-
operative days till discharge of patients in our cohort was 6.8 (range 6-9days). 
One patient in our cohort suffered wide-spread metastases of her breast cancer in the post-
operative follow-up period and unfortunately died 1 year post-operatively. All other 
patients were disease free at last clinical follow-up review. 
The randomised order of clamping sequences for each patient is shown in Table 4.2. 
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Patient Sequence 1 Sequence 2 Sequence 3 Sequence 4 
1 
Both Vessels 
Clamped 
SIEA Clamped / 
SIEV Unclamped 
Both Vessels 
Unclamped 
SIEA Unclamped / 
SIEV Clamped 
2 
Both Vessels 
Clamped 
Both Unclamped 
SIEA Unclamped / 
SIEV Clamped 
SIEA Clamped / 
SIEV Unclamped 
3 
Both Vessels 
Clamped 
Both Unclamped 
SIEA Unclamped / 
SIEV Clamped 
SIEA Clamped / 
SIEV Unclamped 
4 
SIEA Clamped / 
SIEV Unclamped 
Both Vessels 
Clamped 
Both Vessels 
Unclamped 
SIEA Unclamped / 
SIEV Clamped 
5 
Both Vessels 
Unclamped 
SIEA Clamped / 
SIEV Unclamped 
Both Vessels 
Clamped 
SIEA Unclamped / 
SIEV Clamped 
6 
SIEA Unclamped 
/ SIEV Clamped 
Both Vessels 
Unclamped 
Both Vessels 
Clamped 
SIEA Clamped / 
SIEV Unclamped 
7 
Both Vessels 
Clamped 
SIEA Clamped / 
SIEV Unclamped 
Both Vessels 
Unclamped 
SIEA Unclamped / 
SIEV Clamped 
8 
Both Vessels 
Unclamped 
SIEA Clamped / 
SIEV Unclamped 
SIEA Unclamped / 
SIEV Clamped 
Both Vessels 
Clamped 
9 SIEV Clamped SIEV Unclamped     
10 SIEV Unclamped SIEV Clamped     
11 
Both Vessels 
Clamped 
Both Vessels 
Unclamped 
SIEA Unclamped / 
SIEV Clamped 
SIEA Clamped / 
SIEV Unclamped 
12 
Both Vessels 
Unclamped 
SIEA Unclamped / 
SIEV Clamped 
Both Vessels 
Clamped 
SIEA Clamped / 
SIEV Unclamped 
Table 4.2: Randomisation order for clamping/unclamping interventions 
No SIEA was identified in patients 9 and 10  
Systolic/Diastolic blood pressure and heart rate were recorded on a 5minute basis for each 
patient during the 30 minute study intervention and flap perfusion measurement period. 
Patient core temperature was recorded every 15minutes. These results are shown in Table 
4.3. 
Patient Mean Arterial Pressure (mmHg) Heart rate (bpm) Core temperature (°C) 
1 64.3 (1.2) 62 (0) 36.9 (0) 
2 57.7 (3.3) 72 (3.1) 37.6 (0.1) 
3 78.2 (1.5) 63 (1.6) 37.6 (0) 
4 61.5 (2) 67 (2.4) 36.5 (0) 
5 76 (0.9) 73 (1) 36.8 (0) 
6 65 (2.3) 64 (2.9) 37.1 (0.1) 
7 72.6 (0.5) 80 (1.3) 37.3 (0.1) 
8 88 (0) 90 (0.8) 37.6 (0.1) 
9 65.6 (1.6) 60 (0.8) 36.7 (0) 
10 69.7 (1.2) 54 (1.9) 37.1 (0.1) 
11 63.7 (1.6) 49 (2) 36.3 (0) 
12 68.5 (0.8) 55 (1.6) 37 (0) 
Table 4.3: Patient peri-operative observations  
(SD in brackets) 
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Patient mean arterial pressure and heart rate data during the study intervention and flap 
perfusion measurement period were plotted into the following box and whisker plots. (See 
Figure 4.1 and 4.2) 
 
Figure 4.1: Boxplots of patient Mean Arterial Pressure (mmHg) during the investigation 
phase of the study. 
Variation exists between patients but there is minimal variability in each individual patients 
MAP during the measurement process. 
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Figure 4.2: Box and whisker plot of patient peri-operative Heart Rate (bpm) 
Variation exists between patients but there is minimal variability in each individual patients 
Heart Rate during the measurement process. 
 
The average interquartile range for patients during the measurement process was 2.2mmHg 
and 2.1(bpm) for mean arterial pressure and heart rate respectively demonstrating cardio-
vascular stability throughout the study measurement process.  
4.3.2 Intra-operative Details 
Intra-operative details for all patients are summarised in Table 4.4. 
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Table 4.4: Summary of operative details for each patient in study 
 
4.3.3 Zone IV Skin Perfusion assessed using LDI 
A static image of each Zone IV of patient flap was obtained, along with a graphical overlay 
(flux image) demonstrating perfusion. Figure 4.3 shows such an LDI image; in this case 
Patient 11 from the study.  
Patient
Type of 
Reconstruction
Mastectomy 
 Side
Mastectomy 
 Weight 
(grams)
Flap 
Side
Perforator 
 Choice
Number of 
Perforators
Flap 
Weight 
(grams)
Flap 
Ischaemia 
Time 
(mins)
1 Immediate Left 988 Right
Medial 
Row
1 731 73
2 Delayed Right NA Right
Medial & 
Lateral 
Row
2 640 68
3 Immediate Left 878 Right
Lateral 
Row
1 1007 80
4 Immediate Right
Not 
Recorded
Left
Lateral 
Row
1
Not 
Recorded
57
5 Immediate Right 825 Left
Medial 
Row
2 598 55
6 Delayed Left NA Right
Lateral 
Row
2 565 81
7 Immediate Right 466 Right
Medial 
Row
1 581 74
8 Immediate Right 750 Left
Medial 
Row
2 864 96
9 Immediate Right 730 Left
Medial 
Row
1 506 36
10 Immediate Left 774 Left
Medial 
Row
1 774 82
11 Immediate Right 590 Left 
Lateral 
Row
1 715 74
12 Immediate Right 743 Left
Medial & 
Lateral 
Row
2 942 59
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Figure 4.3: LDI flux and photo image of Zone IV obtained from patient 11 in this study 
As shown in the key low perfusion = blue, moderate perfusion = green/yellow, high 
perfusion = red 
Unfortunately following servicing the LDI machine immediately malfunctioned with 
problems related to the live video feed resulting in catastrophic system failure. As a result 
the machine was not available for the primary patient LDI scanning sequence. The 
machine was returned to Moor and the problem subsequently resolved. Another software 
malfunction occurred during the study resulting in the inability to achieve LDI scans for 
patient 4 in the study.    
The Median LDI Zone IV skin perfusion values for each patient assessed using LDI is 
shown in Table 4.5 and Figure 4.4. 
 
 
 
 
 
 
 
106 
 
 
Patient 
Traditional flap 
(flux) 
Venous 
augmentation  
(flux) 
Arterial 
augmentation 
(flux) 
Art / Vein 
augmentation 
(flux) 
1 xx xx xx xx 
2 101 94 107 127 
3 40 32 37 34 
4 xx xx 57 - 
5 72 80 101 100 
6 62 62 61 85 
7 55 48 68 70 
8 77 82 77 86 
9 79 128 - - 
10 49 45 - - 
11 124 119 122 131 
12 51 50 79 74 
          
Median 67 71 77 86* 
Table 4.5: Median Zone IV skin perfusion results assessed using LDI 
* P Value <0.01 (compared to traditional flap. Malfunction of the Moor LDI machine meant no 
LDI results were obtained for patient 1 and only one sequence for patient 4.  
 
Figure 4.4: Box and whisker plot of median Zone IV skin perfusion for each intervention as 
assessed by LDI 
In comparison to the median flux values observed for the traditional flap (67), there is an 
increase in skin perfusion upon SIEV (71); SIEA (77) and combined SIEA/SIEV (86) 
augmentation. The increased perfusion upon combined SIEA and SIEV augmentation was 
significant (p<0.01). 
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Perfusion data was widely distributed but the box and whisker plot shows a trend to 
increasing perfusion by unclamping the various components of the superficial vascular 
system. The largest observed increase in Zone IV perfusion is observed when the flap is 
augmented using both the SIEA and SIEV. 
Data was found to be normally distributed and the results of a repeated measures ANOVA 
showed there to be a statistically significant difference between the clamping interventions. 
(p=0.008). (See Appendix A) 
Assessment for differences between the traditional flap and the various vascular 
augmentation interventions by the Bonferroni correction method are summarised in Table 
4.6 
Type of 
vascular 
augmentation  
Difference of mean 
perfusion traditional vs 
vascular augmentation 
(flux) 
Lower 95% 
Confidence 
Interval 
Upper 95% 
Confidence 
Interval 
Adjusted 
p-value 
Venous 
augmentation 
+3 -8.884 14.88 1.0000 
Arterial 
augmentation 
+11.19 -1.763 24.14 0.1073 
Arterial and 
Venous 
augmentation 
+18.06 5.112 31.01 0.0045* 
Table 4.6: Bonferroni correction pairwise comparisons between traditional flap and vascular 
augmentation interventions 
 
Zone IV skin perfusion was found to be significantly increased upon vascular 
augmentation of flaps with both the SIEA and SIEV (p=0.0045) 
4.3.4 Zone IV skin perfusion assessed using ICG Angiography  
A greyscale image of the area being scanned along with a correlating visual graphical 
display was also obtained. (See Figure 4.5)  
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Figure 4.5: SPY scan of Zone IV of patient 11 in this study 
low perfusion = blue, moderate perfusion = yellow/orange and high perfusion  = red 
The Zone IV skin perfusion values for each patient assessed using ICG angiography is 
shown in Table 4.7 and Figure 4.6.  
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Patient 
Traditional flap 
(units) 
Venous 
augmentation 
(units) 
Arterial 
augmentation 
(units) 
Art / Vein 
augmentation 
(units) 
1 52 69 100 107 
2 53 74 76 55 
3 28 50 49 43 
4 94 42 207 144 
5 58 36 88 134 
6 150 148 20 88 
7 19 35 73 83 
8 46 34 45 20 
9 51 128 - - 
10 23 16 - - 
11 79 107 125 53 
12 95 108 63 17  
          
Median 53 60 75 83 
Table 4.7: Mean Zone IV skin perfusion results assessed using ICG angiography 
 
 
 
Figure 4.6: Box and whisker plot of median Zone IV skin perfusion for each intervention as 
assessed by ICG angiography 
In comparison to the Traditional Flap (53) there is increased skin perfusion upon SIEV (60), 
SIEA (75) and combined SIEV/SIEA (83) augmentation. Although these results did not reach 
significance (p>0.05). 
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Skin perfusion as assessed by ICG angiography also shows a trend towards increasing 
perfusion as the SIE vascular components are unclamped. 
Data was found to be normally distributed and the results of a repeated measures ANOVA 
showed that there were no statistically significant differences between the clamping 
interventions. (p=0.734). (See Appendix A) 
4.3.5 Zone IV fat perfusion assessed using ICG Angiography  
The Zone IV fat perfusion data obtained from ICG angiography is shown in Table 4.8 and 
Figure 4.7.  
Patient 
Traditional flap 
(units) 
Venous 
augmentation 
(units) 
Arterial 
augmentation 
(units) 
Art / Vein 
augmentation 
(units) 
1 35 36 71 64 
2 31 111 58 90 
3 45 26 26 44 
4 61 19 119 68 
5 47 51 58 80 
6 53 89 29 50 
7 19 21 53 67 
8 48 34 55 32 
9 22 77 - - 
10 23 17 - - 
11 27 50 50 130 
12 67 56 64 59 
          
Median 40 43 57 66 
Table 4.8: Mean Zone IV fat perfusion results assessed using ICG angiography 
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Figure 4.7: Box and whisker plot of median Zone IV fat perfusion for each intervention as 
assessed by ICG angiography 
In comparison to the Traditional Flap (40) there is increased fat perfusion upon SIEV (43), 
SIEA (57) and combined SIEV/SIEA (66) augmentation. Although these results did not reach 
significance (p>0.05). 
 
The above box and whisker plot is similar to both the LDI and ICG skin perfusion scan 
results and it appears that there is also a trend towards increasing Zone IV fat perfusion 
upon vascular augmentation of the flap. The largest increase in fat perfusion is when both 
the SIEA and SIEV are used in combination to augment the flap. 
Data was found to be normally distributed and the results of a repeated measures ANOVA 
showed there were no statistically significant differences between the clamping 
interventions. (p=0.130). (See Appendix A) 
4.3.6 Effect of Perforator Row 
The effect of the perforator row, upon which the DIEP flap was raised (i.e. medial, lateral 
or medial and lateral row), on Zone IV perfusion between the clamping interventions was 
assessed using a repeated measures ANOVA.  
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The perforator row did not have any statistically significant effect on Zone IV skin 
perfusion between clamping interventions as assessed by LDI (p=0.652). This was also 
true of Zone IV skin (p=0.753) and fat (p=0.081) perfusion as assessed by ICG 
angiography.  
4.3.7 Effect of Perforator Number 
The effect of number of perforators upon which the DIEP flap was raised on Zone IV 
perfusion between the clamping interventions was assessed using a repeated measures 
ANOVA. 
The number of perforators did not have any statistically significant effect on Zone IV skin 
perfusion between clamping interventions as assessed by LDI (p=0.678). This was also 
true of Zone IV skin (p=0.695) and fat (p=0.079) perfusion as assessed by ICG 
angiography.  
4.3.8 Sub-analysis excluding Patient 6 
Total flap loss occurred in Patient 6 of our cohort. A separate sub-analysis was undertaken 
using a repeated measures ANOVA after exclusion of this patient. 
There was still a statistically significant difference observed in LDI assessed skin perfusion 
(p=0.021) between the clamping interventions. Bonferroni correction pairwise comparison 
tests between the traditional flap and the clamping interventions showed that the only 
significant difference was observed when both the SIEA and SIEV were unclamped 
(p=0.0156). 
There was still no statistically significant differences in ICG assessed Zone IV skin 
(p=0.161) or fat (p=0.055) perfusion between clamping interventions.  
4.3.9 Sub-analysis excluding Patients 9 and 10 
Patient 9 and 10 within this study did not have an SIEA. A separate sub-analysis was 
undertaken using a repeated measures ANOVA after exclusion of these patients. 
There was still a statistically significant difference observed in LDI assessed skin perfusion 
(p=0.001) between the clamping interventions. Bonferroni correction pairwise comparison 
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tests between the traditional flap and the clamping interventions showed that the only 
significant difference was observed when both the SIEA and SIEV were 
unclamped(p=0.0018). 
There was still no statistically significant differences in ICG assessed Zone IV skin 
(p=0.791) or fat (p=0.159) perfusion between clamping interventions.  
4.4 Discussion 
Our results show that there is a trend towards increasing Zone IV skin and fat perfusion in 
DIEP flaps when the flap is augmented using the contralateral superficial vascular system. 
The largest observed increase to Zone IV perfusion is when both the SIEA and SIEV are 
used in combination to augment the flap. However, this was only statistically significant in 
Zone IV skin perfusion as assessed by LDI (p=0.0045). 
4.4.1 Augmentation with the SIEA, SIEA or Both 
There are very few human in-vivo studies assessing the effects of contralateral arterial or 
venous augmentation of abdominal flaps however there are a multitude of experimental 
studies looking at the importance of venous drainage or arterial inflow in rat abdominal 
flaps.  
Miles et al in 1997 published their findings comparing the effects of different venous 
interventions carried out upon 40 rat pedicled abdominal flaps. In this study their 
intervention groups consisted of a simple pedicled flap; a pedicled flap with additional 
contralateral venous augmentation, a venous only pedicled flap and an arterialised venous 
flap. They found that in the 25 flaps suitable for analysis at the end of their study that the 
only significant increase in flap survivability was found in flaps with additional 
contralateral venous augmentation
164
. Hallock and Rice in 2005 compared a traditional rat 
DIEP flap model versus DIEP flap models augmented with the contralateral vein and 
found that there was a statistically significant increased flap viability in the venous 
augmented group
163
.  
Chang et al in 2004 analysed the effects of various arterial augmentation procedures on 40 
rats. They found that the augmentation of rat abdominal flaps with the contralateral arterial 
system led to a statistically significant improvement in flap survival
162
. 
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Several experimental studies have looked at whether arterial or venous augmentation is 
most important in terms of flap survival. In an early study in 1982 by Nakayama et al 
investigating the effects of arterial input or venous drainage upon distal necrosis in 
abdominal skin flaps raised on 45 rats. They individually compared the effects of arterial 
or venous augmentation to the survivability of the distal portion of these skin flaps. They 
found that arterial augmentation seemed to be the most crucial in determining flap 
survivability. Despite not looking at arterial and venous augmentation in combination they 
still recommended that where possible both additional venous drainage and arterial input 
be used where possible
165
.  
In a study very similar to our own from 1994 Ueda et al divided 32 rat TRAM type 
abdominal flaps into four cohorts
166
. Cohort one had a flap augmented with the 
contralateral SIEA and SIEV; cohort two had augmentation with the SIEA only; cohort 
three SIEV augmentation only and cohort 4 a standard ipsilateral based flap. They found 
that cohort one and two had complete flap survivability in comparison to the others. In 
cohort two there was significant flap oedema post-operatively but this settled by day 4. 
They suggested that both an artery and vein should be utilised to augment flaps where 
possible but believed the arterial input to be most important. Similarly in 2009 Yamamoto 
et al assessed the importance of the contralateral SIEA/SIEV in a rat DIEP flap model
167
. 
They separated 30 rats into three cohorts; SIEA/SIEV both divided; SIEA intact/SIEV 
divided and SIEA divided/SIEV intact. They assessed overall flap survival area and also 
pressure within the venous system. Despite large variation amongst the individual rat flaps 
they found a statistically significant increase in flap area survival occurred in the rats with 
the SIEA intact.  
Our in-vivo perfusion results complement the experimental results found by Ueda’s and 
Yamamoto’s research groups166,167 although our only significant finding in terms of 
increased perfusion was when both the contralateral SIEA and SIEV were present.  
Despite the fact only the LDI results reached statistical significance when the flaps were 
augmented using the contralateral SIEA and SIEV there were large differences in median 
perfusion observed between the traditional flap and flaps augmented with the SIEA alone 
and the SIEA+SIEV in both the LDI and ICG angiography groups; this could indicate that 
these increases in perfusion could be clinically relevant and the reason they failed to reach 
statistical significance was due to the power of our pilot study. The SIEV augmentation 
intervention alone seemed to have little effect on skin and fat perfusion.  
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4.4.1.1 Variability of the SIEA  
During our study we found the SIEA to be completely absent in two (16.7%) of our 
patients (patients 9 and 10). This absence rate is similar to the 13% found by Stern and 
Nahai in 1995 in their series of 31 patients but lower than the 35% quoted by Taylor and 
Daniel in 1975 in their original anatomical dissections of 100 cadavers
66
 or the  51% as 
quoted in-vivo by Chevray in 2004 on their experience of 47 consecutive abdominal flap 
breast reconstructions
65
.  Given that absence of the SIEA may represent altered flap 
vascular anatomy a separate sub-analysis of our results was undertaken excluding patient 9 
and 10. However, this still showed that there was only statistically significant effect on 
Zone IV Skin perfusion assessed by LDI when both the SIEA and SIEV were used to 
augment the flap.  
Patient 4 in our study cohort had large outlying perfusion values as assessed by ICG 
angiography when the flap was arterially augmented using the contralateral SIEA. This is 
particularly interesting secondary to the odd vascular anatomy encountered in dissecting 
this patients contralateral SIE vascular system. Both the SIEA and SIEV in this patient 
were found to be sub-Scarpa in nature. We could find no other descriptions in the literature 
of these vessels noted to be in the sub-Scarpa plane and the influence of such vessels in 
perfusion of DIEP flaps is unknown.  The large increase in perfusion as shown in the ICG 
angiography scans could indeed be due to increased arterial inflow to Zone IV or could be 
due to venous pooling secondary to poor vascular draining of the area by a SIEV in the 
sub-Scarpa plane. Unfortunately the LDI malfunctioned during this patients scanning 
sequence and we did not have these scans to correlate our ICG angiography findings with. 
4.4.1.2 Other factors affecting patient outcome 
One flap loss occurred in Patient 6 of our study cohort. This flap showed some intra-
operative evidence of venous congestion upon initial raising and even prior to detachment 
from the abdomen. Upon detachment and transfer of this flap; despite multiple additional 
venous augmentation procedures (contralateral SIEV to distal IMV augmentation and then 
interposition vein graft from ipsilateral SIEV to secondary DIEV venae comitantes) the 
flap failed secondary to worsening venous congestion and the flap required debridement 5 
days post operatively. Given the intra-operative findings of venous congestion and 
subsequent flap loss it may represent different intra-flap vascular anatomy and as such a 
separate sub-analysis of our results was undertaken excluding patient 6. This still showed 
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that there was only statistically significant effect on Zone IV Skin perfusion assessed by 
LDI when both the SIEA and SIEV were used to augment the flap.  
4.4.2 Model validation and potential confounders 
4.4.2.1 Zone IV selection 
Whilst controversy remains over which area of the DIEP flap should be designated Zone II 
or Zone III there is global consensus on which area is Zone IV. Zone IV is the area of the 
flap which is subject to the worst perfusion and resultant complications of venous 
congestion; fat necrosis and partial flap loss. As a result of the doubtful viability and also 
the fact that Zone IV can be difficult to incorporate geometrically into a reconstruction 
whilst trying to recreate a suitable breast shape, many surgeons would routinely discard 
this section of the flap and we accept that this is the least useful portion of the flap 
clinically. However, in terms of translational research, Zone IV is most likely to resemble a 
failing flap model and thus the results of vascular augmentation may be of particular 
interest to the microsurgical community as a whole as this may give evidence for the use of 
vascular augmentation procedures to salvage failing flaps. We believed that the effect of 
any vascular augmentation procedure is likely to be most obvious in Zone IV. Additionally 
Zone IV is also routinely discarded by the senior operating surgeon involved in this study 
and in terms of ethical accountability any potential consequences to the survivability of 
Zone IV secondary to our interventions (i.e. clamping of SIE vascular system) or any 
unexpected intra-operative findings to this area of the flap during our study would have no 
influence to our patients’ normal standard of care. We accept that it would have been 
favourable to have analysed all Zones of the flap during this research study; however it 
would have significantly added to each patients length of anaesthesia and operation and we 
could not ethically justify the additional time required. Longer operating times have been 
associated with increased risks of post-operative complications
218
. The research performed 
in this study was performed during a routine twenty minute interval, undertaken after the 
flap was initially raised, to allow time for any areas of potential vascular concern within 
the flap to identify themselves and allow a natural comfort break as per the operating 
surgeons’ standard practice. Thus our study did not lengthen the patients’ anaesthesia or 
operation time.  
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4.4.2.2 Clamping Intervention 
In this procedure five minutes was allowed to elapse after any clamping or unclamping 
intervention prior to taking any scanning measurements to allow reactive hyperaemia to 
settle.  This was decided upon following review of the evidence from a previous study by 
Tollan et al which has shown that a period of five minutes is an adequate amount of time to 
allow reactive hyperaemia to settle following clamping and unclamping of vasculature in 
DIEP flaps
211
. 
4.4.2.3 Data Sampling and Analysis 
During sampling and analysis of the LDI and ICG angiography scan images for each 
patient; defined regions of interest were selected within each flap (Zone IV) in order to 
obtain the perfusion values within this area. For each separate patient scan (assessing 
interventions) this region of interest had to be individually selected. Whilst care was taken 
to select the same region of interest for each patient scan; this user-defined area can be 
considered arbitrary in nature. In an effort to reduce bias several precautions were taken. 
Flaps were divided and marked on the operating table into the classical Hartrampf Zones of 
Perfusion prior to the commencement of the operation and these markings can be 
visualised on both the LDI and ICG angiography scan images whilst undergoing analysis 
essentially acting as a reference point upon which to select the region of interest. Only 
Zone IV of the flap was scanned during each intervention process and thus the area to 
select as the region of interest was minimised. All patient scans were undertaken and 
analysed using the same method by the same observer, with training and previous 
experience in both the scan capture and analysis. The median (LDI) and mean (ICG) scan 
results for each area of interest were utilised rather than individual points of reference and 
thus any minor inaccuracies in terms of area selected are unlikely to influence the overall 
results obtained significantly. Despite these precautions the specified location and area 
encompassed by the “region of interest” are therefore accepted as a potential confounder.  
4.4.2.4 Choice of medial or lateral row perforator 
Six patients in our study had DIEP flaps based upon medial row perforators; four upon 
lateral row perforators and two had flaps based upon both medial and lateral row 
perforators. Perforator selection in this study was based clinically upon what appeared to 
be the largest dominant perforating vessel offering easiest dissection with minimal 
collateral damage. Studies have suggested that medial row perforators cross the midline 
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supplying greater perfusion to Zone IV of DIEP flaps whereas lateral row perforators do 
not
76,81,219,220
.  In this study we were only assessing the effect on flap Zone IV perfusion 
pre and post vascular augmentation. Therefore flaps based on medial or lateral row 
perforators are unlikely to affect the perfusion differences observed during our clamping 
and unclamping interventions as each patients (traditional) flap was essentially acting as a 
control. A separate sub-analysis of our results was also undertaken and the perforator row 
did not have any statistically significant effect on the observed results. However baseline 
Zone IV perfusion may be affected based upon medial or lateral row perforators and we 
accept this as a potential confounder.  
4.4.2.5 Perforator number 
Seven patients in our study had DIEP flaps based upon a solitary perforator whereas five 
had flaps based upon two perforators. Number of perforators chosen in this study was 
based upon several factors including non-apparent dominance of a solitary perforator; 
proximity of the perforators to one other and the ease of dissection minimising collateral 
damage. There are various debates in the published literature with regards to the number of 
perforators upon which to base a DIEP flap. Some authors advocate the use of solitary 
perforators believing they provide more reliable perfusion
168
 or fewer complications
53
 
whereas others believe that flaps based upon multiple perforators reduce complication rates 
such as fat necrosis
221-223
. Others failed to find any difference or believe that perforator 
number has no effect on the perfusion or complication rate but instead that selecting the 
dominant perforator from the appropriate row has the most important influence
50,94,224,225
. 
As with perforator row selection irrespective of perforator number in our study cohort we 
were only assessing the difference between each individual patients Zone IV perfusion pre 
and post vascular augmentation and this is unlikely to be affected by number of 
perforators. A separate sub-analysis of our results was also undertaken and perforator 
number did not have any statistically significant effect upon the observed results. However 
baseline Zone IV perfusion may be affected may be affected by number of perforators and 
we accept this as a potential confounder.  
4.4.2.6 Temperature 
Patient core temperature was only recorded twice during the 30 minute research scanning 
process. As such only two measurements were available to compare for each patient. 
Whilst these measurements appeared stable for each patient ideally these should have been 
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recorded prior to each individual scan. Thus inadequate patient temperature recording is 
accepted as a design limitation and potential confounder.  
4.4.2.7 Control Patient 
No control patient, not undergoing any clamping intervention but undergoing the same 
number of scans to that of the research patient cohort, was included in this study. Since 
patients’ own flaps were being used as a control (i.e. traditional flap versus vascular 
augmetation intervention) we did not believe an additional control patient would add much 
in terms of validity to the experiment as both the clamping interventions and scanning 
processes have been validated in previous studies
212,226
. In a similar fashion we did not feel 
it beneficial to scan individual patients abdomens prior to raising the flap as a control for 
“normal values” as it has been shown in the literature that upon raising a flap the blood 
supply grossly changes in comparison to pre-operative values
227
. 
4.4.2.8 Performance Bias 
All flap dissection and raising in this study was by a single senior Consultant Plastic 
Surgeon with significant experience in the technique. Mr Mackay’s failure rate for free 
DIEP flap breast reconstruction is less than 2% over the past five year period; well below 
the quoted acceptable range of less than 5%
90
 for free tissue transfer and in keeping with 
the 1.95% quoted in the National Mastectomy and Breast Reconstruction Audit
228
. All 
flaps were raised as per his standard protocol and given his career experience in the 
technique performance bias is likely to be minimal but we accept it as a potential 
confounder. 
4.4.3 Conclusion 
In conclusion from the findings of our initial pilot study we believe that vascular 
augmentation of DIEP flaps using the contralateral SIE vascular system leads to an 
increase in Zone IV perfusion. Our results show that the biggest increase in Zone IV 
perfusion occurs when flaps are augmented using both the SIEA and SIEV in combination. 
Therefore from our preliminary work we would suggest that when Zone IV of a DIEP flap 
is to be incorporated into the reconstruction rather than being discarded that both 
components of the SIE vascular system (SIEA and SIEV) are used to augment the flap. 
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Chapter 5: The effects of vascular augmentation on 
abdominal flap Zone I / IV perfusion and main 
pedicle arterial blood flow in an experimental 
animal model 
5.1 Introduction 
In 2001 Oskar et al were the first to describe an experimental animal model upon which to 
raise perforator flaps
214
. In their study they successfully raised abdominal flaps in Sprague 
Dawley rats based upon solitary musculocutaneous perforators and found that these flaps 
had similar areas of survival to traditionally used random pattern pedicled flaps raised in 
rats. They proposed that the rat was a reliable experimental model for further research into 
perforator flaps. This model was further validated subsequently by Ozkan et al in 2006
229
. 
Whilst the vascular supply to the lower abdominal tissue is similar in rats and humans 
there are several differences which must be taken into account when using the rat 
abdominal perforator flap model. In humans the dominant blood supply to the lower 
abdominal tissue comes from the caudal DIE vessels (cf. 1.5) whereas in rats the dominant 
supply comes from the cranial Deep Superior Epigastric (DSE) vessels
230,231
. (See Figure 
5.1) 
 
Figure 5.1: Contrast injection study in Sprague Dawley rat showing dominance of cranial 
(DSE) vessels 
Image reproduced with permission from Wolters Kluwer Health, Inc. (Hallock & Rice 1995)
230
 
Thus any perforator flaps based upon the lower abdominal tissue in rats must take account 
of this cranial dominance and factor it in to any research studies using the model opting 
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instead to base the perforator flaps on the DSE vessels. Another major anatomical 
difference is that unlike the defined medial and lateral rows branching from the deep 
source vessels in humans, there is no such defined branching pattern in the deep vessels of 
rats
230
. As such it is not possible to perform research based upon medial or lateral rows in 
the rat abdominal model. 
Despite these anatomical vascular differences since the description by Oskar et al
214
 the rat 
abdominal perforator flap model as an analogue to human abdominal perforator flaps has 
become widely accepted and established in plastic surgery research
94,163,167,168
.  
Whilst our own study (cf. Chapter 4) suggests that vascular augmentation of the DIEP flap 
will lead to a greater perfusion of Zone IV, the concern would be that the addition of 
another supplementary pedicle could potentially lead to a decreased main pedicle blood 
flow and overall flap perfusion in a similar way to that occurring when more than one 
perforator is utilised as found by Douglas et al
168
. There were no studies addressing this 
concern in the literature. 
The aim of this experimental study was to assess in-vivo, using a rat abdominal flap model 
as an analogue to a DIEP flap, the effects on Zone I / IV perfusion and on main pedicle 
arterial blood flow by vascular augmentation using the contralateral vascular system. 
5.2 Methods 
In a randomised fashion (cf. 3.2.5) left or right islanded abdominal flaps were raised in 12 
Sprague Dawley rats so that the flap was obtaining its vascular supply from a pedicle 
containing the cranial most perforating artery and vein from the DSEA and DSEV (main 
pedicle) on one side of the flap and the contralateral DSEA and DSEV pedicle (vascular 
augment pedicle) containing only the caudal most perforating artery and vein (cf. 3.2.9). 
Flaps were divided into Hartrampf’s four Zones of perfusion (cf. 1.6.4). The vascular 
augment pedicle was clamped and unclamped and the resultant effects on Zone I and Zone 
IV perfusion assessed using LDF flowmetry (cf. 3.2.7.2). The effect of the vascular 
augment intervention on blood flow through the main pedicle was also assessed using 
transit-time ultrasound flowmetry (cf. 3.2.8.3). 
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5.3 Results 
5.3.1 Animals 
Twelve consecutive male outbred Sprague Dawley rats; obtained from Harlan UK Ltd., 
Bicester, Oxfordshire, UK; were used in this research carried out between 31/01/2013 to 
04/03/2013. Seven animals (58%) were randomised to have a flap based upon the right 
side and the five upon the left (42%). The average weight of the animals used in this study 
was 344grams.  
A summary of animal demographics and mean intra-operative measurements are shown in 
Table 5.1. 
Animal 
Weight 
(grams) 
Flap 
side 
Oxygen 
saturation 
(%) 
Heart 
rate 
(bpm) 
Core 
temperature 
(°C) 
1 343 Right 98.5 382 37.2 
2 351 Left 98 390 37.7 
3 335 Right 99 386 37.7 
4 343 Left 98 333 37.9 
5 353 Right 97 380 37.6 
6 377 Left 98 428 38.0 
7 366 Left 97.5 376 37.5 
8 386 Left 98 367 37.8 
9 300 Right 99.5 381 37.3 
10 314 Right 99 349 37.3 
11 323 Right 99 344 37.0 
12 333 Right 96 368 37.2 
Table 5.1: Summary of pre and peri-operative characteristics 
 
5.3.2 Perfusion 
5.3.2.1 Zone I vs Zone IV perfusion 
Perfusion values obtained for Zone I and Zone IV in the traditional flap model and in the 
vascular augmented flap model are shown in Table 5.2 and Figure 5.2. 
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Animal 
Perfusion (flux) 
Zone I Zone IV 
1 27.5 18.1 
2 36.1 12.9 
3 51.7 13.9 
4 31.7 20.1 
5 23.3 16.9 
6 89 37.5 
7 22.9 7.7 
8 91.7 5.0 
9 97.7 23.4 
10 37.9 16.2 
11 24.9 17.5 
12 58.9 21.9 
      
Median 37 17.2 
Table 5.2: Mean Zone I/IV perfusion of the traditional flaps 
 
 
 
Figure 5.2: Box and whisker plot of median Zone I versus Zone IV perfusion in a traditional 
flap 
In a traditional flap Zone I (37.0) perfusion is significantly higher than Zone IV (17.2) 
perfusion (p<0.01). 
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It is obvious from the figure above that there is a greater degree of perfusion in Zone I in 
comparison to Zone IV. 
The effects of vascular augmentation on abdominal flap Zone I vs Zone IV perfusion are 
shown in Table 5.3 and Figure 5.3. 
Animal 
Perfusion (flux) 
Zone I Zone IV 
1 16.5 19.5 
2 34.9 13.4 
3 45.0 23.8 
4 26.8 21.0 
5 19.5 28.8 
6 74.1 35.0 
7 14.9 14.9 
8 64.7 12.8 
9 43.2 49.5 
10 58.8 62.4 
11 20.5 24.8 
12 44.7 32.1 
      
Median 39.1 24.3 
Table 5.3: Mean Zone I/IV perfusion of vascular augmented flaps 
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Figure 5.3: Box and whisker plot of median Zone I versus Zone IV perfusion in the vascular 
augmented flaps. 
In a vascular augmented flap Zone I (39.1) perfusion is higher than Zone IV (24.3) perfusion 
although this does not reach significance (p>0.05). 
 
There is still greater perfusion in Zone I than Zone IV in a vascular augmented flap 
however the observed difference between the Zones is not as apparent as in the traditional 
flap. 
The differences in median perfusion between Zone I and Zone IV are summarised in Table 
5.4. 
Type of Flap 
Median 
Zone I 
perfusion 
(flux) 
Median 
Zone IV 
perfusion 
(flux) 
Difference between 
Zone I and Zone IV 
(flux) 
p value 
Traditional Flap 37 17.2 19.8 0.003 
Vascular 
Augmented Flap 
39.1 24.3 14.8 0.168 
Table 5.4: Zone I vs Zone IV perfusion 
 
In the traditional flap model Zone IV has a statistically significant poorer degree of 
perfusion in comparison to Zone I (p=0.003). In the vascular augmented flap model whilst 
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there still appears to be a greater degree of perfusion in Zone I when compared to Zone IV 
however this difference is no longer statistically significant (p=0.168). 
5.3.2.2 Traditional Flap vs Vascular Augmented Flap 
Perfusion values in Zone I and Zone IV in the traditional flap model and the vascular 
augmented flap model area summarised in Table 5.5 and Figure 5.4. 
  Zone I Perfusion (flux) Zone IV Perfusion (flux) 
Animal 
Traditional 
Flap 
Vascular 
Augmented Flap 
Traditional 
Flap 
Vascular 
Augmented Flap 
1 27.5 16.5 18.1 19.5 
2 36.1 34.9 12.9 13.4 
3 51.7 45 13.9 23.8 
4 31.7 26.8 20.1 21 
5 23.3 19.5 16.9 28.8 
6 89 74.1 37.5 35 
7 22.9 14.9 7.7 14.9 
8 91.7 64.7 5 12.8 
9 97.7 43.2 23.4 49.5 
10 37.9 58.8 16.2 62.4 
11 24.9 20.5 17.5 24.8 
12 58.9 44.7 21.9 32.1 
  
   
  
Median 37 39.1 17.2 24.3 
Table 5.5: Mean Zone I and Zone IV perfusion for traditional flaps versus vascular 
augmented flaps 
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Figure 5.4: Box and whisker plot of median LDF perfusion in Zone I and Zone IV for 
traditional and vascular augmented flaps 
Vascular Augmentation of the traditional flap significantly improves Zone I (p<0.05) and to a 
greater degree Zone IV (p<0.01) perfusion. 
 
It can be observed from the box and whisker plot that there is an increase in Zone IV 
perfusion upon vascular augmentation of the flap.  
Traditional versus vascular augmented flap differences in both Zones are summarised in 
Table 5.6. 
Flap 
Zone 
Traditional flap 
perfusion (flux) 
Vascular 
Augmented flap 
perfusion (flux) 
Difference in perfusion 
traditional vs vascular 
augmentation (flux) 
p value 
I 37 39.1 +2.1 0.025 
IV 17.2 24.3 +7.1 0.007 
Table 5.6: Traditional versus vascular augmented flap 
 
From our results it is evident that vascular augmentation of the abdominal flap leads to a 
statistically significant increase in in Zone IV perfusion (p=0.007). The spread of data was 
wide but there also appears to be an increase in Zone I perfusion, although to a much 
smaller degree. (p=0.025). 
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5.3.3 Flow 
Flow values observed through the main pedicle DSEA in the traditional flap and the 
vascular augmented flap for each animal are shown in Table 5.7 and Figure 5.5. 
Animal 
Flow ml/min 
Traditional Flap Vascular Augmented Flap 
1 0.25 0.23 
2 0.33 0.3 
3 0.48 0.43 
4 0.29 0.2 
5 0.3 0.15 
6 0.34 0.29 
7 0.42 0.37 
8 0.37 0.36 
9 0.45 0.31 
10 0.48 0.45 
11 0.29 0.25 
12 0.79 0.65 
      
Median 0.37 0.31 
Table 5.7: Main DSEA flow in the traditional flap model compared to the vascular augmented 
flap model 
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Figure 5.5: Box and whisker plot of median main pedicle blood flow rate in traditional versus 
vascular augmented flaps 
In comparison to the flow observed in a Traditional flap (0.37ml/min) the flow in a vascular 
augmented flap (0.31ml/mins) is significantly lower (p<0.01). 
 
It is shown that there is great inter-animal variability for the rats used in this study with 
regards to flow but there appears to be a decrease in flow through the main pedicle when 
vascular augmentation of the abdominal flap is performed. 
The effects of vascular augmentation on arterial blood flow through the main pedicle of the 
abdominal flap are summarised in Table 5.8.  
Type of Flap Flow (ml/min) 
Traditional Flap 0.37 
Vascular Augmented Flap 0.31 
Difference in flow -0.06 
p value 0.003 
Table 5.8: Effect of abdominal flap vascular augmentation on main pedicle flow  
 
From our results it has been shown that there is a statistically significant reduction in flow 
through the main DSEA when vascular augmentation of the abdominal flap is performed.  
(p=0.003) 
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5.3.3.1 Pulsatility Index 
The pulsatility index was also calculated for each of the animals in this study and is shown 
in Table 5.9 and Figure 5.6. 
Animal 
Pulsatility Index 
Traditional Flap Vascular Augmented Flap 
1 4.58 4.27 
2 3.65 3.40 
3 6.11 2.86 
4 3.89 7.31 
5 0.81 10.48 
6 4.73 9.81 
7 2.84 2.35 
8 3.74 2.71 
9 0.30 0.46 
10 1.16 1.13 
11 3.49 3.65 
12 1.87 1.55 
  
 
  
Median 3.49 2.86 
Table 5.9: Pulsatility Index for traditional and vascular augmented flaps 
 
 
131 
 
 
 
Figure 5.6: Box and whisker plot of median Pulsatility Index in traditional flap model vs 
vascular augmented flap model 
There is wide inter animal variability but there appears to be a higher pulsatility index in a 
traditional flap (3.49) compared to a vascular augmented flap (2.86) although this failed to 
reach significance (p>0.05).   
 
The above box and whisker plot shows that the data is widely spread but that there is a 
decrease in median Pulsatility Index. 
The effects of vascular augmentation of the abdominal flap on Pulsatility Index are 
summarised in Table 5.10.  
Type of Flap Median Pulsatility Index 
Traditional Flap 3.49 
Vascular Augmented Flap 2.86 
Difference 0.63 
p value 0.969 
Table 5.10: Effect of vascular augmentation of abdominal flap on Pulsatility Index 
 
There is decrease in Pulsatility Index following vascular augmentation of the flap; however 
this difference failed to reach statistical significance. (p=0.969) 
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5.4 Discussion 
The results from our study show that in a traditional perforator abdominal flap and a 
vascular augmented flap, perfusion was higher in Zone I when compared to Zone IV, 
however this difference was only found to be statistically significant in the traditional flap 
model. (p=0.003 vs p=0.168). Perfusion in Zone IV was increased significantly upon 
vascular augmentation of the flaps (p=0.007) and the same was also found in Zone I 
(p=0.025). There was also a significant reduction in main pedicle arterial flow when 
vascular augmentation of the flap was performed (p=0.003) whilst the pulsatility index 
decreased. 
Our significant findings of increased perfusion as assessed by LDF in Zone I in 
comparison to Zone IV helps to validate the rat perforator abdominal flap model used in 
this study. Our animal study correlates with our human study in that vascular augmentation 
of flaps leads to an overall increase in Zone IV perfusion. Zone I perfusion was also found 
to have increased however there was found to be a reduction in main pedicle arterial flow 
and pulsatility index. 
5.4.1 Model Validation and Potential Confounders 
5.4.1.1 Selection of Zone I and Zone IV 
Zone I represents the area of best perfusion within a flap and Zone IV the area of worst 
perfusion. This has been well shown in both human studies
73-75,212
 and in rat models
94,226
. It 
was for this reason that these zones were selected to compare in this study. Whilst it would 
have been ideal to have measured the perfusion in all Zones of the rat perforator abdominal 
flap model simultaneously this would not have been possible secondary to the small size of 
the flaps. Despite using the smallest LDF probe it was incredibly difficult during this study 
to site even two probes on the flaps concurrently. In order to measure all Zones it would 
have required that 2-3 separate measurement periods be undertaken and this would have 
led to less robust results as recording of the perfusion between Zones during exactly the 
same interval, such as that measured in this study, could not have been undertaken.   
5.4.1.2 Perfusion 
Of the few studies using LDF to assess rat abdominal skin flap perfusion
94,230,232,233
 only a 
recent animal model experiment by Douglas utilised the same LDF system and software as 
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that used in our study to allow comparison
226
. In this study perforator abdominal flaps were 
raised in 20 Wistar rats and the effects of perforator number and location on perfusion in 
Zones I-IV were being assessed. Douglas found that mean Zone I perfusion (34.55units) 
was higher than Zone IV perfusion (17.85) for flaps based on a cranial perforator. These 
results correlate well with our findings that mean Zone I perfusion (49.44) is greater than 
mean Zone IV perfusion (17.85) for similarly raised flaps. The slightly higher perfusion 
values found in our study may be secondary to the difference in strain of rat used (Sprague 
Dawley versus Wistar) and that our rats had a higher average weight (344grams versus 
322grams). Despite the use of different LDF systems Hallock and Rice in an experimental 
rat study using Sprague Dawley rats in 2004 also found Zone IV perfusion to be 
significantly lower than that of Zone I further corroborating our findings
94
. 
5.4.1.3 Flow and Pulsatility Index 
In a study by Rickard et al in 2009 investigating the development of a model to assess 
microvascular anastomotic techniques in vessels with size mismatch, flow rates through 
the femoral arteries of Wistar rats were assessed in the same fashion to that used in this 
study
234
. Flow rates of 2.39m1/min and 2.882ml/min are quoted which are significantly 
greater than those found in our study. However, given that the femoral vessel was being 
assessed in this study it is not surprising that the flow rates are much greater as the 
diameter of the femoral artery is much larger than that of the superior epigastric. 
In another study by Douglas assessing the effect of varying the number and location of 
perforators on main pedicle arterial flow in Wistar rats, mean flow values of 0.21(range 
0.09-0.4)ml/min are quoted for flaps raised on a cranial perforator
168,226
. This is much 
lower than the mean 0.40 (range 0.15-0.65)ml/min found in our cohort. However, there 
was a great degree of variability between animals in both studies and again the difference 
between strains in the rats used in each study and the larger weight of our rats could 
account for the differences observed.   
Only flow through the main pedicle DSEA was assessed during this study. In the animals 
used in this study we found these vessels to be approximately 0.25-0.35mm in diameter.  A 
previous study assessing the microvascular transfer of free rectus abdominus 
myocutaneous flaps in Sprague Dawley rats by Zhang et al has previously quoted that the 
mean vessel diameter of the DSEA was 0.4-0.5mm
235
. However the rats used in this study 
were much larger than our own weighting between 400-500grams and this could account 
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for the observed difference. Whilst the microcirculation transit-time flow probes used in 
this study can detect flow rates in vessels of 0.25-0.5mm we could not position 2 
concurrently on both the artery and the vein due to the size of the probes without placing 
undue tension on the vessels. We also found detection of flow within the vein to be 
extremely difficult and as such only arterial flow rate was measured and we accept this as a 
potential confounder.  
We found that vascular augmentation of the rat abdominal flaps led to a significant 
decrease in main arterial pedicle blood flow. A similar finding was found by Douglas, in 
the aforementioned study, when assessing the total number of perforators upon which to 
base a flap
168
. She found that by increasing the number of perforators used to supply a flap 
there was a decrease in main pedicle flow.  
5.4.1.4 Perforator Selection 
In all flaps raised in our animal cohort the ipsilateral most cranial perforator and the 
contralateral most caudal perforator were selected upon which to base the flaps and 
perform the study. The reasoning behind this choice of perforator configuration was in 
terms of translational research as it is likely to be the most useful in terms of potential 
vascular augmentation of flaps. By having such a perforator configuration it allows the 
maximal pedicle length available (without the use of interposition grafts) to subsequently 
augment a flap. For example if this configuration was chosen in a human subject the entire 
length of the ipsilateral DIEA and DIEV distal to the first perforator (caudal in humans) 
would be available to potentially use as afferent vessels to augment the flap. Conversely 
the entire length of the contralateral DIEA and DIEV from proximal to the last perforator 
(cranial in humans) to their origin would be available as recipient/efferent vessels upon 
which to perform vascular augmentation of the flap. 
5.4.1.5 Genetic Variability of Animal 
All rats used in this study were male out-bred Sprague Dawley rats. Sprague Dawley rats 
are the most commonly used out-bred strain of rat in experimental research
236
 and have 
been used extensively in abdominal flap models
94,162,163,214,229,230
. We accept the genetic 
variability of the out-bred strain as a potential confounder however our justification for 
utilising this strain was that they tend to be of a larger size and thus any experiments 
requiring meticulous dissection of the small perforating blood vessels more feasible and 
less prone to complications. 
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5.4.1.6 Performance bias 
A single surgeon with some previous microsurgical experience was responsible for 
performing all procedures and measuring the results. However as exposure/experience was 
gained in rat abdominal perforator flap dissection and raising it is feasible that flaps were 
raised quicker and more efficiently in the latter animals in the cohort and we accept this as 
a potential confounder. Potential consequences of efficient flap raising could be that those 
animals in the latter part of our study would have higher rates of flow and perfusion 
secondary to shorter anaesthetic time to reach that point. However given that we were 
comparing the difference in perfusion and flow between the traditional flap (essentially 
control) against the vascular augmented flap on each individual rat it is unlikely that this 
will have affected our results.  
5.4.1.7 Temperature 
Temperature is known to influence cutaneous blood flow as shown by Bircher et al
208
 and 
also the transit-time ultrasonic probes used to measure flow are calibrated to operate at 
approximately 37°C. As such room temperature in this experiment was kept constant 
between 21-24.5°C and the animal temperature continuously monitored by specialist 
animal technicians and attempts to maintain core temperature made at 37-38°C using an 
ambient heat source. Mean temperature for all animals was stable and kept within this 
range. However we accept that temperature can be a confounding factor. 
5.4.1.8 Intra-observer error 
All results were analysed by the same individual, to reduce inter-observer error; however 
the possibility of intra-observer error remains and we accept this as a potential confounder. 
5.4.2 Conclusion 
In conclusion from the findings of our study it has been shown that vascular augmentation 
of the rat abdominal perforator flap using the contralateral pedicle leads to an increase in 
Zone IV perfusion however this also coincides with a decrease in main pedicle arterial 
flow. Further studies in this area are required to assess if these findings correlate in human 
subjects. 
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Chapter 6: The use of real-time digital video in the 
assessment of post-operative outcomes of breast 
reconstruction. 
6.1 Introduction 
Standardised pre and post-operative photographs are still the most commonly used method 
of recording breast reconstruction outcomes. Whilst this method is readily available and 
reproducible it is inherently flawed by the fact that the images obtained are static and two 
dimensional. These images only provide limited information to the assessor and it is 
difficult to ascertain the degree of volume associated with the reconstruction. 
Recently more complex methods of assessment utilising three-dimensional capture 
technology coupled with computer assessment software allowing objective measurement 
of volume have been described
202,203
. However these assessment methods have largely 
been utilised for research purposes as they require specialist software, expertise and /or 
equipment not routinely available in most breast or plastic surgery units. 
A major advantage in terms of free tissue transfer breast reconstruction over implant based 
reconstruction is that the reconstruction is more likely to feel and to move like a normal 
breast.  
In 2005 a study by Gui et al evaluating post-operative outcome methods after immediate 
breast reconstruction they specifically comment upon the point that standardised 
photography failed to convey the impact of movement upon breast reconstruction and felt 
that better assessment may be made utilising video clips, but noted that there were no such 
studies comparing the use of still photographs with video footage
187
.  
The aim of this study was to assess whether standardised real-time digital video footage 
was a valid assessment tool in assessing post-operative outcomes and to compare its use 
against standardised static photography. 
6.2 Methods 
35 patients post breast reconstruction underwent photography (cf. 3.3.6), digital video 
capture (cf. 3.3.7) and completed Breast Cancer Treatment Outcomes Scale (BCTOS) 
questionnaires (cf. 3.3.5). The photographs/video clips were randomised and shown to a 21 
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member panel. Opinions on aesthetic aspects of the reconstruction were assessed using the 
BCTOS and Harris scale (cf. 3.3.9). 
Panel inter-rater agreement and patient-panel correlation was assessed using Kendall’s 
Coefficient of Concordance and Spearman’s rank correlation tests respectively (cf. 3.3.10). 
6.3 Results 
35 patients were recruited to this study carried out between 06/08/2012 and 30/01/2013. A 
summary of patient demographics and type of surgery are shown in Table 6.1.  
Age in years   
  Mean 52 
  Standard Deviation ±7 
  Range 35-67 
Side of reconstruction, n (%)   
  Left 21 (60%) 
  Right 14 (40%) 
Type of reconstruction, n (%)   
  Implant 3 (9%) 
  Latissimus dorsi (LD) flap plus implant 5 (14%) 
  Extended Latissimus Dorsi (LD) flap 15 (43%) 
  Free tissue transfer (abdominal flaps) 12 (34%) 
Table 6.1: Summary of patient demographics and type of surgery 
 
All 35 patients underwent the photography and video capture processes uneventfully. 
Unfortunately one set of patient photographs were corrupted during the transfer process 
from camera to computer and as such there were only 34 patients included in the 
photography assessment process. All 35 digital video clips were available for assessment. 
The average file storage size of each photo and video set were 0.38 megabytes and 14.9 
megabytes respectively. Each video clip ranged approximately (Range 140-194 seconds) 
6.3.1 Inter-rater Agreement 
A summary of the total panel inter-rater agreement scores are shown in Table 6.2. 
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Aspect of cosmesis assessed Photograph Assessment Score Video Assessment Score 
Overall 0.507 0.548 
Size 0.514 0.514 
Shape 0.486 0.505 
Elevation 0.514 0.514 
p<0.001 for all quoted values 
Table 6.2: Total panel inter-rater agreement scores 
 
Overall there was a “moderate” degree of inter-rater agreement amongst the panel in all 
categories. However there was a slightly greater degree of panel inter-rater reliability using 
video assessment in comparison to photographs to assess the overall cosmesis of the 
reconstruction (0.548 vs 0.507) and to assess shape (0.505 vs 0.486). There was no 
difference in levels of panel inter-rater agreement between the two methods in terms of 
assessing size and elevation (0.514 vs 0.514). 
A summary of individual panel type inter-rater agreement scores are shown in Table 6.3.  
 
Table 6.3: Inter-rater agreement based on panel composition 
 
On dividing the panel members into their respective cohorts (plastic surgery, general 
surgery and non-surgical) the highest degree of inter-rater agreement (moderate-strong) 
occurs amongst the plastic surgery panel utilising both photographs and video images.  The 
plastic surgery panel members showed a slightly lower level of agreement using video 
footage to assess the “overall” quality of the reconstruction (0.655 vs 0.640) but actually 
agreed more using video to assess the individual components of the reconstruction (size, 
shape and elevation).  
 
6.3.2 Patient/Panel Correlation 
The correlation between panel scores and patient self-assessment scores are shown in 
Table 6.4.  
 
Photographs Video Photographs Video Photographs Video Photographs Video
Plastic Surgery 0.655 0.64 0.637 0.678 0.545 0.6 0.475 0.565
General Surgery 0.552 0.563 0.564 0.51 0.516 0.48 0.418 0.443
Non-Surgical 0.496 0.574 0.5 0.529 0.518 0.584 0.384 0.401
Overall Cosmesis Size Shape ElevationPanel 
Composition
p <0.001 for all  quoted values
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Panel Composition Photographs p -value Video p - value 
Plastic Surgery 0.217 0.204 0.282 0.091 
General Surgery 0.357 0.032 0.466 0.004 
Non-Surgical 0.083 0.629 0.346 0.036 
Total 0.281 0.097 0.311 0.061 
Table 6.4: Correlation between patient and panel scores as assessed using photographs 
versus video 
 
Upon comparing the patient self-scores in comparison to the median panel scores obtained 
using still photographs and video assessment, the correlation was generally low for both 
assessment methods. However, a greater degree of correlation exists between the patient 
and the panel when using video footage as the assessment material (0.311 vs 0.281). The 
General Surgery panel showed the greatest degree of correlation with the patients’ own 
views using both photography and video footage to assess. The non-surgical panel showed 
the least degree of correlation using the still photographs as the assessment medium but 
showed a significant increase in correlation when using the video footage (0.083 vs 0.346). 
6.3.3 Assessment Panel Preference 
All 21 members (100%) of the panel were of the opinion that video clip footage was more 
useful in terms of assessing the post-operative outcome of breast reconstruction and that it 
yielded more information than the still photograph images. 
6.4 Discussion 
The total panel results from this study show that; whilst marginal, video is equivalent or 
better than still photographs in terms of inter-rater reliability. The Plastic surgeon sub-
division of the panel had the highest degree of inter-rater reliability and this may reflect 
their experience in terms of assessing reconstruction outcomes. 
Given that patient satisfaction is the goal in any form of reconstruction it is of importance 
to have an assessment tool which more accurately correlates with patient self-evaluation. 
Our results show that digital video footage assessment gives significantly better correlation 
between patient views and panel views in comparison to still photograph assessment. This 
again could be due to the fact that it offers a greater degree of information with regards to 
the reconstruction (such as mobility) which is not apparent on static photographs. It is also 
apparent that the greatest degree of correlation between patient perception and sub-panel 
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(in both photograph and video clip assessment) occurred with the General Breast Surgeons. 
This is interesting and may be worth further investigation.  
All 21 members of the assessment panel felt that video footage yielded a greater amount of 
information upon which to base their assessment. It was readily apparent throughout the 
assessment process that the video clips were capturing information which would not be 
apparent on standardised photographs. In particular these included significant “muscle 
twitching” of innervated Latissimus Dorsi flaps whilst moving the arm and also the relative 
absence of reconstruction movement in patients with implant only based reconstructions. 
Many published articles analysing ordinal data such as the results obtained in this study 
have focussed on utilising Kappa scores to assess inter-rater reliability
189,190,198-200
. These 
kappa scores however only measure the level of “absolute agreement” between raters and 
fail to take into account the magnitude of difference observed using ordinal data. The 
Kendall Coefficient of Concordance is a better measure of agreement for ordinal responses 
as it calculates the consistency amongst raters by also taking the ranking of the scores into 
account
237
. Furthermore several of the papers have changed their assessment scales by 
dichotomising categories of the scale to obtain higher kappa scores which may invariably 
skew the results
198,200
. 
The model demonstration video which was created for the purposes of this study proved 
very effective in terms of providing a standardised routine for the patients to emulate. One 
concern raised after the completion of this study was that each digital video clip was too 
long at between 140-194 seconds. This was in part due to the fact that the original 
demonstration script duplicated each of the movements twice. It is feasible that the length 
of the video clips can easily be reduced to half the duration by omitting the duplication of 
each of these movements and creating a more streamlined instructional video. This would 
confer several benefits in that; the video capture process would be quicker; assessment 
time shorter and the file size of all video clips would be significantly reduced. 
Breasts are not static by nature and move to a huge degree through the effects of gravity 
and bodily motion. In an effort to achieve symmetry (the goal of breast reconstruction) the 
natural breast motion should not be overlooked. In the post-operative assessment process 
there is no way to judge this on standardised photographs. Real-time digital video capture 
offers a suitable replacement to the outdated standardised photographs commonly used in 
current practice. These could easily be incorporated into both the pre and post-operative 
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assessment process in most modern plastic surgery departments as an adjunct to 
standardised photographs.  
Furthermore using the protocol in this study the same static images obtained via 
photography can easily be acquired from the video clips using a “screen-grab” type 
technique thereby reducing the need for patients to undergo two different capture processes 
and completely replacing standardised photography. 
When Gui et al originally theorised that video footage may provide a more accurate 
assessment than static photographs alone they foresaw several problems in terms of 
specialist equipment, cost, storage space and standardisation
187
.  Since then technology, 
software and storage media have advanced significantly as well as becoming cheaper.  As 
a result these issues are no longer as constraining as previously highlighted. Whilst the 
average file size associated with the digital video clips in this study (14.9 megabytes) was 
39.2 times greater than that of the digital photograph files (0.38megabytes) it is still 
relatively small in comparison to the capacity of most modern storage media which often 
have gigabytes or terabytes of space.  
Through the use of real time digital video capture a huge amount of information can be 
obtained in a short period of time and the results available for subsequent review and 
analysis.  
6.4.1 Potential Confounders 
6.4.1.1 Nipple Reconstruction / Areolar Complex Tattooing 
In order to ensure that patients had completed all oncological, adjuvant and major 
reconstructive procedures it was decided to recruit those patients attending for areolar 
complex tattooing. Areolar complex tattooing is also usually only performed in patients 
once their reconstructions have had time to settle (i.e. scars to heal and the effects of ptosis 
to become apparent). By choosing these patients the aim was also to reduce inconvenience 
as they were already planning to attend for their procedure and standard photographs and 
the video process would only add approximately 15minutes onto their appointment.  
Patients from a variety of consultants within the unit were included and due to differences 
within consultants routine practice there was variability as to whether patients had nipple 
reconstruction or not, i.e. some consultants prefer to tattoo prior to nipple reconstruction 
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and some consultants prefer to tattoo after nipple reconstruction. Also some patients 
included in this study had already had previous tattooing procedures carried out and were 
attending to have the previous tattoo augmented and as a result already had some element 
of nipple areolar complex during the photo and video process. 
Whilst this introduced a degree of variability into our patient sampling it was unlikely to 
interfere with statistical comparisons or validation of the technique of real time digital 
video capture. The comparisons were made only between the panel assessment scores for 
each individual patient individually and no comparisons were made between scores for 
different patients. However we do accept this degree of variability could be considered as a 
potential confounder. 
6.4.1.2 Types of Breast Reconstruction 
Patients included in this study varied upon which type of breast reconstruction they had 
(cf. 1.3). As such there was a degree of variability introduced into our patient sampling. 
However, no comparison was made between panel assessment scores given to different 
reconstructions. Panel member assessment scores were only compared against each other 
for each individual patients’ photographs and video footage to assess for concordance. 
Whilst it may be an interesting prospect to compare the varying reconstructive techniques 
utilising real time digital video footage, the purpose of this study was only to validate it as 
a technique. 
6.4.1.3 Symmetrising Surgery 
Some patients included in our cohort had contralateral symmetrising surgery whilst others 
did not. This led to variability in our sample with occasional large size/shape/elevation 
mismatches between the reconstructed breast and the contralateral breast. However given 
that the purpose of the study was to assess inter-rater agreement between panel members 
and no comparison was made between patients it would be unlikely to have any influence 
on the statistical results obtained (it would be expected that if a large size mismatch 
existed, panel members assessment scores would reflect this and inter-rater agreement can 
be measured.) 
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6.4.2 Conclusion 
From our initial findings we have demonstrated that real time digital video is a valid 
method of capturing patient reconstructions for later analysis. Coupled with panel review it 
provides a method of assessing post-operative outcomes of breast reconstruction and has 
advantages in comparison to still photographs in terms of inter-rater agreement and 
correlation with patient self-assessment. 
 
  
144 
 
 
Chapter 7: Discussion 
Breast cancer is the commonest type of cancer to affect women in the United Kingdom; 
accounting for 30% of all new cases of female cancer
238
. Surgical treatment is the current 
mainstay of breast cancer management, although this is often augmented by chemotherapy, 
endocrine therapy and radiotherapy. A large multidisciplinary team approach is used in the 
individual assessment, management and follow-up of every breast cancer patient. 
Surgical treatment options vary dependent upon the size, location, histopathological type, 
number, receptor status and grade of the tumour(s) present within the breast tissue. Other 
factors such as genetic risk, patient age, patient health and patient choice also play 
important roles in the choice of surgical treatment. The surgical options can be broadly 
divided into breast conserving surgery, where only the tumour is removed and a portion 
(often the majority) of the patient’s own breast tissue is conserved; and mastectomy which 
involves the complete removal of the breast. Despite modern standard of care favouring 
breast conservation surgery in those patients with low grade cancers and new oncoplastic 
techniques allowing a larger number of cancers to be managed via breast conserving 
surgery it has been shown that greater than 16,000 mastectomies are still required in the 
United Kingdom each year
228
.  
Current joint national guidelines state that, disease permitting, all females due to undergo 
mastectomy for breast cancer should be offered breast reconstruction surgery
239
.  The 
National Mastectomy Audit and Breast Reconstruction audit published in 2011 showed 
that 21% of women undergoing mastectomy opted to have an immediate reconstruction 
with a further 11% undergoing delayed reconstruction
228
. The audit highlighted several key 
points and issues associated with breast reconstruction. Firstly breast reconstruction 
procedures are safe with few complications requiring emergency transfer to intensive or 
high dependency care (<1%) and low levels of mortality (<0.3%). Women opting for 
breast reconstruction had greater levels of physical, emotional and sexual well-being than 
those undergoing mastectomy alone. Yet despite these factors only 21% of women who 
underwent mastectomy had immediate breast reconstruction and the findings of the audit 
suggested that some patients may not have been offered the option of reconstruction based 
upon geographical location or due to the clinician involved in their care feeling they were 
not adequate candidates for a variety of reasons. Previous concerns that immediate breast 
reconstruction may be detrimental to patient outcomes have been shown to be false
240,241
 
and there is no significant difference in survival rates between patients undergoing 
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immediate or delayed reconstructions
242-244
. Subsequent to the audit findings, joint national 
guidelines (“Oncoplastic breast surgery – a guide to good clinical practice) were released 
in 2012 stipulating that all patients requiring mastectomy be offered immediate breast 
reconstruction and the relative and absolute contra-indications to immediate breast 
reconstructions were defined to raise awareness and provide clarity for both breast cancer 
patients and the clinicians involved in their care
239
. As a result of these guidelines and the 
fact that the incidence of breast cancer in the UK is increasing, whilst the associated 
mortality rate is decreasing
238
, then it is likely that the number of breast reconstruction 
procedures performed will also increase. 
Another interesting point raised by the audit was that out of the common reconstructions 
available to patients, implant only, pedicled autologous LD flap +/- implant or free tissue 
transfer, those patients undergoing autologous reconstructions in the form of pedicled or 
free flap had higher outcome scores than those undergoing implant based reconstructions. 
In the delayed setting free tissue transfer outcome scores were the highest out of all 
reconstructions
228
. These findings agree with evidence in the literature which suggests that 
patients undergoing autologous tissue transfer reconstruction have higher levels of 
satisfaction than those undergoing implant based reconstruction
24-26,31,32
 and that in the 
longer term these patients may be happier from an aesthetic point of view with their 
reconstructions
24,26
. Despite this the audit showed that the majority of patients undergoing 
immediate reconstruction had implant based reconstructions and alluded to the fact that 
access to autologous tissue reconstruction may be limited to some patients  (particularly in 
the immediate setting)
228
. This may have been due to several factors including, lack of 
specialist services in the region offering autologous based reconstructions, funding 
concerns, lack of theatre time available to accommodate the increased duration of 
autologous reconstructive procedures and logistical difficulties in terms of the co-
ordination between the various surgical teams involved in autologous tissue reconstruction. 
Irrespective of services offered within each region the joint national guidelines have 
recommended that all reconstructive options be discussed with each patient
239
. Recent 
evidence has also been published suggesting that whilst implant based reconstruction may 
be slightly cheaper initially that in the long-term autologous based reconstructions are 
more cost-effective
245,246
. With emphasis on development of oncoplastic breast services, 
increasing evidence base as to the benefit of autologous tissue reconstruction and 
experience in perforator based flaps, then it is likely that the number of autologous based 
breast reconstructions and free abdominal flaps being performed will also increase. 
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The other significant point highlighted by the audit was that involvement of patients 
throughout their cancer treatment and reconstructive journey is paramount to ensuring the 
best quality of care
228
. This includes providing adequate information to facilitate their 
informed contribution to the decision making process. In this respect PROMs are one 
method of assessing the care we are providing. However difficulties exist in using PROMs 
to assess post-operative aesthetic results as we know these outcome measures are 
influenced by a variety of different factors. It was recommended that, as a minimum 
standardised photographs should be taken as an objective cosmetic outcome measure and 
that satisfaction with cosmetic outcome should be assessed by PROMs at three and 
eighteen months.  
As discussed the number of autologous based breast reconstruction procedures, in 
particular free tissue transfer, is likely to increase in current practice. Therefore it is 
important that every effort be made to ensure that these procedures are safe with low rates 
of complications and are able to fulfil the reconstructive goal in terms of size, shape and 
texture. Furthermore due to deficiencies in the use of patient reported outcome measures in 
the aesthetic assessment of post-operative results other accurate assessment tools are 
required in order to be able to compare post-operative results. Research into the field of 
free tissue breast transfer and post-operative breast reconstruction assessment is required to 
ensure the best of care is available to each patient.   
7.1 Summary of results 
The research contained within this thesis addresses some of the concerns discussed above. 
It was recognised that vascular complications associated with free DIEP flaps can occur 
and are most likely to occur in areas of the flap furthest from the perforating vessels. 
Additional vascular augmentation procedures to improve perfusion to the DIEP flap have 
been described, however the evidence for their use is limited; confined to case or small 
series based studies. We undertook a pilot study using LDI and ICG angiography to 
objectively assess the effects of vascular augmentation procedures on Zone IV perfusion of 
DIEP flaps using the contralateral SIE vascular system. Our findings suggest that there 
does appear to be a trend towards increasing perfusion to Zone IV skin and fat when the 
flap is augmented using the SIEA and SIEV. SIEV augmentation alone seemed to have the 
least effect on perfusion to Zone IV which is interesting since most DIEP flap problems 
seem to occur as a result of venous congestion. Whilst SIEV augmentation alone may help 
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venous drainage in some failing flaps it was apparent that this augmentation alone would 
not improve overall Zone IV perfusion. SIEA augmentation led a much greater degree of 
perfusion however SIEA augmentation alone did not lead to statistically significant results. 
The only statistically significant increase in perfusion found in this study was when both 
the SIEA and SIEV in combination were used to augment the flap. However this was only 
a pilot study with a small cohort number and given the large difference in median 
perfusion observed upon SIEA augmentation alone it is likely that this may be clinically 
relevant and the failure to reach statistical significance could be due to the power 
considerations of the study. The results obtained from this pilot study could be used to 
make power calculations to assess the sample size required for a larger study.  We accept 
that experimental nature of this study and that the arbitrary values obtained via LDI and 
ICG angiography are very difficult to interpret in terms of translational research as these 
values differ widely between individual patients and upon the type of machine or software 
used. As such no exact values of perfusion, like those contained within this study, 
correlating with flap viability have been published in the literature. In our study given the 
fact that Zone IV was discarded immediately after the research measurement process we 
also accept that the follow-up is inadequate to assess the effects of vascular augmentation 
on fat necrosis or overall outcome of reconstruction.  
From our human study it was apparent that vascular augmentation of DIEP flaps led to an 
increase in Zone IV perfusion however we wished to investigate the effect that this 
augmentation procedure may have on Zone I perfusion and main pedicle blood flow. An 
experimental animal based study raising abdominal perforator flaps on rats was undertaken 
and the effect of vascular augmentation on these flaps utilising the contralateral pedicle 
and a caudal perforator was assessed. The results from our animal study corroborated our 
human study findings in that vascular augmentation does indeed significantly increase 
Zone IV perfusion. It also increased Zone I perfusion to a smaller degree. However the 
findings of our study showed that whilst vascular augmentation of the rat abdominal flaps 
raised perfusion it decreased blood flow through the main arterial pedicle. The effect that 
this decrease upon main pedicle flow has on overall flap viability is uncertain and as 
discussed previously flap flow/perfusion is a complex process with multiple interdependent 
variables (cf. 1.2.3).  It may be that this decrease in main pedicle flow is a transient process 
or with little effect on skin/fat perfusion and we accept that the follow up in this 
experimental study is inadequate to assess these points. 
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It was identified that current methods of post-operative outcome assessment following 
breast reconstruction are flawed secondary to the fact that patient reported outcome 
assessment of aesthetic outcome has many additional confounding factors and also current 
photography and panel assessment methods have poor inter-rater agreement and patient 
correlation. Whilst newer techniques have been developed to attempt to provide more 
robust objective methods of assessment, the equipment / expertise required to utilise these 
are out-with those commonly available to the majority of Breast or Plastic Surgery units. 
Digital video recording equipment and medical illustration staff trained in filmography are 
available in the majority of Breast and Plastic Surgery units. We undertook a study to 
assess whether real-time digital video footage may be a valid assessment tool coupled with 
panel assessment and to compare its use to current standardised photography. Through this 
research we validated the use of real time digital video in the post-operative outcome 
assessment of breast reconstruction patients. We have devised a protocol outlining a 
simple, reproducible sequence of movements for patients to perform whilst being recorded 
to allow subjective assessment. Patients found this an easy intervention to comply with and 
the assessment panel universally agreed that it offered more information upon which to 
base an assessment.  Furthermore our results suggest that not only is real-time digital video 
a valid option in post-operative outcome assessment but that it provides more consistent 
inter-rater agreement with regards to cosmesis and shape. It also has an increased level of 
correlation with patient satisfaction in comparison to conventional photography. 
7.2 Potential Clinical Implications 
Our research into the effects of vascular augmentation of DIEP flaps using the contralateral 
SIE vascular system suggests that this does increase Zone IV perfusion to the flap. This 
could potentially allow the inclusion of Zone IV if required such as when a larger skin 
paddle is needed in delayed reconstructions. Whilst additional anastomoses would increase 
the operative time for patients the ability to utilise larger more robust flaps flaps could 
reduce the need for subsequent revision procedures. This should be undertaken with 
caution however and we would not recommend routinely carrying out the vascular 
augmentation procedures as our findings also suggest that such procedures may have 
deleterious effects upon main pedicle arterial flow. Further in-vivo investigational work is 
required in this area. 
The technique and use of real-time digital video capture in post-operative breast 
reconstruction outcome assessment has been validated by this research.  From our 
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experience and the patients involved in our study it is an acceptable reproducible way to 
record clinical information.  Real time digital video footage yields more information than 
standardised photographs and appears to be a superior to standardised photography in 
panel assessment. Given the readily available nature of digital video capture in modern 
practice coupled with cost effective storage media we believe that real time digital video 
footage could be a potential replacement for standardised photographs in the field of breast 
reconstruction outcome recording and assessment. Some may comment that still images 
may be required on occasion, for example to publish in a hard copy journal, but these 
images can easily be obtained from the real time digital video footage by pausing the 
playback of the recording at the desired time and obtaining a still image via screen capture. 
7.3 Future Work 
With regards to the vascular augmentation of DIEP flaps, even though these interventions 
are commonly undertaken in clinical practice as salvage procedures, we believe that further 
clinical studies are required. Prior to carrying out such vascular augmentation procedures 
pro-actively, studies should be undertaken to assess the potential deleterious effects it may 
have on the rest of the flap. We propose that a further in-vivo human study should be 
undertaken and the effects on main pedicle blood flow and Zone I-IV perfusion assessed 
after vascular augmentation of the flap.  
With regards to the use of real time digital video in the post-operative outcome assessment 
of breast reconstruction further work could be undertaken to shorten the length of the video 
clips recorded by providing a more succinct sequence of movements for the patient to 
perform. This could easily be achieved by removing the repetition of movements at each 
stage from our established protocol and producing a new model demonstration for patients 
to copy. We believe that this would result in a video capture process of approximately the 
same time; or indeed shorter than the photography process which patients currently 
undergo. Once the shortened video sequence was revalidated a large scale study comparing 
the various breast reconstruction options (implant based or autologous) could be 
undertaken using video footage coupled with panel assessment and patient satisfaction.  
Another interesting project to consider with regards to real time digital video would be 
whether the capture process could be fully automated. In our initial study patients found it 
easy to copy the model demonstration coupled with audio cues being played to them 
during the recording process. We believe that a set-up could easily be arranged in which a 
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patient could independently control their own recording process. Such a set-up would 
consist of a private room containing a digital video camera and a television monitor to play 
the model demonstration. A spot could be marked on the floor dictating where the patient 
should stand facing the camera and television screen. The patient would be provided with a 
a remote control to activate the model playback process. By linking the playback initiation 
with the commencement of the recording capture process the patient themselves can 
choose when to begin. An automated real-time digital video capture system like this to 
replace traditional photography could have huge benefits for both breast reconstruction 
patients and the healthcare system. An automated patient driven system would empower 
the patient allowing them to control one aspect of their reconstructive journey pre and post 
operatively. It would also be beneficial in terms of respect for patient privacy as they 
would not need to undress in front of an additional member of staff (i.e. photographer). 
There would also be cost saving implications of such a system as it is feasible that any 
private room (i.e. clinic room) could be utilised to carry out the capture process in 
comparison to a dedicated photography studio. Also it would reduce the need for 
photography staff and chaperones (if required). 
Future studies could also investigate the possibility of four dimensional breast 
reconstruction capture and assessment. This could be achieved by incorporating a real time 
capturing component into the three-dimensional process already described by Henseler et 
al.
202,203
 This could provide extremely detailed objective measurements at the same time as 
assessing the effects of mobility. Whilst it is unlikely that such a system could be used in 
current clinical practice it could provide a useful research tool. 
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Appendices 
Appendix A 
 
 
Figure A 1: Minitab output for repeated measures ANOVA LDI Zone IV Skin Perfusion 
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Figure A 2: Minitab output for repeated measures ANOVA ICG Zone IV Skin Perfusion 
 
 
Figure A 3: Minitab output for repeated measures ANOVA ICG Zone IV Fat Perfusion 
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Appendix B 
 
Figure B 1: Patient breast reconstruction questionnaire form 
  
154 
 
 
List of References 
1. Jacobson JH, Suarez EL. Microsurgery in anastomosis of small vessels. Surgical 
Forum 1960:243-5. 
2. Kleinert HE, Kasdan ML, Romero JL. Small blood-vessel anastomosis for salvage 
of severely injured upper extremity. The Journal of bone and joint surgery American 
volume 1963;45-A:788-96. 
3. Komatsu S, Tamai S. Successful replantation of a completely cut-off thumb. Plast 
Reconstr Surg 1968;42:374-7. 
4. Buncke Jr HJ, Schulz WP. Total ear reimplantation in the rabbit utilising 
microminiature vascular anastomoses. Br J Plast Surg 1966;19:15-22. 
5. Buncke Jr HJ, Buncke CM, Schulz WP. Immediate Nicoladoni procedure in the 
rhesus monkey, or hallux-to-hand transplantation, utilising microminiature vascular 
anastomoses. Br J Plast Surg 1966;19:332-7. 
6. McLean DH, Buncke HJJ. Autotransplant of omentum to a large scalp defect, with 
microsurgical revascularization. Plast Reconstr Surg 1972;49:268-74. 
7. McGregor IA, Jackson IT. The groin flap. Br J Plast Surg 1972;25:3-16. 
8. Taylor GI, Daniel RK. The free flap: composite tissue transfer by vascular 
anastomosis. Aust N Z J Surg 1973;43:1-3. 
9. Taylor GI. The angiosomes of the body and their supply to perforator flaps. Clinics 
in Plastic Surgery;30:331-42. 
10. Blondeel PN, Van Landuyt KHI, Monstrey SJM, et al. The “Gent” Consensus on 
Perforator Flap Terminology: Preliminary Definitions. Plastic and Reconstructive Surgery 
2003;112:1378-83. 
11. Manchot C. Die Hautarterien des menschlichen Körpers. Leipzig: FCW Vogel; 
1889. 
12. Taylor GI, Pan W-R. The Angiosome Concept and Tissue Transfer. St Louis, 
Missouri: Quality Medical Publishing Inc; 2014. 
13. Taylor GI, Palmer JH. The vascular territories (angiosomes) of the body: 
experimental study and clinical applications. Br J Plast Surg 1987;40:113-41. 
14. Watterson PA, Taylor GI, Crock JG. The venous territories of muscles: anatomical 
study and clinical implications. Br J Plast Surg 1988;41:569-85. 
15. Taylor GI, Caddy CM, Watterson PA, Crock JG. The venous territories 
(venosomes) of the human body: experimental study and clinical implications. Plast 
Reconstr Surg 1990;86:185-213. 
16. Taylor GI, Chubb DP, Ashton MW. True and 'choke' anastomoses between 
perforator angiosomes: part i. anatomical location. Plast Reconstr Surg 2013;132:1447-56. 
17. Taylor GI, Corlett RJ, Caddy CM, Zelt RG. An anatomic review of the delay 
phenomenon: II. Clinical applications. Plast Reconstr Surg 1992;89:408-16; discussion 17-
8. 
18. Dhar SC, Taylor GI. The delay phenomenon: the story unfolds. Plast Reconstr Surg 
1999;104:2079-91. 
19. Saint-Cyr M, Schaverien M, Arbique G, Hatef D, Brown SA, Rohrich RJ. Three- 
and four-dimensional computed tomographic angiography and venography for the 
investigation of the vascular anatomy and perfusion of perforator flaps. Plast Reconstr 
Surg 2008;121:772-80. 
20. Saint-Cyr M, Wong C, Schaverien M, Mojallal A, Rohrich RJ. The perforasome 
theory: vascular anatomy and clinical implications. Plast Reconstr Surg 2009;124:1529-44. 
21. Taylor GI, Corlett RJ, Dhar SC, Ashton MW. The anatomical (angiosome) and 
clinical territories of cutaneous perforating arteries: development of the concept and 
designing safe flaps. Plast Reconstr Surg 2011;127:1447-59. 
22. Ganong. Review of Medical Physiology. In. 22nd ed: Lange; 2005:581-2. 
155 
 
 
23. Godfrey PM, Godfrey NV, Romita MC. Restoring the Breast to Match the Normal 
Side. Ann Plast Surg 1993;31:392-8. 
24. Alderman AK, Kuhn LE, Lowery JC, Wilkins EG. Does patient satisfaction with 
breast reconstruction change over time? Two-year results of the Michigan Breast 
Reconstruction Outcomes Study. Journal of the American College of Surgeons 
2007;204:7-12. 
25. Alderman AK, Wilkins EG, Lowery JC, Kim M, Davis JA. Determinants of Patient 
Satisfaction in Postmastectomy Breast Reconstruction. Plast Reconstr Surg 2000;106:769-
76. 
26. Christensen BO, Overgaard J, Kettner LO, Damsgaard TE. Long-term evaluation of 
postmastectomy breast reconstruction. Acta oncologica (Stockholm, Sweden) 
2011;50:1053-61. 
27. Zhong T, McCarthy C, Min S, et al. Patient satisfaction and health-related quality 
of life after autologous tissue breast reconstruction: a prospective analysis of early 
postoperative outcomes. Cancer 2012;118:1701-9. 
28. Atisha D, Alderman AK, Lowery JC, Kuhn LE, Davis J, Wilkins EG. Prospective 
analysis of long-term psychosocial outcomes in breast reconstruction: two-year 
postoperative results from the Michigan Breast Reconstruction Outcomes Study. Annals of 
Surgery 2008;247:1019-28. 
29. Howes B, Fosh B, Watson D, et al. Autologous fat grafting for whole breast 
reconstruction. Plast Reconstr Surg Glob Open 2014;2:e124. 
30. Losken A, Pinell XA, Sikoro K, Yezhelyev MV, Anderson E, Carlson GW. 
Autologous Fat Grafting in Secondary Breast Reconstruction. Ann Plast Surg 
2011;66:518-22. 
31. Saulis AS, Mustoe TA, Fine NA. A Retrospective Analysis of Patient Satisfaction 
with Immediate Postmastectomy Breast Reconstruction: Comparison of Three Common 
Procedures. Plast Reconstr Surg 2007;119:1669-76. 
32. Weichman KE, Broer PN, Thanik VD, et al. Patient-Reported Satisfaction and 
Quality of Life following Breast Reconstruction in Thin Patients: A Comparison between 
Microsurgical and Prosthetic Implant Recipients. Plast Reconstr Surg 2015;136:213-20. 
33. Yueh JH, Slavin SA, Adesiyun T, et al. Patient Satisfaction in Postmastectomy 
Breast Reconstruction: A Comparative Evaluation of DIEP, TRAM, Latissimus Flap, and 
Implant Techniques. Plast Reconstr Surg 2010;125:1585-95. 
34. Cormack GC, Lamberty BGH. The Arterial Anatomy of Skin Flaps: Churchill 
Livingstone 1986. 
35. Boyd JB, Taylor GI, Corlett R. The Vascular Territories of the Superior Epigastric 
and the Deep Inferior Epigastric Systems. Plast Reconstr Surg 1984;73:1-14. 
36. Rozen WM, Kapila S, Donahoe S. Why there are two rows of deep inferior 
epigastric artery perforators despite variability in the number of deep inferior epigastric 
artery trunks: An anatomical and embryological argument. Clinical anatomy (New York, 
NY) 2011;24:786-8. 
37. Taylor GI, Corlett R, Boyd JB. The Extended Deep Inferior Epigastric Flap: A 
Clinical Technique. Plast Reconstr Surg 1983;72:751-64. 
38. Rozen WM, Murray AC, Ashton MW, et al. The cutaneous course of deep inferior 
epigastric perforators: implications for flap thinning. J Plast Reconstr Aesthet Surg 
2009;62:986-90. 
39. Carramenha e Costa MA, Carriquiry C, Vasconez LO, Grotting JC, Herrera RH, 
Windle BH. An anatomic study of the venous drainage of the transverse rectus abdominis 
musculocutaneous flap. Plast Reconstr Surg 1987;79:208-17. 
40. Imanishi N, Nakajima H, Minabe T, Chang H, Aiso S. Anatomical relationship 
between arteries and veins in the paraumbilical region. Br J Plast Surg 2003;56:552-6. 
156 
 
 
41. Rozen WM, Pan W-R, Le Roux CM, Taylor GI, Ashton MW. The Venous 
Anatomy of the Anterior Abdominal Wall: An Anatomical and Clinical Study. Plast 
Reconstr Surg 2009;124:848-53. 
42. Tai Y, Hasegawa H. A transverse abdominal flap for reconstruction after radical 
operations for recurrent breast cancer. Plast Reconstr Surg 1974;53:52-4. 
43. Holmström H. The Free Abdominoplasty Flap and Its Use in Breast 
Reconstruction: An Experimental Study and Clinical Case Report. Scandinavian journal of 
plastic and reconstructive surgery and hand surgery / Nordisk plastikkirurgisk forening 
[and] Nordisk klubb for handkirurgi 1979;13:423-7. 
44. Robbins TH. Rectus abdominis myocutaneous flap for breast reconstruction. Aust 
N Z J Surg 1979;49:527-30. 
45. Drever JM. Total Breast Reconstruction. Ann Plast Surg 1981;7:54-61. 
46. Dinner MI, Labandter HP, Dowden RV. The role of the rectus abdominis 
myocutaneous flap in breast reconstruction. Plast Reconstr Surg 1982;69:209-15. 
47. Hartrampf CR, Scheflan M, Black PW. Breast reconstruction with a transverse 
abdominal island flap. Plast Reconstr Surg 1982;69:216-25. 
48. Koshima I, Soeda S. Inferior epigastric artery skin flaps without rectus abdominis 
muscle. Br J Plast Surg 1989;42:645-8. 
49. Allen RJ, Treece P. Deep Inferior Epigastric Perforator Flap for Breast 
Reconstruction. Ann Plast Surg 1994;32:32-8. 
50. Blondeel PN. One hundred free DIEP flap breast reconstructions: a personal 
experience. Br J Plast Surg 1999;52:104-11. 
51. Hamdi M, Weiler-Mithoff EM, Webster MH. Deep inferior epigastric perforator 
flap in breast reconstruction: experience with the first 50 flaps. Plast Reconstr Surg 
1999;103:86-95. 
52. Blondeel N, Vanderstraeten GG, Monstrey SJ, et al. The donor site morbidity of 
free DIEP flaps and free TRAM flaps for breast reconstruction. Br J Plast Surg 
1997;50:322-30. 
53. Gill PS, Hunt JP, Guerra AB, et al. A 10-Year Retrospective Review of 758 DIEP 
Flaps for Breast Reconstruction. Plast Reconstr Surg 2004;113:1153-60. 
54. Nahabedian MY, Momen B, Galdino G, Manson PN. Breast Reconstruction with 
the free TRAM or DIEP flap: patient selection, choice of flap, and outcome. Plast Reconstr 
Surg 2002;110:466-75; discussion 76-7. 
55. Nahabedian MY, Momen B. Lower abdominal bulge after deep inferior epigastric 
perforator flap (DIEP) breast reconstruction. Ann Plast Surg 2005;54:124-9. 
56. Nahabedian MY, Dooley W, Singh N, Manson PN. Contour abnormalities of the 
abdomen after breast reconstruction with abdominal flaps: the role of muscle preservation. 
Plast Reconstr Surg 2002;109:91-101. 
57. Sailon AM, Schachar JS, Levine JP. Free transverse rectus abdominis 
myocutaneous and deep inferior epigastric perforator flaps for breast reconstruction: a 
systematic review of flap complication rates and donor-site morbidity. Ann Plast Surg 
2009;62:560-3. 
58. Nelson JA, Guo Y, Sonnad SS, et al. A Comparison between DIEP and muscle-
sparing free TRAM flaps in breast reconstruction: a single surgeon's recent experience. 
Plast Reconstr Surg 2010;126:1428-35. 
59. Kroll SS, Sharma S, Koutz C, et al. Postoperative morphine requirements of free 
TRAM and DIEP flaps. Plast Reconstr Surg 2001;107:338-41. 
60. Man LX, Selber JC, Serletti JM. Abdominal wall following free TRAM or DIEP 
flap reconstruction: a meta-analysis and critical review. Plast Reconstr Surg 2009;124:752-
64. 
61. Blondeel PN, Arnstein M, Verstraete K, et al. Venous congestion and blood flow in 
free transverse rectus abdominis myocutaneous and deep inferior epigastric perforator 
flaps. Plast Reconstr Surg 2000;106:1295-9. 
157 
 
 
62. Grotting JC. The free abdominoplasty flap for immediate breast reconstruction. 
Ann Plast Surg 1991;27:351-4. 
63. Volpe AG, Rothkopf DM, Walton RL. The versatile superficial inferior epigastric 
flap for breast reconstruction. Ann Plast Surg 1994;32:113-7. 
64. Arnez ZM, Khan U, Pogorelec D, Planinsek F. Breast reconstruction using the free 
superficial inferior epigastric artery (SIEA) flap. Br J Plast Surg 1999;52:276-9. 
65. Chevray PM. Breast reconstruction with superficial inferior epigastric artery flaps: 
a prospective comparison with TRAM and DIEP flaps. Plast Reconstr Surg 
2004;114:1077-83; discussion 84-5. 
66. Taylor GI, Daniel RK. The anatomy of several free flap donor sites. Plast Reconstr 
Surg 1975;56:243-53. 
67. Stern HS, Nahai F. The versatile superficial inferior epigastric artery free flap. Br J 
Plast Surg 1992;45:270-4. 
68. Spiegel AJ, Khan FN. An Intraoperative algorithm for use of the SIEA flap for 
breast reconstruction. Plast Reconstr Surg 2007;120:1450-9. 
69. Coroneos CJ, Heller AM, Voineskos SH, Avram R. SIEA versus DIEP Arterial 
Complications: A Cohort Study. Plast Reconstr Surg 2015;135:802e-7e. 
70. Scheflan M, Dinner MI. The transverse abdominal island flap: part I. Indications, 
contraindications, results, and complications. Ann Plast Surg 1983;10:24-35. 
71. Scheflan M, Dinner MI. The Transverse Abdominal Island Flap: Part II. Surgical 
Technique. Ann Plast Surg 1983;10:120-9. 
72. Dinner MI, Dowden RV, Scheflan M. Refinements in the use of the transverse 
abdominal island flap for postmastectomy reconstruction. Ann Plast Surg 1983;11:362-72. 
73. Hallock GG. Physiological studies using laser Doppler flowmetry to compare blood 
flow to the zones of the free TRAM flap. Ann Plast Surg 2001;47:229-33. 
74. Holm C, Mayr M, Höfter E, Ninkovic M. Perfusion Zones of the DIEP Flap 
Revisited: A Clinical Study. Plast Reconstr Surg 2006;117:37-43. 
75. Keller A. Perfusion zones of the DIEP flap revisited: a clinical study. Plast 
Reconstr Surg 2006;118:1076-7; author reply 7. 
76. Rozen WM, Ashton MW, Le Roux CM, Pan WR, Corlett RJ. The perforator 
angiosome: a new concept in the design of deep inferior epigastric artery perforator flaps 
for breast reconstruction. Microsurgery 2010;30:1-7. 
77. Rozen WM, Ashton MW. Re: The perforasome theory: vascular anatomy and 
clinical implications. Plast Reconstr Surg 2010;125:1845-6. 
78. Chow SP, Chen DZ, Gu YD. The Significance of Venous Drainage in Free Flap 
Transfer. Plast Reconstr Surg 1993;91:713-5. 
79. Boutros SG. Double venous system drainage in deep inferior epigastric perforator 
flap breast reconstruction: a single-surgeon experience. Plast Reconstr Surg 2013;131:671-
6. 
80. Niranjan NS. Venous augmentation of the free TRAM flap. Br J Plast Surg 
2001;54:335-7. 
81. Schaverien M, Saint-Cyr M, Arbique G, Brown SA. Arterial and Venous 
Anatomies of the Deep Inferior Epigastric Perforator and Superficial Inferior Epigastric 
Artery Flaps. Plast Reconstr Surg 2008;121:1909-19. 
82. Tutor EG, Auba C, Benito A, Rabago G, Kreutler W. Easy venous superdrainage in 
DIEP flap breast reconstruction through the intercostal branch. J Reconstr Microsurg 
2002;18:595-8. 
83. Tran NV, Buchel EW, Convery PA. Microvascular complications of DIEP flaps. 
Plast Reconstr Surg 2007;119:1397-405; discussion 406-8. 
84. Wechselberger G, Schoeller T, Bauer T, Ninkovic M, Otto A, Ninkovic M. Venous 
superdrainage in deep inferior epigastric perforator flap breast reconstruction. Plast 
Reconstr Surg 2001;108:162-6. 
158 
 
 
85. Kroll SS. Fat Necrosis in Free Transverse Rectus Abdominis Myocutaneous and 
Deep Inferior Epigastric Perforator Flaps. Plast Reconstr Surg 2000;106:576-83. 
86. Schaverien MV, Ludman CN, Neil-Dwyer J, et al. Relationship between venous 
congestion and intraflap venous anatomy in DIEP flaps using contrast-enhanced magnetic 
resonance angiography. Plast Reconstr Surg 2010;126:385-92. 
87. Selber JC, Serletti JM. The Deep Inferior Epigastric Perforator Flap: Myth and 
Reality. Plast Reconstr Surg 2010;125:50-8. 
88. Khansa I, Momoh AO, Patel PP, Nguyen JT, Miller MJ, Lee BT. Fat necrosis in 
autologous abdomen-based breast reconstruction: a systematic review. Plast Reconstr Surg 
2013;131:443-52. 
89. Peeters WJ, Nanhekhan L, Van Ongeval C, Fabré G, Vandevoort M. Fat Necrosis 
in Deep Inferior Epigastric Perforator Flaps: An Ultrasound-Based Review of 202 Cases. 
Plast Reconstr Surg 2009;124:1754-8. 
90. Khouri RK, Cooley BC, Kunselman AR, et al. A prospective study of 
microvascular free-flap surgery and outcome. Plast Reconstr Surg 1998;102:711-21. 
91. Vega S, Smartt JM, Jr., Jiang S, et al. 500 Consecutive patients with free TRAM 
flap breast reconstruction: a single surgeon's experience. Plast Reconstr Surg 
2008;122:329-39. 
92. Wax MK, Rosenthal E. Etiology of late free flap failures occurring after hospital 
discharge. The Laryngoscope 2007;117:1961-3. 
93. Guzzetti T, Thione A. The basilic vein: an alternative drainage of DIEP flap in 
severe venous congestion. Microsurgery 2008;28:555-8. 
94. Hallock GG, Rice DC. Comparison of TRAM and DIEP flap physiology in a rat 
model. Plast Reconstr Surg 2004;114:1179-84. 
95. Liu TS, Ashjian P, Festekjian J. Salvage of congested deep inferior epigastric 
perforator flap with a reverse flow venous anastomosis. Ann Plast Surg 2007;59:214-7. 
96. Lundberg J, Mark H. Avoidance of complications after the use of deep inferior 
epigastric perforator flaps for reconstruction of the breast. Scandinavian journal of plastic 
and reconstructive surgery and hand surgery / Nordisk plastikkirurgisk forening [and] 
Nordisk klubb for handkirurgi 2006;40:79-81. 
97. Mehrara BJ, Santoro T, Smith A, et al. Alternative venous outflow vessels in 
microvascular breast reconstruction. Plast Reconstr Surg 2003;112:448-55. 
98. Nosrati NN, Tholpady SS, Socas J, Cohen AC, Cacioppo JR. Microvascular 
lifeboats: a stepwise approach to intraoperative venous congestion in DIEP flap breast 
reconstruction. Plast Reconstr Surg 2015;135:639e-40e. 
99. Rohde C, Keller A. Novel technique for venous augmentation in a free deep 
inferior epigastric perforator flap. Ann Plast Surg 2005;55:528-30. 
100. Villafane O, Gahankari D, Webster M. Superficial inferior epigastric vein (SIEV): 
'lifeboat' for DIEP/TRAM flaps. Br J Plast Surg 1999;52:599. 
101. Semple JL. Retrograde microvascular augmentation (turbocharging) of a single-
pedicle TRAM flap through a deep inferior epigastric arterial and venous loop. Plast 
Reconstr Surg 1994;93:109-17. 
102. Hallock GG. Simplified nomenclature for compound flaps. Plast Reconstr Surg 
2000;105:1465-70; quiz 71-2. 
103. Civelek B, Kargi E, Akoz T, Sensoz O. Turbocharge or supercharge? Plast 
Reconstr Surg 1998;102:1303. 
104. Galanis C, Nguyen P, Koh J, Roostaeian J, Festekjian J, Crisera C. Microvascular 
lifeboats: a stepwise approach to intraoperative venous congestion in DIEP flap breast 
reconstruction. Plast Reconstr Surg 2014;134:20-7. 
105. Enajat M, Rozen WM, Whitaker IS, Smit JM, Acosta R. A single center 
comparison of one versus two venous anastomoses in 564 consecutive DIEP flaps: 
Investigating the effect on venous congestion and flap survival. Microsurgery 
2010;30:185-91. 
159 
 
 
106. Yeh Y, Cummins HZ. Localized Fluid Flow Measurements with an He–Ne Laser 
Spectrometer. Applied Physics Letters 1964;4:176-8. 
107. Foreman JW, George EW, Lewis RD. Measurement of  Localised Flow Velocities 
in Gases with a Laser Doppler Flowmeter. Applied Physics Letters 1965;7:77-8. 
108. Stern MD. In vivo evaluation of microcirculation by coherent light scattering. 
Nature 1975;254:56-8. 
109. Niazi ZBM, Essex TJH, Papini R, Scott D, McLean NR, Black MJM. New laser 
doppler scanner, a valuable adjunct in burn depth assessment. Burns 1993;19:485-9. 
110. O'Reilly TJ, Spence RJ, Taylor RM, Scheulen JJ. Laser Doppler flowmetry 
evaluation of burn wound depth. The Journal of burn care & rehabilitation 1989;10:1-6. 
111. Park DH, Hwang JW, Jang KS, Han DG, Ahn KY, Baik BS. Use of laser Doppler 
flowmetry for estimation of the depth of burns. Plast Reconstr Surg 1998;101:1516-23. 
112. Heller L, Levin LS, Klitzman B. Laser Doppler flowmeter monitoring of free-tissue 
transfers: blood flow in normal and complicated cases. Plast Reconstr Surg 
2001;107:1739-45. 
113. Hellner D, Schmelzle R. Laser Doppler monitoring of free microvascular flaps in 
maxillofacial surgery. Journal of cranio-maxillo-facial surgery : official publication of the 
European Association for Cranio-Maxillo-Facial Surgery 1993;21:25-9. 
114. Jones BM, Mayou BJ. The Laser Doppler flowmeter for microvascular monitoring: 
a preliminary report. Br J Plast Surg 1982;35:147-9. 
115. Walkinshaw M, Holloway A, Bulkley A, Engrav LH. Clinical evaluation of laser 
Doppler blood flow measurements in free flaps. Ann Plast Surg 1987;18:212-7. 
116. Yuen JC, Feng Z. Monitoring free flaps using the laser Doppler flowmeter: five-
year experience. Plast Reconstr Surg 2000;105:55-61. 
117. Fox IJ, Brooker LG, Heseltine DW, Essex HE, Wood EH. A tricarbocyanine dye 
for continuous recording of dilution curves in whole blood independent of variations in 
blood oxygen saturation. Proceedings of the staff meetings Mayo Clinic 1957;32:478-84. 
118. Fox IJ, Wood EH. Applications of dilution curves recorded from the right side of 
the heart or venous circulation with the aid of a new indicator dye. Proceedings of the staff 
meetings Mayo Clinic 1957;32:541-50. 
119. Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S. The use of indocyanine 
green in the measurement of hepatic blood flow and as a test of hepatic function. Clinical 
science 1961;21:43-57. 
120. Kogure K, Choromokos E. Infrared absorption angiography. Journal of applied 
physiology 1969;26:154-7. 
121. Kogure K, David NJ, Yamanouchi U, Choromokos E. Infrared absorption 
angiography of the fundus circulation. Archives of ophthalmology 1970;83:209-14. 
122. Hochheimer BF. Angiography of the retina with indocyanine green. Archives of 
ophthalmology 1971;86:564-5. 
123. Flower RW, Hochheimer BF. Clinical infrared absorption angiography of the 
choroid. Am J Ophthalmol 1972;73:458-9. 
124. Flower RW, Hochheimer BF. A clinical technique and apparatus for simultaneous 
angiography of the separate retinal and choroidal circulations. Investigative ophthalmology 
1973;12:248-61. 
125. Owens SL. Indocyanine green angiography. The British journal of ophthalmology 
1996;80:263-6. 
126. Raabe A, Beck J, Gerlach R, Zimmermann M, Seifert V. Near-infrared indocyanine 
green video angiography: a new method for intraoperative assessment of vascular flow. 
Neurosurgery 2003;52:132-9; discussion 9. 
127. Alander JT, Kaartinen I, Laakso A, et al. A Review of Indocyanine Green 
Fluorescent Imaging in Surgery. Int J Biomed Imaging 2012;2012:26. 
160 
 
 
128. Rubben A, Eren S, Krein R, Younossi H, Bohler U, Wienert V. Infrared 
videoangiofluorography of the skin with indocyanine green--rat random cutaneous flap 
model and results in man. Microvascular research 1994;47:240-51. 
129. Holm C, Mayr M, Hofter E, Becker A, Pfeiffer UJ, Muhlbauer W. Intraoperative 
evaluation of skin-flap viability using laser-induced fluorescence of indocyanine green. Br 
J Plast Surg 2002;55:635-44. 
130. Holm C, Tegeler J, Mayr M, Becker A, Pfeiffer UJ, Muhlbauer W. Monitoring free 
flaps using laser-induced fluorescence of indocyanine green: a preliminary experience. 
Microsurgery 2002;22:278-87. 
131. Yamamoto T, Narushima M, Doi K, et al. Characteristic indocyanine green 
lymphography findings in lower extremity lymphedema: the generation of a novel 
lymphedema severity staging system using dermal backflow patterns. Plast Reconstr Surg 
2011;127:1979-86. 
132. Namikawa K, Yamazaki N. Sentinel lymph node biopsy guided by indocyanine 
green fluorescence for cutaneous melanoma. European journal of dermatology : EJD 
2011;21:184-90. 
133. Green HA, Bua D, Anderson RR, Nishioka NS. Burn depth estimation using 
indocyanine green fluorescence. Archives of dermatology 1992;128:43-9. 
134. Henschen S, Busse MW, Zisowsky S, Panning B. Determination of plasma volume 
and total blood volume using indocyanine green: a short review. J Med 1993;24:10-27. 
135. Still J, Law E, Dawson J, Bracci S, Island T, Holtz J. Evaluation of the circulation 
of reconstructive flaps using laser-induced fluorescence of indocyanine green. Ann Plast 
Surg 1999;42:266-74. 
136. Cherrick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observations 
on its physical properties, plasma decay, and hepatic extraction. J Clin Invest 1960;39:592-
600. 
137. Franklin DL, Baker DW, Rushmer RF. Pulsed Ultrasonic Transit Time Flowmeter. 
Bio-Medical Electronics, IRE Transactions on 1962;9:44-9. 
138. Drost CJ. Vessel Diameter-Independent Volume Flow Measurements Using 
Ultrasound. Proceedings of San Diego Biomedical Symposium 1978;17:299-302. 
139. Laustsen J, Pedersen EM, Terp K, et al. Validation of a new transit time ultrasound 
flowmeter in man. European journal of vascular and endovascular surgery : the official 
journal of the European Society for Vascular Surgery 1996;12:91-6. 
140. Ali RS, Garrido A, Ramakrishnan V. Stacked free hemi-DIEP flaps: a method of 
autologous breast reconstruction in a patient with midline abdominal scarring. Br J Plast 
Surg 2002;55:351-3. 
141. DellaCroce FJ, Sullivan SK, Trahan C. Stacked deep inferior epigastric perforator 
flap breast reconstruction: a review of 110 flaps in 55 cases over 3 years. Plast Reconstr 
Surg 2011;127:1093-9. 
142. Murray A, Wasiak J, Rozen WM, Ferris S, Grinsell D. Stacked abdominal flap for 
unilateral breast reconstruction. J Reconstr Microsurg 2015;31:179-86. 
143. Figus A, Fioramonti P, Ramakrishnan V. Stacked free SIEA/DIEP flap for 
unilateral breast reconstruction in a thin patient with an abdominal vertical midline scar. J 
Reconstr Microsurg 2007;23:523-5. 
144. Mayo JL, Allen RJ, Sadeghi A. Four-flap Breast Reconstruction: Bilateral Stacked 
DIEP and PAP Flaps. Plast Reconstr Surg Glob Open 2015;3:e383. 
145. Delay E, Garson S, Tousson G, Sinna R. Fat injection to the breast: technique, 
results, and indications based on 880 procedures over 10 years. Aesthetic surgery journal / 
the American Society for Aesthetic Plastic surgery 2009;29:360-76. 
146. Laporta R, Longo B, Sorotos M, Pagnoni M, Santanelli di Pompeo F. Breast 
Reconstruction with Delayed Fat-Graft-Augmented DIEP Flap in Patients with Insufficient 
Donor-Site Volume. Aesthetic plastic surgery 2015;39:339-49. 
161 
 
 
147. Harashina T, Sone K, Inoue T, Fukuzumi S, Enomoto K. Augmentation of 
circulation of pedicled transverse rectus abdominis musculocutaneous flaps by 
microvascular surgery. Br J Plast Surg 1987;40:367-70. 
148. Marck KW, van der Biezen JJ, Dol JA. Internal mammary artery and vein 
supercharge in TRAM flap breast reconstruction. Microsurgery 1996;17:371-4. 
149. Pennington DG, Nettle WJ, Lam P. Microvascular augmentation of the blood 
supply of the contralateral side of the free transverse rectus abdominis musculocutaneous 
flap. Ann Plast Surg 1993;31:123-6; discussion 6-7. 
150. Yanaga H, Tai Y, Kiyokawa K, Inoue Y, Rikimaru H. An ipsilateral 
superdrainaged transverse rectus abdominis myocutaneous flap for breast reconstruction. 
Plast Reconstr Surg 1999;103:465-72. 
151. Arnez ZM, Scamp T. The bipedicled free TRAM flap. Br J Plast Surg 1992;45:214-
8. 
152. Li S, Mu L, Li Y, et al. Breast reconstruction with the free bipedicled inferior 
TRAM flap by anastomosis to the proximal and distal ends of the internal mammary 
vessels. J Reconstr Microsurg 2002;18:161-8. 
153. Mu L, Xu J, Liu Y, et al. Breast Reconstruction with Free Bipedicled TRAM or 
DIEP Flaps by Anastamosis to the Proximal and Distal Ends of the Internal Mammary 
Vessels. Seminars in Plastic Surgery 2002;16:061-8. 
154. Hamdi M, Khuthaila DK, Van Landuyt K, Roche N, Monstrey S. Double-pedicle 
abdominal perforator free flaps for unilateral breast reconstruction: new horizons in 
microsurgical tissue transfer to the breast. J Plast Reconstr Aesthet Surg 2007;60:904-12; 
discussion 13-4. 
155. Koolen PG, Lee BT, Lin SJ, Erhard HA, Greenspun DT. Bipedicle-conjoined 
perforator flaps in breast reconstruction. The Journal of surgical research 2015;197:256-64. 
156. Mohan AT, Patel NG, Malata CM. Combination of the superior and inferior pedicle 
"continuities" for anastomosis of an SIEA flap to a contralateral DIEP flap in double-
pedicled abdominal free flaps: A further modification of the Hamdi classification. J Plast 
Reconstr Aesthet Surg 2014;67:e237-9. 
157. O'Neill AC, Ngan NC, Platt J, Mahomed A, Zhong T, Hofer SO. A decision-
making algorithm for recipient vein selection in bipedicle deep inferior epigastric artery 
perforator flap autologous breast reconstruction. J Plast Reconstr Aesthet Surg 
2014;67:1089-93. 
158. Rabey NG, Erel E, Malata CM. Double-pedicled abdominal free flap using an 
entirely new microvascular combination of DIEP and SIEA vascular pedicles for unilateral 
breast reconstruction: a novel addition to the Hamdi classification. Plast Reconstr Surg 
2012;130:767e-9e. 
159. Salgarello M, Barone-Adesi L, Sturla M, Masetti R, Mu L. Needing a large DIEAP 
flap for unilateral breast reconstruction: double-pedicle flap and unipedicle flap with 
additional venous discharge. Microsurgery 2010;30:111-7. 
160. Xu H, Dong J, Wang T. Bipedicle deep inferior epigastric perforator flap for 
unilateral breast reconstruction: seven years' experience. Plast Reconstr Surg 
2009;124:1797-807. 
161. Tseng CY, Lang PO, Cipriani NA, Song DH. Pedicle Preservation Technique for 
Arterial and Venous Turbocharging of Free DIEP and Muscle-Sparing TRAM Flaps. Plast 
Reconstr Surg 2007;120:851-4. 
162. Chang H, Nobuaki I, Minabe T, Nakajima H. Comparison of three different 
supercharging procedures in a rat skin flap model. Plast Reconstr Surg 2004;113:277-83. 
163. Hallock GG, Rice DC. Efficacy of venous supercharging of the deep inferior 
epigastric perforator flap in a rat model. Plast Reconstr Surg 2005;116:551-5; discussion 6. 
164. Miles DA, Crosby NL, Clapson JB. The role of the venous system in the abdominal 
flap of the rat. Plast Reconstr Surg 1997;99:2030-3. 
162 
 
 
165. Nakayama Y, Soeda S, Kasai Y. The importance of arterial inflow in the distal side 
of a flap: an experimental investigation. Plast Reconstr Surg 1982;69:61-7. 
166. Ueda K, Harashina T, Oba S, Nagasaka S. Which vessel is more important in the 
supercharged flap--artery, vein, or both? An experimental study. J Reconstr Microsurg 
1994;10:153-5. 
167. Yamamoto Y, Sakurai H, Nakazawa H, Nozaki M. Effect of vascular augmentation 
on the haemodynamics and survival area in a rat abdominal perforator flap model. J Plast 
Reconstr Aesthet Surg 2009;62:244-9. 
168. Douglas HE, Wilkinson MJ, Mackay IR. Effects of perforator number and location 
on the total pedicle flow and perfusion of zone IV skin and fat of DIEP flaps. J Plast 
Reconstr Aesthet Surg 2014;67:212-8. 
169. Cano SJ, Klassen A, Pusic AL. The science behind quality-of-life measurement: a 
primer for plastic surgeons. Plast Reconstr Surg 2009;123:98e-106e. 
170. Pusic AL, Lemaine V, Klassen AF, Scott AM, Cano SJ. Patient-reported outcome 
measures in plastic surgery: use and interpretation in evidence-based medicine. Plast 
Reconstr Surg 2011;127:1361-7. 
171. Ching S, Thoma A, McCabe RE, Antony MM. Measuring Outcomes in Aesthetic 
Surgery: A Comprehensive Review of the Literature. Plast Reconstr Surg 2003;111:469-
80. 
172. Pusic AL, Chen CM, Cano S, et al. Measuring quality of life in cosmetic and 
reconstructive breast surgery: a systematic review of patient-reported outcomes 
instruments. Plast Reconstr Surg 2007;120:823-37; discussion 38-9. 
173. Potter S, Thomson HJ, Greenwood RJ, Hopwood P, Winters ZE. Health-related 
quality of life assessment after breast reconstruction. The British journal of surgery 
2009;96:613-20. 
174. Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of 
a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast 
Reconstr Surg 2009;124:345-53. 
175. Cano SJ, Klassen AF, Scott AM, Cordeiro PG, Pusic AL. The BREAST-Q: further 
validation in independent clinical samples. Plast Reconstr Surg 2012;129:293-302. 
176. Damen THC, Timman R, Kunst EH, et al. High satisfaction rates in women after 
DIEP flap breast reconstruction. J Plast Reconstr Aesthet Surg 2010;63:93-100. 
177. Andrade WN, Baxter N, Semple JL. Clinical determinants of patient satisfaction 
with breast reconstruction. Plast Reconstr Surg 2001;107:46-54. 
178. Fogarty BJ, Brown AP, Miller R, Khan K. TRAM flap versus nonautologous breast 
reconstruction: what do patients really think? Plast Reconstr Surg 2004;113:1146-52. 
179. Spear SL, Newman MK, Bedford MS, Schwartz KA, Cohen M, Schwartz JS. A 
retrospective analysis of outcomes using three common methods for immediate breast 
reconstruction. Plast Reconstr Surg 2008;122:340-7. 
180. Tønseth KA, Hokland BM, Tindholdt TT, Åbyholm FE, Stavem K. Quality of life, 
patient satisfaction and cosmetic outcome after breast reconstruction using DIEP flap or 
expandable breast implant. J Plast Reconstr Aesthet Surg 2008;61:1188-94. 
181. Cocquyt VF, Blondeel PN, Depypere HT, et al. Better cosmetic results and 
comparable quality of life after skin-sparing mastectomy and immediate autologous breast 
reconstruction compared to breast conservative treatment. Br J Plast Surg 2003;56:462-70. 
182. Metcalfe KA, Semple JL, Narod SA. Satisfaction with breast reconstruction in 
women with bilateral prophylactic mastectomy: a descriptive study. Plast Reconstr Surg 
2004;114:360-6. 
183. Hunt GR, Hall GM, Murthy BV, et al. Early discharge following hip arthroplasty: 
patients' acceptance masks doubts and concerns. Health expectations : an international 
journal of public participation in health care and health policy 2009;12:130-7. 
184. Williams B. Patient satisfaction: a valid concept? Social science & medicine (1982) 
1994;38:509-16. 
163 
 
 
185. Williams B, Coyle J, Healy D. The meaning of patient satisfaction: an explanation 
of high reported levels. Social science & medicine (1982) 1998;47:1351-9. 
186. Beesley H, Ullmer H, Holcombe C, Salmon P. How patients evaluate breast 
reconstruction after mastectomy, and why their evaluation often differs from that of their 
clinicians. J Plast Reconstr Aesthet Surg 2012;65:1064-71. 
187. Gui GP, Kadayaprath G, Tan SM, et al. Evaluation of outcome after immediate 
breast reconstruction: prospective comparison of four methods. Plast Reconstr Surg 
2005;115:1916-26. 
188. Asplund O, Nilsson B. Interobserver variation and cosmetic result of submuscular 
breast reconstruction. Scand J Plast Reconstr Surg 1984;18:215-20. 
189. Cardoso MJ, Cardoso J, Santos AC, Barros H, Cardoso de Oliveira M. 
Interobserver agreement and consensus over the esthetic evaluation of conservative 
treatment for breast cancer. Breast 2006;15:52-7. 
190. Charfare H, MacLatchie E, Cordier C, et al. A comparison of different methods of 
assessing cosmetic outcome following breast- conserving surgery and factors influencing 
cosmetic outcome. Br J Med Pract 2010;3:310-5. 
191. Edsander-Nord A, Brandberg Y, Wickman M. Quality of life, patients' satisfaction, 
and aesthetic outcome after pedicled or free TRAM flap breast surgery. Plast Reconstr 
Surg 2001;107:1142-53. 
192. Gahm J, Jurell G, Edsander-Nord A, Wickman M. Patient satisfaction with 
aesthetic outcome after bilateral prophylactic mastectomy and immediate reconstruction 
with implants. J Plast Reconstr Aesthet Surg 2010;63:332-8. 
193. Gui GP, Tan SM, Faliakou EC, Choy C, A'Hern R, Ward A. Immediate breast 
reconstruction using biodimensional anatomical permanent expander implants: a 
prospective analysis of outcome and patient satisfaction. Plast Reconstr Surg 
2003;111:125-38. 
194. Harris JR, Levene MB, Svensson G, Hellman S. Analysis of cosmetic results 
following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat 
Oncol Biol Phys 1979;5:257-61. 
195. Mosahebi A, Ramakrishnan V, Gittos M, Collier J. Aesthetic outcome of different 
techniques of reconstruction following nipple-areola-preserving envelope mastectomy with 
immediate reconstruction. Plast Reconstr Surg 2007;119:796-803. 
196. Sacchini V, Luini A, Tana S, et al. Quantitative and qualitative cosmetic evaluation 
after conservative treatment for breast cancer. Eur J Cancer 1991;27:1395-400. 
197. Potter S, Harcourt D, Cawthorn S, et al. Assessment of cosmesis after breast 
reconstruction surgery: a systematic review. Ann Surg Oncol 2011;18:813-23. 
198. Cardoso MJ, Cardoso J, Amaral N, et al. Turning subjective into objective: the 
BCCT.core software for evaluation of cosmetic results in breast cancer conservative 
treatment. Breast 2007;16:456-61. 
199. Heil J, Dahlkamp J, Golatta M, et al. Aesthetics in breast conserving therapy: do 
objectively measured results match patients' evaluations? Ann Surg Oncol 2011;18:134-8. 
200. Henseler H, Smith J, Bowman A, et al. Subjective versus objective assessment of 
breast reconstruction. J Plast Reconstr Aesthet Surg 2013;66:634-9. 
201. Fitzal F, Krois W, Trischler H, et al. The use of a breast symmetry index for 
objective evaluation of breast cosmesis. Breast 2007;16:429-35. 
202. Henseler H, Khambay BS, Bowman A, et al. Investigation into accuracy and 
reproducibility of a 3D breast imaging system using multiple stereo cameras. J Plast 
Reconstr Aesthet Surg 2011;64:577-82. 
203. Henseler H, Smith J, Bowman A, et al. Objective evaluation of the latissimus dorsi 
flap for breast reconstruction using three-dimensional imaging. J Plast Reconstr Aesthet 
Surg 2012;65:1209-15. 
204. G vB. Statistical rules of thumb. New York: John Wiley and Sons, Inc; 2002. 
164 
 
 
205. Julious SA. Sample size of 12 per group rule of thumb for a pilot study. 
Pharmaceutical Statistics 2005;4:287-91. 
206. Moore CG, Carter RE, Nietert PJ, Stewart PW. Recommendations for Planning 
Pilot Studies in Clinical and Translational Research. Clinical and Translational Science 
2011;4:332-7. 
207. RANDOM.ORG. 2010. (Accessed at https://www.random.org/.) 
208. Bircher A, de Boer EM, Agner T, Wahlberg JE, Serup J. Guidelines for 
measurement of cutaneous blood flow by laser Doppler flowmetry. A report from the 
Standardization Group of the European Society of Contact Dermatitis. Contact dermatitis 
1994;30:65-72. 
209. Fullerton A, Stucker M, Wilhelm KP, et al. Guidelines for visualization of 
cutaneous blood flow by laser Doppler perfusion imaging. A report from the 
Standardization Group of the European Society of Contact Dermatitis based upon the 
HIRELADO European community project. Contact dermatitis 2002;46:129-40. 
210. Pestana IA, Coan B, Erdmann D, Marcus J, Levin LS, Zenn MR. Early experience 
with fluorescent angiography in free-tissue transfer reconstruction. Plast Reconstr Surg 
2009;123:1239-44. 
211. Tollan CJ, Maclaren WM, Mackay IR. Determining reactive hyperaemia time in 
deep inferior epigastric perforators after temporary occlusion to allow the intraoperative 
comparison of vascular territories. J Plast Reconstr Aesthet Surg 2012;65:e161-2. 
212. Tollan CJ. Investigation of factors controlling cutaneous circulation in flaps.: 
University of Glasgow; 2012. 
213. Experimental design/statistics. (Accessed at http://www.nc3rs.org.uk/experimental-
designstatistics.) 
214. Oksar HS, Coskunfrat OK, Özgentas HE. Perforator-Based Flap in Rats: A New 
Experimental Model. Plast Reconstr Surg 2001;108:125-31. 
215. Stanton AL, Krishnan L, Collins CA. Form or function? Part 1. Subjective cosmetic 
and functional correlates of quality of life in women treated with breast-conserving 
surgical procedures and radiotherapy. Cancer 2001;91:2273-81. 
216. Gilmour A, Mackay IR, Young D, Hill ME, Brown L, Malyon AD. The use of real-
time digital video in the assessment of post-operative outcomes of breast reconstruction. J 
Plast Reconstr Aesthet Surg 2014;67:1357-63. 
217. Schmidt RC. Managing Delphi Surveys Using Nonparametric Statistical 
Techniques*. Decision Sciences 1997;28:763-74. 
218. Hardy KL, Davis KE, Constantine RS, et al. The impact of operative time on 
complications after plastic surgery: a multivariate regression analysis of 1753 cases. 
Aesthetic surgery journal / the American Society for Aesthetic Plastic surgery 
2014;34:614-22. 
219. Bailey SH, Saint-Cyr M, Wong C, et al. The single dominant medial row perforator 
DIEP flap in breast reconstruction: three-dimensional perforasome and clinical results. 
Plast Reconstr Surg 2010;126:739-51. 
220. Wong C, Saint-Cyr M, Mojallal A, et al. Perforasomes of the DIEP flap: vascular 
anatomy of the lateral versus medial row perforators and clinical implications. Plast 
Reconstr Surg 2010;125:772-82. 
221. Baumann DP, Lin HY, Chevray PM. Perforator number predicts fat necrosis in a 
prospective analysis of breast reconstruction with free TRAM, DIEP, and SIEA flaps. Plast 
Reconstr Surg 2010;125:1335-41. 
222. Bozikov K, Arnez T, Hertl K, Arnez ZM. Fat necrosis in free DIEAP flaps: 
incidence, risk, and predictor factors. Ann Plast Surg 2009;63:138-42. 
223. Lee BT, Chen C, Nguyen MD, Lin SJ, Tobias AM. A new classification system for 
muscle and nerve preservation in DIEP flap breast reconstruction. Microsurgery 
2010;30:85-90. 
165 
 
 
224. Figus A, Mosahebi A, Ramakrishnan V. Microcirculation in DIEP flaps: a study of 
the haemodynamics using laser Doppler flowmetry and lightguide reflectance 
spectrophotometry. J Plast Reconstr Aesthet Surg 2006;59:604-12; discussion 13. 
225. Vandevoort M, Vranckx JJ, Fabre G. Perforator topography of the deep inferior 
epigastric perforator flap in 100 cases of breast reconstruction. Plast Reconstr Surg 
2002;109:1912-8. 
226. Douglas HE. Perforating blood vessel selection in deep inferior epigastric artery 
perforator flaps.: University of Glasgow; 2014. 
227. Figus A, Mosahebi A, Ramakrishnan V. Microcirculation in DIEP flaps: a study of 
the haemodynamics using laser Doppler flowmetry and lightguide reflectance 
spectrophotometry. Journal of Plastic, Reconstructive & Aesthetic Surgery 2006;59:604-
12. 
228. Centre TNI. National Mastectomy and Breast Reconstruction Audit; 2011. 
229. Ozkan O, Koshima I, Gonda K. A supermicrosurgical flap model in the rat: a free 
true abdominal perforator flap with a short pedicle. Plast Reconstr Surg 2006;117:479-85. 
230. Hallock GG, Rice DC. Physiologic Superiority of the Anatomic Dominant Pedicle 
of the TRAM Flap in a Rat Model. Plast Reconstr Surg 1995;96:111-8. 
231. Taylor GI, Minabe T. The Angiosomes of the Mammals and Other Vertebrates. 
Plast Reconstr Surg 1992;89:181-215. 
232. Marks NJ. Quantitative analysis of skin flap blood flow in the rat using laser 
Doppler velocimetry. Journal of the Royal Society of Medicine 1985;78:308-14. 
233. Patel S, Knapp CF, Donofrio JC, Salcido R. Temperature effects on surface 
pressure-induced changes in rat skin perfusion: implications in pressure ulcer development. 
Journal of rehabilitation research and development 1999;36:189-201. 
234. Rickard RF, Wilson J, Hudson DA. Characterization of a rodent model for the 
study of arterial microanastomoses with size discrepancy (small-to-large). Laboratory 
Animals 2009;43:350-6. 
235. Zhang F, Lineaweaver WC, Kao S, et al. Microvascular transfer of the rectus 
abdominis muscle and myocutaneous flap in rats. Microsurgery 1993;14:420-3. 
236. Sprague Dawley® Outbred Rat. (Accessed at 
http://www.harlan.com/products_and_services/research_models_and_services/research_m
odels/sprague_dawley_outbred_rat.hl.) 
237. Siegel S, Castellan NJ. Nonparametric Statistics for The Behavioral Sciences. 2nd 
ed. New York: McGraw-Hill; 1988. 
238. Cancer Incidence in the UK in 2011. (Accessed at 
http://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/common-
cancers-compared#ref-2.) 
239. Oncoplastic Breast Surgery - A guide to good clinical practice. 2012. (Accessed at 
http://www.associationofbreastsurgery.org.uk/media/4525/oncoplastic_breast_surgery_-
_a_guide_to_good_practice.pdf.) 
240. Hussien M, Salah B, Malyon A, Wieler-Mithoff EM. The effect of radiotherapy on 
the use of immediate breast reconstruction. Eur J Surg Oncol 2004;30:490-4. 
241. Yule GJ, Concannon MJ, Croll G, Puckett CL. Is there liability with chemotherapy 
following immediate breast construction? Plast Reconstr Surg 1996;97:969-73. 
242. Malata CM, McIntosh SA, Purushotham AD. Immediate breast reconstruction after 
mastectomy for cancer. The British journal of surgery 2000;87:1455-72. 
243. Noone RB, Frazier TG, Noone GC, Blanchet NP, Murphy JB, Rose D. Recurrence 
of breast carcinoma following immediate reconstruction: a 13-year review. Plast Reconstr 
Surg 1994;93:96-106; discussion 7-8. 
244. Petit JY, Le MG, Mouriesse H, et al. Can breast reconstruction with gel-filled 
silicone implants increase the risk of death and second primary cancer in patients treated 
by mastectomy for breast cancer? Plast Reconstr Surg 1994;94:115-9. 
166 
 
 
245. Atherton DD, Hills AJ, Moradi P, Muirhead N, Wood SH. The economic viability 
of breast reconstruction in the UK: Comparison of a single surgeon’s experience of 
implant; LD; TRAM and DIEP based reconstructions in 274 patients. J Plast Reconstr 
Aesthet Surg 2011;64:710-5. 
246. Damen THC, Wei W, Mureau MAM, et al. Medium-term cost analysis of breast 
reconstructions in a single Dutch centre: A comparison of implants, implants preceded by 
tissue expansion, LD transpositions and DIEP flaps. J Plast Reconstr Aesthet Surg 
2011;64:1043-53. 
 
 
